
<html lang="en"     class="pb-page"  data-request-id="98ac71ac-cdb9-40de-9315-a5744154c861"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm100732t;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2010.53.issue-24"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="A Novel Pyrazolo[1,5-a]pyrimidine Is a Potent Inhibitor of Cyclin-Dependent Protein Kinases 1, 2, and 9, Which Demonstrates Antitumor Effects in Human Tumor Xenografts Following Oral Administration" /></meta><meta name="dc.Creator" content="Dean A.  Heathcote" /></meta><meta name="dc.Creator" content="Hetal  Patel" /></meta><meta name="dc.Creator" content="Sebastian H. B.  Kroll" /></meta><meta name="dc.Creator" content="Pascale  Hazel" /></meta><meta name="dc.Creator" content="Manikandan  Periyasamy" /></meta><meta name="dc.Creator" content="Mary  Alikian" /></meta><meta name="dc.Creator" content="Seshu K.  Kanneganti" /></meta><meta name="dc.Creator" content="Ashutosh S.  Jogalekar" /></meta><meta name="dc.Creator" content="Bodo  Scheiper" /></meta><meta name="dc.Creator" content="Marion  Barbazanges" /></meta><meta name="dc.Creator" content="Andreas  Blum" /></meta><meta name="dc.Creator" content="Jan  Brackow" /></meta><meta name="dc.Creator" content="Alekasandra  Siwicka" /></meta><meta name="dc.Creator" content="Robert D. M.  Pace" /></meta><meta name="dc.Creator" content="Matthew J.  Fuchter" /></meta><meta name="dc.Creator" content="James P.  Snyder" /></meta><meta name="dc.Creator" content="Dennis C.  Liotta" /></meta><meta name="dc.Creator" content="Paul. S.  Freemont" /></meta><meta name="dc.Creator" content="Eric O.  Aboagye" /></meta><meta name="dc.Creator" content="R. Charles  Coombes" /></meta><meta name="dc.Creator" content="Anthony G. M.  Barrett" /></meta><meta name="dc.Creator" content="Simak  Ali" /></meta><meta name="dc.Description" content="Cyclin-dependent protein kinases (CDKs) are central to the appropriate regulation of cell proliferation, apoptosis, and gene expression. Abnormalities in CDK activity and regulation are common feat..." /></meta><meta name="Description" content="Cyclin-dependent protein kinases (CDKs) are central to the appropriate regulation of cell proliferation, apoptosis, and gene expression. Abnormalities in CDK activity and regulation are common feat..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 16, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm100732t" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm100732t" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm100732t" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm100732t" /></link>
        
    
    

<title>A Novel Pyrazolo[1,5-a]pyrimidine Is a Potent Inhibitor of Cyclin-Dependent Protein Kinases 1, 2, and 9, Which Demonstrates Antitumor Effects in Human Tumor Xenografts Following Oral Administration | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm100732t" /></meta><meta property="og:title" content="A Novel Pyrazolo[1,5-a]pyrimidine Is a Potent Inhibitor of Cyclin-Dependent Protein Kinases 1, 2, and 9, Which Demonstrates Antitumor Effects in Human Tumor Xenografts Following Oral Administration" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0009.jpeg" /></meta><meta property="og:description" content="Cyclin-dependent protein kinases (CDKs) are central to the appropriate regulation of cell proliferation, apoptosis, and gene expression. Abnormalities in CDK activity and regulation are common features of cancer, making CDK family members attractive targets for the development of anticancer drugs. Here, we report the identification of a pyrazolo[1,5-a]pyrimidine derived compound, 4k (BS-194), as a selective and potent CDK inhibitor, which inhibits CDK2, CDK1, CDK5, CDK7, and CDK9 (IC50 = 3, 30, 30, 250, and 90 nmol/L, respectively). Cell-based studies showed inhibition of the phosphorylation of CDK substrates, Rb and the RNA polymerase II C-terminal domain, down-regulation of cyclins A, E, and D1, and cell cycle block in the S and G2/M phases. Consistent with these findings, 4k demonstrated potent antiproliferative activity in 60 cancer cell lines tested (mean GI50 = 280 nmol/L). Pharmacokinetic studies showed that 4k is orally bioavailable, with an elimination half-life of 178 min following oral dosing in mice. When administered at a concentration of 25 mg/kg orally, 4k inhibited human tumor xenografts and suppressed CDK substrate phosphorylation. These findings identify 4k as a novel, potent CDK selective inhibitor with potential for oral delivery in cancer patients." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm100732t"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm100732t">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm100732t&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm100732t&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm100732t&amp;href=/doi/10.1021/jm100732t" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 8508-8522</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm100608j" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm100531u" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">A Novel Pyrazolo[1,5-<i>a</i>]pyrimidine Is a Potent Inhibitor of Cyclin-Dependent Protein Kinases 1, 2, and 9, Which Demonstrates Antitumor Effects in Human Tumor Xenografts Following Oral Administration</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dean+A.++Heathcote">Dean A. Heathcote</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hetal++Patel">Hetal Patel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sebastian+H.+B.++Kroll">Sebastian H. B. Kroll</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pascale++Hazel">Pascale Hazel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Manikandan++Periyasamy">Manikandan Periyasamy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary++Alikian">Mary Alikian</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Seshu+K.++Kanneganti">Seshu K. Kanneganti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ashutosh+S.++Jogalekar">Ashutosh S. Jogalekar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bodo++Scheiper">Bodo Scheiper</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marion++Barbazanges">Marion Barbazanges</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andreas++Blum">Andreas Blum</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jan++Brackow">Jan Brackow</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alekasandra++Siwicka">Alekasandra Siwicka</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+D.+M.++Pace">Robert D. M. Pace</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+J.++Fuchter">Matthew J. Fuchter</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+P.++Snyder">James P. Snyder</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dennis+C.++Liotta">Dennis C. Liotta</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul.+S.++Freemont">Paul. S. Freemont</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric+O.++Aboagye">Eric O. Aboagye</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=R.+Charles++Coombes">R. Charles Coombes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anthony+G.+M.++Barrett">Anthony G. M. Barrett</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simak++Ali">Simak Ali</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Dept of Oncology, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, England</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Chemistry, Imperial College London, London SW7 2AZ, England</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Division of Molecular Biosciences, Imperial College London, London SW7 2AZ, England</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Department of Chemistry, Emory University, Atlanta GA30322, United States</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +44 20 8383 3789. Fax: +44 20 8383 5830. E-mail: <a href="/cdn-cgi/l/email-protection#25564c48444e0b44494c654c485540574c44490b44460b504e"><span class="__cf_email__" data-cfemail="c8bba1a5a9a3e6a9a4a188a1a5b8adbaa1a9a4e6a9abe6bda3">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm100732t&amp;href=/doi/10.1021%2Fjm100732t" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 8508–8522</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 16, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 June 2010</li><li><span class="item_label"><b>Published</b> online</span>16 November 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 December 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm100732t" title="DOI URL">https://doi.org/10.1021/jm100732t</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8508%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDean%2BA.%2BHeathcote%252C%2BHetal%2BPatel%252C%2BSebastian%2BH.%2BB.%2BKroll%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D24%26contentID%3Djm100732t%26title%3DA%2BNovel%2BPyrazolo%255B1%252C5-a%255Dpyrimidine%2BIs%2Ba%2BPotent%2BInhibitor%2Bof%2BCyclin-Dependent%2BProtein%2BKinases%2B1%252C%2B2%252C%2Band%2B9%252C%2BWhich%2BDemonstrates%2BAntitumor%2BEffects%2Bin%2BHuman%2BTumor%2BXenografts%2BFollowing%2BOral%2BAdministration%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8522%26publicationDate%3DDecember%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm100732t"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4467</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">51</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm100732t" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;A Novel Pyrazolo[1,5-a]pyrimidine Is a Potent Inhibitor of Cyclin-Dependent Protein Kinases 1, 2, and 9, Which Demonstrates Antitumor Effects in Human Tumor Xenografts Following Oral Administration&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Dean&quot;,&quot;last_name&quot;:&quot;A. Heathcote&quot;},{&quot;first_name&quot;:&quot;Hetal&quot;,&quot;last_name&quot;:&quot;Patel&quot;},{&quot;first_name&quot;:&quot;Sebastian&quot;,&quot;last_name&quot;:&quot;H. B. Kroll&quot;},{&quot;first_name&quot;:&quot;Pascale&quot;,&quot;last_name&quot;:&quot;Hazel&quot;},{&quot;first_name&quot;:&quot;Manikandan&quot;,&quot;last_name&quot;:&quot;Periyasamy&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;Alikian&quot;},{&quot;first_name&quot;:&quot;Seshu&quot;,&quot;last_name&quot;:&quot;K. Kanneganti&quot;},{&quot;first_name&quot;:&quot;Ashutosh&quot;,&quot;last_name&quot;:&quot;S. Jogalekar&quot;},{&quot;first_name&quot;:&quot;Bodo&quot;,&quot;last_name&quot;:&quot;Scheiper&quot;},{&quot;first_name&quot;:&quot;Marion&quot;,&quot;last_name&quot;:&quot;Barbazanges&quot;},{&quot;first_name&quot;:&quot;Andreas&quot;,&quot;last_name&quot;:&quot;Blum&quot;},{&quot;first_name&quot;:&quot;Jan&quot;,&quot;last_name&quot;:&quot;Brackow&quot;},{&quot;first_name&quot;:&quot;Alekasandra&quot;,&quot;last_name&quot;:&quot;Siwicka&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;D. M. Pace&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;J. Fuchter&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;P. Snyder&quot;},{&quot;first_name&quot;:&quot;Dennis&quot;,&quot;last_name&quot;:&quot;C. Liotta&quot;},{&quot;first_name&quot;:&quot;Paul.&quot;,&quot;last_name&quot;:&quot;S. Freemont&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;O. Aboagye&quot;},{&quot;first_name&quot;:&quot;R.&quot;,&quot;last_name&quot;:&quot;Charles Coombes&quot;},{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;G. M. Barrett&quot;},{&quot;first_name&quot;:&quot;Simak&quot;,&quot;last_name&quot;:&quot;Ali&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;8508-8522&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm100732t&quot;},&quot;abstract&quot;:&quot;Cyclin-dependent protein kinases (CDKs) are central to the appropriate regulation of cell proliferation, apoptosis, and gene expression. Abnormalities in CDK activity and regulation are common features of cancer, making CDK family members attractive targets for the development of anticancer drugs. Here, we report the identification of a pyrazolo[1,5-a]pyrimidine derived compound, 4k (BS-194), as a selective and potent CDK inhibitor, which inhibits CDK2, CDK1, CDK5, CDK7, and CDK9 (IC50 = 3, 30, 30, 250, and 90 nmol/L, respectively). Cell-based studies showed inhibition of the phosphorylation of CDK substrates, Rb and the RNA polymerase II C-terminal domain, down-regulation of cyclins A, E, and D1, and cell cycle block in the S and G2/M phases. Consistent with these findings, 4k demonstrated potent antiproliferative activity in 60 cancer cell lines tested (mean GI50 = 280 nmol/L). Pharmacokinetic studies showed that 4k is orally bioavailable, with an elimination half-life of 178 min following oral dosing in mi&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100732t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100732t" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100732t&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100732t" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100732t&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100732t" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm100732t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100732t&amp;href=/doi/10.1021/jm100732t" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm100732t" /></input><a href="/doi/pdf/10.1021/jm100732t" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm100732t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm100732t%26sid%3Dliteratum%253Aachs%26pmid%3D21080703%26genre%3Darticle%26aulast%3DHeathcote%26date%3D2010%26atitle%3DA%2BNovel%2BPyrazolo%255B1%252C5-a%255Dpyrimidine%2BIs%2Ba%2BPotent%2BInhibitor%2Bof%2BCyclin-Dependent%2BProtein%2BKinases%2B1%252C%2B2%252C%2Band%2B9%252C%2BWhich%2BDemonstrates%2BAntitumor%2BEffects%2Bin%2BHuman%2BTumor%2BXenografts%2BFollowing%2BOral%2BAdministration%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D24%26spage%3D8508%26epage%3D8522%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290969" title="Cell and molecular biology">Cell and molecular biology</a>,</li><li><a href="/action/doSearch?ConceptID=290682" title="Post-translational modification">Post-translational modification</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jmcmar.2010.53.issue-24/production/jmcmar.2010.53.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/medium/jm-2010-00732t_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100732t&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Cyclin-dependent protein kinases (CDKs) are central to the appropriate regulation of cell proliferation, apoptosis, and gene expression. Abnormalities in CDK activity and regulation are common features of cancer, making CDK family members attractive targets for the development of anticancer drugs. Here, we report the identification of a pyrazolo[1,5<i>-a</i>]pyrimidine derived compound, <b>4k</b> (BS-194), as a selective and potent CDK inhibitor, which inhibits CDK2, CDK1, CDK5, CDK7, and CDK9 (IC<sub>50</sub> = 3, 30, 30, 250, and 90 nmol/L, respectively). Cell-based studies showed inhibition of the phosphorylation of CDK substrates, Rb and the RNA polymerase II C-terminal domain, down-regulation of cyclins A, E, and D1, and cell cycle block in the S and G<sub>2</sub>/M phases. Consistent with these findings, <b>4k</b> demonstrated potent antiproliferative activity in 60 cancer cell lines tested (mean GI<sub>50</sub> = 280 nmol/L). Pharmacokinetic studies showed that <b>4k</b> is orally bioavailable, with an elimination half-life of 178 min following oral dosing in mice. When administered at a concentration of 25 mg/kg orally, <b>4k</b> inhibited human tumor xenografts and suppressed CDK substrate phosphorylation. These findings identify <b>4k</b> as a novel, potent CDK selective inhibitor with potential for oral delivery in cancer patients.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13701" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13701" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cyclin-dependent kinases (CDK<a class="ref internalNav" href="#fn1" aria-label="a">a</a><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: CDK, cyclin dependent kinase; Rb, retinoblastoma; PolII, RNA polymerase II; CKI, CDK inhibitory protein; HUVEC, human normal vascular endothelial cells; PBMC, peripheral blood mononuclear cells; SRB, sulforhodamine B; FACS, fluorescence-activated cell sorter, ADME-Tox, absorption, distribution, metabolism, excretion, and toxicity; PO, per oral, IV, intravenous; IP, intraperitoneal.</p></div>) are serine/threonine kinases that regulate progression through the cell cycle. CDK4 and CDK6 mediate progression through the G<sub>1</sub> growth phase, CDK2 is required for entry into and transition through the DNA replication or synthesis (S) phase, and CDK1 controls progression through G<sub>2</sub> and mitosis. CDK7, together with its partners cyclin H and MAT1, form the CDK activating kinase (CAK), which activates the cell cycle CDKs by phosphorylating them at a threonine residue in the activation segment (T-loop).<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a></div><div class="NLM_p">Deregulation of cell cycle progression is a universal characteristic of cancer, and the majority of human cancers have abnormalities in some component of CDK activity, frequently through elevated and/or inappropriate CDK activation. Examples include cyclin overexpression, for example, cyclin D1 overexpression is commonly observed in breast cancer,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and loss of expression of CDK inhibitory proteins (CKI) through mutational or epigenetic alterations, for example, p16 loss has been observed in skin, lung, breast, and colorectal cancer (for review see ref <a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">5</a>). Synthetic inhibitors of CDK activity therefore present as a logical approach in the development of new cancer therapies. However, the development of inhibitors selective for a particular CDK has been questioned by the finding that inhibition of some CDKs may lead to compensation by other CDKs. For example, cells from mice that have been ablated for CDK2 are able to cycle, and CDK2<sup>−/−</sup> mice are viable,<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> while evidence for compensation of CDK2 by CDK1 has been forthcoming.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> Similarly, CDK4<sup>−/−</sup> and CDK6<sup>−/−</sup> mice are viable, although the double null mice show late embryonic lethality.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10-12)</a> Hence, a highly selective inhibitor of CDK2, 4, or 6 may be subject to clinical resistance due to the potential for compensation. However, acquisition of CDK dependence seems to feature in some tumor types. For example, despite the fact that CDK4 is not required for normal mammary gland development, it does appear to be important for induction of mammary tumors in mouse models.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a> The CDK4/CDK6 partner cyclin D1 is similarly required for HER2- and Ras-induced mammary tumors, but not for Myc and Wnt1 induced mammary tumors,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> indicating that, at least in some tumor types, requirement for selective CDKs is acquired during the process of tumorigenesis in a process that is dependent on the pathway leading to tumor formation.<a onclick="showRef(event, 'ref3 ref17'); return false;" href="javascript:void(0);" class="ref ref3 ref17">(3, 17)</a></div><div class="NLM_p">We reasoned that inhibitors of CDK7 could be potentially important in cancer therapy, as they would inhibit activation of many of the cyclin-dependent kinases involved in cell cycle progression. Moreover, as part of the TFIIH general transcription factor complex, CDK7/CycH/MAT1 mediates the phosphorylation of the C-terminal domain of the largest subunit of RNA polymerase II, an event required for promoter clearance and transcription initiation.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18-20)</a> In carrying out a screen for CDK7 inhibitors, we identified a compound, <b>4k</b>, which inhibits CDK7 but is also a potent inhibitor of CDK1, CDK2, CDK5, and CDK9. In further evaluating the activity of <b>4k</b>, we show that <b>4k</b> potently inhibits growth of the great majority of cancer cell lines examined and inhibits phosphorylation of CDK substrates at submicromolar concentrations. A number of inhibitors that target cell cycle CDKs have been identified and some have been evaluated clinically, including roscovitine (Seliciclib), SCH-727965, and AT7519 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21-23)</a><b>4k</b> is a pyrazolopyrimidine as is SCH-727965. Unlike many other CDK inhibitors, however, we show that <b>4k</b> is orally bioavailable and inhibits tumor growth in vivo. As such, <b>4k</b> is an important new CDK inhibitor with clinical potential.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/medium/jm-2010-00732t_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of some CDK inhibitors currently in clinical evaluation. See text for references.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100732t&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68521" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68521" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Identification of <b>4k</b></h3><div class="NLM_p">Of the CDK inhibitors currently undergoing clinical trials (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), a structural class that has yielded several CDK-selective ATP antagonists is the 2,6,9-trisubstituted purines, exemplified by roscovitine, which shows good biological and pharmacological properties. However, our computational analysis has shown that the pyrazolo[1,5-<i>a</i>]pyrimidine core has a less favorable aqueous solvation energy than the corresponding purine, suggesting that this compound class would be more readily transferred into the hydrophobic kinase active site.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> In this study, a range of pyrazolopyrimidines were synthesized and tested for CDK activity.</div><div class="NLM_p">The compounds were readily accessible from dichloropyrazolo[1,5-<i>a</i>]pyrimidine <b>1</b> by sequential selective substitution of the C-7 chloride using benzylamine followed by palladium-catalyzed displacement of the C-5 chloride under Buchwald−Hartwig reaction conditions, as described previously (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Protection of the benzylic amine as a carbamate was essential for successful C-5 amination. Following deprotection, the analogues were assayed for CDK activity by measurement of free ATP remaining in the kinase reaction, as determined using a luciferase assay.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/medium/jm-2010-00732t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Pyrazolopyrimidines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100732t&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) BnNH<sub>2</sub>, EtOH, reflux, 16 h, 95%; (b) Boc<sub>2</sub>O, THF, cat. DMAP, 25 °C, 20 h, 96%; (c) amine, Pd<sub>2</sub>(dba)<sub>3</sub>, <i>rac</i>-BINAP, NaO<sup>t</sup>Bu, 100 °C, 16 h, 40−99%; (d) MeOH, HCl, 25 °C, 3 h, 67−99%.</p></p></figure><div class="NLM_p">The high potency offered by the pyrazolopyrimidine core was highlighted by the effective inhibition of several CDKs by <b>4a</b>, which bears the roscovitine side chain (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Table 1">Supporting Information Table 1</a>). Deletion of the free hydroxyl group in <b>4b</b> had a large detrimental effect on the potency. Interestingly, chain elongation and replacement of the hydroxyl by a terminal amine <b>4c</b> selectively increases potency toward CDK7. Compound <b>4c</b>, which we have previously reported (BS-181), inhibits CDK7 activity up to 83% while demonstrating only weak inhibition of the other CDKs. Compound <b>4c</b> inhibited CDK7 activity, with an IC<sub>50</sub> of 21 nm/L, with greater than 40-fold selectivity over other CDKs and a wider range of 70 kinases and additionally showed antitumor activity in vivo.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">Further long chain C-5 analogues were synthesized, and nitrile <b>4d</b> showed a similar inhibition of CDK7 activity (IC<sub>50</sub> 20 nm/L) while also showing increased CDK2 inhibition. Similarly, amidine <b>4e</b> showed only a slight decrease in CDK7 inhibition (IC<sub>50</sub> 40 nm/L), however, this also proved to be a highly potent CDK2 inhibitor.</div><div class="NLM_p">Having identified <b>4c</b> as a potent and selective CDK7 inhibitor, it was decided to further investigate the SAR around the C-5 side chain against CDK potency and selectivity. Several analogues containing a terminal basic residue in combination with a free hydroxyl group were investigated. These were readily synthesized from alkene <b>6</b> (see Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) via cross metathesis, or oxidation/Wittig reactions followed by reduction of the resultant alkene prior to Buchwald−Hartwig coupling. However, the parent alkene <b>4f</b> showed decreased inhibition compared to the analogue with the roscovitine side chain <b>4a</b>, and none of the analogues with the functionalized side chains <b>4g</b>, <b>4h</b>, or <b>4i</b> showed any significant inhibition of the CDKs.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/medium/jm-2010-00732t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. First Generation Synthesis of 4k and 4l<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100732t&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <i>t</i>-BuMe<sub>2</sub>SiCl, Et<sub>3</sub>N, cat. DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 25 °C, 16 h, 99%; (b) <b>2</b>, Pd<sub>2</sub>(dba)<sub>3</sub>, <i>rac</i>-BINAP, NaO<sup>t</sup>Bu, 100 °C, 16 h, 43%; (c) cat. OsO<sub>4</sub>, NMO, MeCN, H<sub>2</sub>O, 25 °C, 45 min, <b>3k</b> 42%, <b>3l</b> 33%; (d) MeOH, HCl, 25 °C, 3 h, <b>4k</b> 79%, <b>4l</b> 67%.</p></p></figure><div class="NLM_p">The importance of free hydroxyl groups however, was reinforced by the high CDK7 inhibition and good selectivity demonstrated by the 2-(2-hydroxyethoxy)-ethylamino analogue <b>4j</b>. Accordingly, further hydroxylated compounds were synthesized by dihydroxylation of the vinyl residue present in <b>3f</b>, which after diastereoisomer separation and deprotection yielded the two amino triols <b>4k</b> and <b>4l</b> (BS-195). Both diastereoisomers proved to be highly active against a range of CDKs.</div><div class="NLM_p"><b>4k</b> was chosen for further study because it inhibited CDK2 with an IC<sub>50</sub> = 3 nmol/L (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>; <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Figure 1">Supporting Information Figure 1</a>), an IC<sub>50</sub> more than 30-fold lower than that showed by roscovitine (IC<sub>50</sub> = 100 nmol/L).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a><b>4k</b> also inhibited CDK1 (IC<sub>50</sub> = 33 nmol/L), CDK5 (IC<sub>50</sub> = 30 nmol/L), and CDK9 (IC<sub>50</sub> = 90 nmol/L) and was a less potent inhibitor of CDK7 (IC<sub>50</sub> = 250 nmol/L), whereas CDK4 and CDK6 were not inhibited by <b>4k</b>. Compound <b>4l</b> gave a similar profile of CDK inhibition, however, <b>4k</b> had the advantage of being a crystalline solid. Compound <b>4k</b> was therefore selected for development due to both potency and ease of purification. In addition, the relative configuration of the molecule and by analogy its absolute stereochemistry was readily assigned by an X-ray crystal structure determination (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/medium/jm-2010-00732t_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structure of <b>4k</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100732t&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibition of Cyclin-Dependent Protein Kinase Activity by <b>4k</b><a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="(" /></col><col align="char" char="(" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char="(">roscovitine <br /></br>IC<sub>50</sub> (μM) (SD)</th><th class="colsep0 rowsep0" align="center" char="("><b>4k</b><br /></br>IC<sub>50</sub> (μM) (SD)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK1</td><td class="colsep0 rowsep0" align="char" char="(">2.1 (0.5)</td><td class="colsep0 rowsep0" align="char" char="(">0.033 (0.01)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK2</td><td class="colsep0 rowsep0" align="char" char="(">0.1 (0.05)</td><td class="colsep0 rowsep0" align="char" char="(">0.003 (0.001)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK4</td><td class="colsep0 rowsep0" align="char" char="(">13.5 (0.2)</td><td class="colsep0 rowsep0" align="char" char="(">20 (1.3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK5</td><td class="colsep0 rowsep0" align="char" char="(">0.16 (0.2)</td><td class="colsep0 rowsep0" align="char" char="(">0.03 (0.006)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK6</td><td class="colsep0 rowsep0" align="char" char="(">23.5 (1.3)</td><td class="colsep0 rowsep0" align="char" char="(">35.5 (1.3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK7</td><td class="colsep0 rowsep0" align="char" char="(">0.54 (0.09)</td><td class="colsep0 rowsep0" align="char" char="(">0.25 (0.04)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK9</td><td class="colsep0 rowsep0" align="char" char="(">0.95 (0.17)</td><td class="colsep0 rowsep0" align="char" char="(">0.09 (0.01)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">The mean IC<sub>50</sub> values (μM) for roscovitine and <b>4k</b>, obtained from three experiments, are shown, together with the standard deviation (SD) from the mean. The line graphs from which IC<sub>50</sub> values were obtained are shown in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Figure 1">Supporting Information Figure 1</a>.</p></div></div></div><div class="NLM_p">The initial synthesis of <b>4k</b> using a nonselective late stage alkene dihydroxylation reaction usefully gave access to both diastereoisomers, however, the diastereoisomer separation was laborious and unsuitable once <b>4k</b> had been selected for development (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Accordingly, an alterative route to enantiomerically and diastereomerically pure <b>4k</b> was investigated. We decided to introduce a fully functionalized C-5 side chain through the existing Buchwald−Hartwig coupling reaction, therefore a synthesis of the requisite fully protected amino-triol was required.</div><div class="NLM_p">(−)-Diethyl tartrate (<b>8</b>) was converted to the corresponding cyclic sulfate using reaction conditions developed by Sharpless, by conversion to the cyclic sulfite with thionyl chloride, followed by ruthenium catalyzed oxidation to the cyclic sulfate.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Subsequent ring S<sub>N</sub>2 opening using sodium azide gave the requisite azido-alcohol <b>9</b>. However, the oxidation reaction proved to be capricious, and as a consequence of difficulties encountered with handling of the cyclic sulfate, a more reliable method was investigated. Direct S<sub>N</sub>2 ring-opening of the cyclic sulfite with sodium azide with careful control of temperature was highly effective, giving azide <b>9</b> in 70% yield.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The diester was readily reduced to triol <b>10</b> by lithium borohydride generated in situ in EtOH.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> It was necessary to protect the free hydroxyl groups to prevent competitive <i>O</i>-arylation in the Buchwald−Hartwig coupling, and it was hoped to achieve this in a single operation. However, attempts to protect all the hydroxyl groups as an orthoester by condensation with trimethyl orthoacetate or trimethyl orthobenzoate with acid catalysis failed. Attempts to prepare the triple methoxymethyl ether were complicated by formation of cyclic acetals and were only low yielding. A two-step procedure was therefore employed with the vicinal diol first being protected as an acetonide and the primary alcohol subsequently protected by methoxymethylation. Catalytic hydrogenation over palladium on charcoal gave the required fully protected amine <b>12</b>, which underwent high yielding Buchwald−Hartwig coupling to produce the protected <b>4k</b> precursor <b>13</b>. Global deprotection under acidic conditions gave <b>4k</b> as a single stereoisomer (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). The <sup>1</sup>H and <sup>13</sup>C NMR spectra of <b>4k</b> are shown in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Figures 2 and 3">Supporting Information Figures 2 and 3</a>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/medium/jm-2010-00732t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0008.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Second Generation Synthesis of 4k<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100732t&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) SOCl<sub>2</sub>, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 1 h; (b) NaN<sub>3</sub>, DMF, 12 h, 70% (2 steps); (c) NaBH<sub>4</sub>,LiCl, EtOH, 0 °C, 12 h; (d) (MeO)<sub>2</sub>CMe<sub>2</sub>, TsOH, Me<sub>2</sub>CO, 50 °C, 3 h; (e) MOMCl,<i>i</i>Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 12 h, 70% (3 steps); (f) H<sub>2</sub>, Pd/C, MeOH, 1 h, 97%; (g) <b>2</b>,Pd<sub>2</sub>(dba)<sub>3</sub>, <i>rac</i>-BINAP, NaO<sup>t</sup>Bu, 100 °C, 16 h, 95%; (h) MeOH, HCl, 25 °C, 3 h, 90%.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> <b>4k</b> Is a Potent Inhibitor of CDK1, CDK2, CDK7, and CDK9</h3><div class="NLM_p">Determination of the CDK selectivity of <b>4k</b>, performed by assaying inhibition of the activities of 76 proteins kinases representing members of different kinase classes (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), showed significant inhibition of CAMKKβ, CK1, DYRK1A, ERK1, ERK2, and IRR at 10000 nmol/L but a less than 50% inhibition of these kinases when <b>4k</b> was used at a concentration of 1000 nmol/L (data not shown), suggestive of IC<sub>50</sub> values >1000 nmol/L. In confirmation of this, the IC<sub>50</sub> values for CAMKKβ, CK1, DYRK1A, ERK1, ERK2, and IRR were determined as 2450, 1040, 2100, 3730, 3110, and 1800 nmol/L, respectively. The only exception was ERK8, whose activity was inhibited by 74% with 10 μmol/L <b>4k</b> and the IC<sub>50</sub> was determined as 330 nmol/L (data not shown), 100-fold higher than the IC<sub>50</sub> for CDK2, about 10-fold higher IC<sub>50</sub> than that obtained for CDK1 or CDK5.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibition of Protein Kinases by <b>4k</b><a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="3" align="center"><b>4k</b> (10 μM)</th><th class="colsep0 rowsep0" colspan="3" align="center"><b>4k</b> (10 μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">enzyme</th><th class="colsep0 rowsep0" align="center" char=".">% activity <br /></br>remaining</th><th class="colsep0 rowsep0" align="center" char=".">SD</th><th class="colsep0 rowsep0" align="center">enzyme</th><th class="colsep0 rowsep0" align="center" char=".">% activity <br /></br>remaining</th><th class="colsep0 rowsep0" align="center" char=".">SD</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MKK1</td><td class="colsep0 rowsep0" align="char" char=".">65</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="left">AMPK</td><td class="colsep0 rowsep0" align="char" char=".">88</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ERK1</td><td class="colsep0 rowsep0" align="char" char=".">42</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="left">MARK3</td><td class="colsep0 rowsep0" align="char" char=".">82</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ERK2</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">BRSK2</td><td class="colsep0 rowsep0" align="char" char=".">108</td><td class="colsep0 rowsep0" align="char" char=".">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JNK1</td><td class="colsep0 rowsep0" align="char" char=".">93</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="left">MELK</td><td class="colsep0 rowsep0" align="char" char=".">88</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JNK2</td><td class="colsep0 rowsep0" align="char" char=".">94</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="left">CK1</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p38a MAPK</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="left">CK2</td><td class="colsep0 rowsep0" align="char" char=".">89</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">P38b MAPK</td><td class="colsep0 rowsep0" align="char" char=".">94</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="left">DYRK1A</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p38g MAPK</td><td class="colsep0 rowsep0" align="char" char=".">112</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="left">DYRK2</td><td class="colsep0 rowsep0" align="char" char=".">75</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p38s MAPK</td><td class="colsep0 rowsep0" align="char" char=".">86</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">DYRK3</td><td class="colsep0 rowsep0" align="char" char=".">88</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ERK8</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">NEK2a</td><td class="colsep0 rowsep0" align="char" char=".">102</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RSK1</td><td class="colsep0 rowsep0" align="char" char=".">75</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="left">NEK6</td><td class="colsep0 rowsep0" align="char" char=".">87</td><td class="colsep0 rowsep0" align="char" char=".">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RSK2</td><td class="colsep0 rowsep0" align="char" char=".">90</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">IKKb</td><td class="colsep0 rowsep0" align="char" char=".">80</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDK1</td><td class="colsep0 rowsep0" align="char" char=".">84</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="left">PIM1</td><td class="colsep0 rowsep0" align="char" char=".">103</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PKBa</td><td class="colsep0 rowsep0" align="char" char=".">103</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="left">PIM2</td><td class="colsep0 rowsep0" align="char" char=".">94</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PKBb</td><td class="colsep0 rowsep0" align="char" char=".">105</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="left">PIM3</td><td class="colsep0 rowsep0" align="char" char=".">101</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SGK1</td><td class="colsep0 rowsep0" align="char" char=".">92</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">SRPK1</td><td class="colsep0 rowsep0" align="char" char=".">62</td><td class="colsep0 rowsep0" align="char" char=".">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">S6K1</td><td class="colsep0 rowsep0" align="char" char=".">77</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">MST2</td><td class="colsep0 rowsep0" align="char" char=".">86</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PKA</td><td class="colsep0 rowsep0" align="char" char=".">93</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">EFK2</td><td class="colsep0 rowsep0" align="char" char=".">92</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ROCK 2</td><td class="colsep0 rowsep0" align="char" char=".">102</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="left">HIPK2</td><td class="colsep0 rowsep0" align="char" char=".">73</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PRK2</td><td class="colsep0 rowsep0" align="char" char=".">106</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="left">PAK4</td><td class="colsep0 rowsep0" align="char" char=".">55</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PKCa</td><td class="colsep0 rowsep0" align="char" char=".">96</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">PAK5</td><td class="colsep0 rowsep0" align="char" char=".">65</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PKC ζ</td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="left">PAK6</td><td class="colsep0 rowsep0" align="char" char=".">85</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PKD1</td><td class="colsep0 rowsep0" align="char" char=".">97</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="left">Src</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="char" char=".">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MSK1</td><td class="colsep0 rowsep0" align="char" char=".">96</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">Lck</td><td class="colsep0 rowsep0" align="char" char=".">85</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MNK1</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="left">CSK</td><td class="colsep0 rowsep0" align="char" char=".">77</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MNK2</td><td class="colsep0 rowsep0" align="char" char=".">136</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="left">FGF-R1</td><td class="colsep0 rowsep0" align="char" char=".">86</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MAPKAP-K2</td><td class="colsep0 rowsep0" align="char" char=".">111</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="left">IRR</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PRAK</td><td class="colsep0 rowsep0" align="char" char=".">97</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="left">EPH A2</td><td class="colsep0 rowsep0" align="char" char=".">116</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CAMKKb</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">MST4</td><td class="colsep0 rowsep0" align="char" char=".">92</td><td class="colsep0 rowsep0" align="char" char=".">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CAMK1</td><td class="colsep0 rowsep0" align="char" char=".">93</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left">SYK</td><td class="colsep0 rowsep0" align="char" char=".">120</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SmMLCK</td><td class="colsep0 rowsep0" align="char" char=".">101</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="left">YES1</td><td class="colsep0 rowsep0" align="char" char=".">89</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PHK</td><td class="colsep0 rowsep0" align="char" char=".">62</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="left">IKKe</td><td class="colsep0 rowsep0" align="char" char=".">94</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CHK1</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="left">TBK1</td><td class="colsep0 rowsep0" align="char" char=".">87</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CHK2</td><td class="colsep0 rowsep0" align="char" char=".">61</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left">IGF1-R</td><td class="colsep0 rowsep0" align="char" char=".">67</td><td class="colsep0 rowsep0" align="char" char=".">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GSK3b</td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="left">VEG-FR</td><td class="colsep0 rowsep0" align="char" char=".">92</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK2-cyclin A</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">BTK</td><td class="colsep0 rowsep0" align="char" char=".">91</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PLK1</td><td class="colsep0 rowsep0" align="char" char=".">68</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">IR-HIS</td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PLK1 (okadaic acid)</td><td class="colsep0 rowsep0" align="char" char=".">97</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="left">EPH-B3</td><td class="colsep0 rowsep0" align="char" char=".">72</td><td class="colsep0 rowsep0" align="char" char=".">13</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Inhibition of 76 protein kinases by <b>4k</b> at a concentration of 10 μmol/L. The assay was carried out in duplicate. Percentage of kinase activity remaining is shown, together with the standard deviations (SD).</p></div></div></div><div class="NLM_p">A 1.8 Å crystal structure of <b>4k</b> bound to the inactive form of CDK2 was obtained by soaking the ligand into preformed CDK2 crystals. After molecular replacement with the published CDK2 structure, clear and unambiguous density for the ligand was found within the CDK2 ATP binding site (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A,D). Compound <b>4k</b> binds in a similar fashion to roscovitine, with the core heterocyclic ring occupying approximately the same position as the ATP purine ring.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The phenyl ring substituent occupies a hydrophobic pocket outside the ATP binding site, while N1 and N6 each form a hydrogen bond to the L83 main chain, as seen in the structure of roscovitine bound to CDK2 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B,C). In addition, the three side chain hydroxyl groups of <b>4k</b> form several water-mediated interactions with CDK2 backbone and side chain atoms, involving residues E12, T14. D86, Q131, and D145 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B). This is in contrast to roscovitine, where the number of stabilizing water-mediating interactions between the single ligand hydroxyl group and CDK2 is limited (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>C). The structure suggests that the increased potency of <b>4k</b> in CDK2 inhibition assays compared to roscovitine could be due to tighter binding of the former to the inactive state of CDK2. The increased affinity of <b>4k</b> compared to roscovitine stems from its ability to form a network of water mediated interactions within the CDK2 ATP binding pocket. Due to a major movement of the glycine loop (residues 12−20) upon cyclin binding to CDK2, it is expected that the <b>4k</b> hydroxyl substituents will form different interactions in the active complex, and we are currently progressing studies to obtain a structure for <b>4k</b> bound to the active CDK2-cyclin A complex. Notwithstanding, the crystallography data confirm <b>4k</b> structure and binding to CDK2.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/medium/jm-2010-00732t_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structure of <b>4k</b> bound to CDK2. (A) Shown is the <b>4k</b> difference electron density map after refinement, contored at 2.9σ. (B) <b>4k</b> binding site in CDK2 is shown with hydrogen bonding interactions depicted as dashed lines. Water-mediated interactions are also shown. Carbon atoms are colored in cyan, nitrogen in blue, and oxygen in red. Water molecules are represented as red crosses. (C) Roscovitine binding site in CDK2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2A4L">2A4L</a>), as (B). (D) Summary of CDK2-<b>4k</b> data collection and refinement statistics.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100732t&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> <b>4k</b> Promotes Cell Cycle Arrest and Inhibits Cancer Cell Growth</h3><div class="NLM_p">A panel of cell lines representing a range of tumor types, including breast, lung, prostate, and colorectal cancer, were treated with increasing concentrations of <b>4k</b> for 72 h. Determination of proliferation using the sulforhodamine B (SRB) assay showed that growth was inhibited for all cell lines tested, with 50% growth inhibition (GI<sub>50</sub>) values of 100−500 nmol/L (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). By contrast, GI<sub>50</sub> values for roscovitine ranged between 7.8−35.7 μmol/L for the same cell lines. Interestingly, human normal vascular endothelial cells (HUVEC) (GI<sub>50</sub> = 6.3 μmol/L) were somewhat less sensitive to <b>4k</b> than the cancer lines.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Growth Inhibitory Activity of <b>4k</b><a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="(" /></col><col align="char" char="(" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left">cell type</th><th class="colsep0 rowsep0" align="left">cell line</th><th class="colsep0 rowsep0" align="center" char="(">roscovitine <br /></br>GI<sub>50</sub> (μM) (SD)</th><th class="colsep0 rowsep0" align="center" char="("><b>4k</b><br /></br>GI<sub>50</sub> (μM) (SD)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">breast</td><td class="colsep0 rowsep0" align="left">MCF-7</td><td class="colsep0 rowsep0" align="char" char="(">7.8 (0.2)</td><td class="colsep0 rowsep0" align="char" char="(">0.3 (0.1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">MDA-MB-231</td><td class="colsep0 rowsep0" align="char" char="(">22.6 (0.1)</td><td class="colsep0 rowsep0" align="char" char="(">0.3 (0.1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">MCF-10A</td><td class="colsep0 rowsep0" align="char" char="(">16.3 (0.1)</td><td class="colsep0 rowsep0" align="char" char="(">0.1 (0.1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">colorectal</td><td class="colsep0 rowsep0" align="left">COLO-205</td><td class="colsep0 rowsep0" align="char" char="(">24.9 (0.2)</td><td class="colsep0 rowsep0" align="char" char="(">0.12 (0.1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">HCT-116</td><td class="colsep0 rowsep0" align="char" char="(">15.5 (0.1)</td><td class="colsep0 rowsep0" align="char" char="(">0.1 (0.1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="left">A549</td><td class="colsep0 rowsep0" align="char" char="(">15 (0.2)</td><td class="colsep0 rowsep0" align="char" char="(">0.2 (0.1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">osteosarcoma</td><td class="colsep0 rowsep0" align="left">SaOS2</td><td class="colsep0 rowsep0" align="char" char="(">13.9 (0.1)</td><td class="colsep0 rowsep0" align="char" char="(">0.25 (0.1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">prostate</td><td class="colsep0 rowsep0" align="left">PC3</td><td class="colsep0 rowsep0" align="char" char="(">25.2 (0.1)</td><td class="colsep0 rowsep0" align="char" char="(">0.5 (0.1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="left">HepG2</td><td class="colsep0 rowsep0" align="char" char="(">25.9 (0.2)</td><td class="colsep0 rowsep0" align="char" char="(">1.0 (0.1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ovarian</td><td class="colsep0 rowsep0" align="left">Sk-Ov-3</td><td class="colsep0 rowsep0" align="char" char="(">35.7 (0.2)</td><td class="colsep0 rowsep0" align="char" char="(">0.3 (0.2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human normal <br /></br>umbilical vein <br /></br>endothelial cells (HUVEC)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="(">3.7 (0.1)</td><td class="colsep0 rowsep0" align="char" char="(">6.3 (0.1)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">The mean IC<sub>50</sub> values (μM) were obtained using the sulforhodamine B (SRB) assay. Shown are the mean values derived from at least three replicates, together with the standard deviations (SD) from the means.</p></div></div></div><div class="NLM_p">On the basis of our findings, <b>4k</b> was submitted to the Developmental Therapeutics Program at the NCI (<a href="http://dtp.nci.nih.gov" class="extLink">http://dtp.nci.nih.gov</a>) for testing using the NCI60 cancer cell line screen. In this screen, treatment with <b>4k</b> showed potent inhibition of all 60 cancer lines (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A, <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Figure 4">Supporting Information Figure 4</a>), with GI<sub>50</sub> < 1 μmol/L (mean GI<sub>50</sub> = 2.81 × 10<sup>−7</sup> mol/L). For the great majority of the lines, the 50% lethal concentration (LC<sub>50</sub>) was >100 μmol/L (mean LC<sub>50</sub> > 10 × 10<sup>−4</sup> mol/L) (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Table 2">Supporting Information Table 2</a>). For comparison, in the same cell panel, flavopiridol is a potent inhibitor of cancer cell growth (mean GI<sub>50</sub> = 7.47 × 10<sup>−8</sup> mol/L) but lethal concentration for flavopiridol is reached at submicromolar concentrations (LC<sub>50</sub> = 9.04 × 10<sup>−7</sup> mol/L) (<a href="http://dtp.nci.nih.gov" class="extLink">http://dtp.nci.nih.gov</a>).</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/medium/jm-2010-00732t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>4k</b> treatment of HCT116 cells leads to cancer cell growth inhibition, cell cycle arrest, and inhibition of CDK substrate phosphorylation. (A) Growth inhibition profiles for the NCI 60 cancer cell panel. For details of the growth profiles of the individual cell lines see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. (B) Effect of <b>4k</b> on cell cycle kinetics. <b>4k</b> at the concentrations shown was added to HCT116 cells for 24 h prior to fixation, staining with propidium iodide (PI), and flow cytometric analysis. The percentage of cells in the sub-G1 (apoptosis), G1, S-phase, and G2/M, as determined from three independent experiments, are shown. Error bars represent the standard errors of the mean (SEM). <i>P</i>-Values were determined using Student’s <i>t</i> test, in which comparison between the DMSO control, and <b>4k</b> treatment at each concentration was carried out. Asterisks (*) denote <i>p</i> < 0.05. (C−E) Molecular pharmacology of <b>4k</b> on HCT116 cells. Cell lysates prepared from HCT116 cells treated with <b>4k</b> or roscovitine for 4 or 24 h were immunoblotted for various proteins or phosphorylated forms, as labeled.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100732t&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Flow cytometric analysis of HCT116 cells treated with 1 and 10 μmol/L <b>4k</b> showed a significant reduction in cells in G1, with a concomitant increase in cells in S and G2/M phases of the cell cycle (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B; <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Figure 5">Supporting Information Figure 5</a>), as would be expected from the potent inhibition of CDK1 and CDK2, but not of CDK4 and CDK6, by <b>4k</b>. Similar effects were observed in MCF-7 cells (data not shown). There was also an increase in the sub-G1 population, suggestive of a small, but significant amount of apoptosis at 1 and 10 μmol/L <b>4k</b>, which was confirmed by annexin V staining (data not shown).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> <b>4k</b> Inhibits Phosphorylation of CDK Substrates and Promotes Loss of Cyclin Expression</h3><div class="NLM_p last">Immunoblotting of whole cell lysates prepared from HCT116 colon cancer cells treated with <b>4k</b> for 4 and 24 h showed inhibition of the phosphorylation of the CDK2 substrate RB at Ser-780, Ser-795, Ser-801, Ser-807/Ser-811, and Thr-821 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C,D), the CDK1 substrate protein phosphatase type 1α (PP1a) at Thr-320, and the CDK9 substrate Ser-2 in the C-terminal domain (CTD) of RNA polymerase II (PolII). Altered levels of CDKs or cyclins did not accompany inhibition of RB and PolII phosphorylation at 4 h following <b>4k</b> addition (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>E). By contrast, at 24 h, levels of cyclin A, cyclin B, and cyclin D1 were dramatically reduced in the case of <b>4k</b> at a concentration of 1 μmol/L. Reduction in the levels of these cyclins was also observed with higher concentrations (30 and 40 μmol/L) of roscovitine. CDK2 levels were not influenced by <b>4k</b> treatment, although its levels were reduced at high concentrations of roscovitine. Phosphorylation of Thr-170 of CDK2 was, however, reduced following 24 h treatment with <b>4k</b>. Together, these results indicate a rapid inhibition of CDK activity following <b>4k</b> addition, with slower acting effects on cyclin levels.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> In Vivo Pharmacokinetic Studies and Tumor Growth Inhibition</h3><div class="NLM_p">To determine whether <b>4k</b> inhibits tumor growth in vivo, nude mice bearing MCF-7 tumors were injected intraperitoneally twice daily with 5 or 10 mg/kg, to give total daily doses of 10 mg/kg or 20 mg/kg, over a period of 14 days. Tumor growth was inhibited in a dose-dependent manner, with 30% and 40% reduction in tumor growth, compared with the control group, for 10 and 20 mg/kg/day doses of <b>4k</b>, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A). At these doses, there was no apparent toxicity, as judged by lack of significant adverse effects on animal weights (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B).</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/medium/jm-2010-00732t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>4k</b> inhibits growth in human breast tumor xenografts. (A) Randomized MCF-7 tumor bearing mice were injected intraperitoneally twice daily with vehicle (control, <i>n</i> = 11) or with 5 or 10 mg/kg of <b>4k</b>, giving a total daily dose of 10 mg/kg/day (<i>n</i> = 8) or 20 mg/kg/day (<i>n</i> = 9), respectively, over a period of 14 days. The change in tumor volume was determined for each animal, as tumor volume relative to the tumor volume of each animal at day 1. The line graphs show the mean tumor volumes for the animals in each treatment group. (B) Shown are the weights of the animals used over the time course of the study. Error bars represent the standard errors of the mean.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100732t&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>4k</b> was found to have favorable absorption, distribution, metabolism, elimination, and toxicity (ADME-Tox) properties. The drug had an aqueous solubility (PBS, pH 7.4) of 54.0 μmol/L (range, 47.16−60.89 μmol/L) and partition coefficient (Log <i>D</i>, <i>n</i>-octanol: PBS pH 7.4) of 3.0. In vitro cellular absorption (A−B permeability, TC7, pH 6.5/7.4) of <b>4k</b> was 9.7 × 10<sup>−6</sup> cm·s<sup>−1</sup> (range, 9.32−10.06 × 10<sup>−6</sup> cm·s<sup>−1</sup>; recovery = 91±%) at a test concentration of 10 μmol/L. In the same assay, the absorption of propranolol used as control was 54.2 × 10<sup>−6</sup> cm·s<sup>−1</sup> (range, 53.64−54.81 × 10<sup>−6</sup> cm·s<sup>−1</sup>; recovery = 85±%). Whereas plasma protein binding did not differ significantly between mouse and human, microsomal metabolism was found to be more favorable for human compared to mouse liver microsomes (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Injection of <b>4k</b> at 10 mg/kg into mice via the intraperitoneal (IP), intravenous (IV), and oral (PO) routes of administration of resulted in terminal elimination half-lives of 147, 210, and 178 min, respectively, with the measured plasma concentration at 15 min of 10474 (SEM = 5634), 25351 (SEM = 780), and 9347 (SEM = 551) ng/mL, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>; Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). One of two metabolites detected after intravenous administration of <b>4k</b> was identified as an oxidative (hydroxylated) metabolite (data not shown).</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/medium/jm-2010-00732t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Pharmacokinetic determination of <b>4k</b> levels. The mean plasma concentration of <b>4k</b> over time was determined for four mice at each time point following <b>4k</b> administration. Error bars represent the standard errors of the mean.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100732t&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro Plasma Protein Binding and Microsomal Metabolism of <b>4k</b><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="3" align="left">plasma protein binding</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left" valign="top">test concentration, μM</th><th class="colsep0 rowsep0" align="left" valign="top">% protein bound (human)</th><th class="colsep0 rowsep0" align="left" valign="top">% protein bound (mouse)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4k</b>, 10</td><td class="colsep0 rowsep0" align="left">94.3 (94.0 −94.5)</td><td class="colsep0 rowsep0" align="left">88.3 (86.0−90.6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">quinidine, 10</td><td class="colsep0 rowsep0" align="left">71.1 (65.3−76.9)</td><td class="colsep0 rowsep0" align="left">71.1 (70.0−72.2)</td></tr></tbody></table><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="3" align="left">in vitro metabolism (metabolic stability) (liver microsomes)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left" valign="top">test concentration, μM</th><th class="colsep0 rowsep0" align="left" valign="top">parent remaining (human) (%)</th><th class="colsep0 rowsep0" align="left" valign="top">parent remaining (human) (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4k</b>, 1.0</td><td class="colsep0 rowsep0" align="left">83 (80.6−84.8)</td><td class="colsep0 rowsep0" align="left">29 (28.8−29.1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">propranolol, 1.0</td><td class="colsep0 rowsep0" align="left">74 (73.5−75.2)</td><td class="colsep0 rowsep0" align="left">37 (34.7−39.6)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Data are mean values (range). Incubation: 0 and 60 min at 37 °C. Substrate/co-factor: test compound (1 μM), NADP (1 mM), G6P (5 mM), G6PDHase (1 U/mL) with 0.6% methanol, 0.6% acetonitrile (<i>n</i> = 2).</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Parameters for <b>4k</b><a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left">route of admin- istration</th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char=".">bioavail-ability (%)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (min)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (min)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>last</sub> (min·ng/mL)</th><th class="colsep0 rowsep0" align="center" char=".">AUCINF (min·mg/mL)</th><th class="colsep0 rowsep0" align="center" char=".">terminal points</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">73</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char=".">15604</td><td class="colsep0 rowsep0" align="char" char=".">147</td><td class="colsep0 rowsep0" align="char" char=".">1583520</td><td class="colsep0 rowsep0" align="char" char=".">158188</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PO</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">88</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">9347</td><td class="colsep0 rowsep0" align="char" char=".">178</td><td class="colsep0 rowsep0" align="char" char=".">1922912</td><td class="colsep0 rowsep0" align="char" char=".">1926751</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr></tbody></table><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left">route of admin-istration</th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center" char=".">Cl (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>z</sub> (mL/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (mL/kg)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>last</sub> (min·ng/mL)</th><th class="colsep0 rowsep0" align="center" char=".">AUCINF (min·mg/mL)</th><th class="colsep0 rowsep0" align="center" char=".">terminal points</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IV</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">210</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">1391</td><td class="colsep0 rowsep0" align="char" char=".">754</td><td class="colsep0 rowsep0" align="char" char=".">2174209</td><td class="colsep0 rowsep0" align="char" char=".">2182968</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">The studies were carried out in mice and the pharmacokinetic parameters were derived from noncompartmental model using WinNonlin 5.2. <i>T</i><sub>1/2</sub> = elimination half-life. Cl = total body clearance. <i>V</i><sub>z</sub> = volume of distribution. <i>V</i><sub>ss</sub> = an estimate of the volume of distribution at steady state. AUC<sub>last</sub> = area under the concentration−time curve from the time of dosing to the time of last observation that is greater than the limit of quantitation. AUCINF = area under the concentration−time curve from the time of dosing, extrapolated to infinity. <i>T</i><sub>max</sub> = time of maximum observed concentration. <i>C</i><sub>max</sub> = concentration corresponding to <i>T</i><sub>max</sub>. The bioavailability was calculated based on AUCINF. Terminal points = the number of observations used to calculate the terminal slope.</p></div></div></div><div class="NLM_p">Pharmacokinetic studies indicated good oral bioavailability (88%; <i>n</i> = 3 animals for 8 time points analyzed for each of PO and IV administration) for <b>4k</b>. To determine whether treatment with <b>4k</b> elicits responses in vivo, <b>4k</b> was administered by oral gavage to nu/nu-BALB/c athymic nude mice. Immunostaining and flow cytometric analysis of peripheral blood mononuclear cells (PBMC) isolated 6 h following administration showed that <b>4k</b> at concentrations of 25 mg/mL induced a 60−70% reduction in RB phosphorylation at Thr-821 (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). There were also 25−50% fall in PolII Ser-2 and Ser-5 phosphorylation with 25 mg/mL <b>4k</b>, with reductions in phosphorylation of PolII being maximal at 100 mg/mL <b>4k</b>, although at concentrations of 50 mg/mL or higher, PolII levels also fell. No difference in RB Thr-821 or PolII phosphorylation was evident 24 h following administration with 50 mg/mL <b>4k</b>, although RB Thr-821 phosphorylation was reduced by 50% (<i>p</i> < 0.01), 24 h after administration of 75 mg/mL <b>4k</b> (data not shown).</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/medium/jm-2010-00732t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Oral administration of <b>4k</b> inhibits cyclin-dependent kinase substrate phosphorylation in mouse peripheral blood mononuclear cells. Mouse PBMCs were collected 6 h following dosing of female nude mice by oral gavage at the dose levels shown. PBMCs were incubated with the appropriate primary antibodies, followed by fluorescently labeled secondary antibodies and flow cytometric analysis (<i>n</i> = 4, except for the 100 mg/kg dose where <i>n</i> = 3) to determine the status of (A) Rb, (B) Rb phosphorylated at threonine-821 (Rb Thr821), (C) RNA polymerase II Ser-2 phosphorylation (PolII Ser-2), and (D) total PolII. Error bars represent the standard errors of the mean. <i>P</i>-Values were determined using Student’s <i>t</i> test; # represents <i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100732t&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The above results indicated that oral administration of <b>4k</b> results in rapid down-regulation of RB and PolII phosphorylation but recovery within 24 h. To determine if oral administration of <b>4k</b> inhibits the growth of HCT116 tumor xenografts, animals were treated once daily with 25 mg/kg <b>4k</b> by oral gavage. Tumor growth was inhibited in a dose-dependent manner, with 50% reduction in tumor growth in the 25 mg/kg/day group (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>A), with no significant loss in animal weights in the vehicle or <b>4k</b> treatment groups. (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>B).</div><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/medium/jm-2010-00732t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Oral administration of <b>4k</b> inhibits human tumor xenografts. (A) Female nude mice bearing HCT116 tumor xenografts were dosed by oral gavage with vehicle (<i>n</i> = 8) or <b>4k</b> at a concentration of 25 mg/kg (<i>n</i> = 6). (B) The weights of the animals used over the time course of the study are shown. Error bars represent the standard errors of the mean. <i>P</i>-Values were determined using Student’s <i>t</i> test; # represents <i>p</i> < 0.05, * represents <i>p</i> < 0.01, and ** represents <i>p</i> < 0.001. (C) Shown are representative images for tumor xenografts immunostained using antibodies for Rb, Rb pSer807/811, and Rb pThr821. (D) One thousand nuclei were scored for determining percentage of stained cells in sections from each tumor. The results of the scoring are shown as box plots. Student’s <i>t</i> test analysis showed that pSer807/811 and pThr821 staining was significantly different (<i>p</i> < 0.005) between the vehicle and <b>4k</b> treatment groups, whereas there was no significant difference in levels of total Rb.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100732t&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Immunohistochemical staining of resected tumors showed no difference in Rb level in the vehicle or <b>4k</b> treatment groups (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>C,D). By contrast. levels of Rb phosphorylation at Ser807/811 and Thr821 were decreased in the <b>4k</b> treated tumors when compared with the vehicle treated group (<i>p</i> < 0.005).</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66437" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66437" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Recent studies show that inhibition of individual CDKs required for cell cycle progression may be ineffective cancer treatments either because they are not essential or due to potential compensation by other CDKs.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> For example, in the case of CDK2, a popular target for drug discovery due to its role in progression through the S phase, inhibition of this kinase was insufficient to prevent cancer cell proliferation,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> whereas combined depletion of CDK2 and CDK1 in cancer cells resulted in greater cell cycle arrest than seen with depletion of CDK2 or CDK1 alone.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In this context, the potent CDK1 and CDK2 inhibitory activity of <b>4k</b> provides an attractive therapeutic approach. Further, inhibition of CDK9 activity and consequent reduction in PolII activity has been shown to augment the growth inhibitory effects of CDK1 and CDK2 inhibition in cancer cell lines;<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> here, <b>4k</b> inhibited CDK9, as well as CDK7 and reduced PolII phosphorylation at Ser-2 and Ser-5 in vitro and in vivo. Phosphorylation of Rb regulates its interaction with E2F transcription factors, interaction with hypophosphorylated Rb repressing the expression of E2F-regulated genes. Many other interactions have been described, in particular, with proteins containing LXCXE motifs, including histone deacetylases HDAC1 and HDAC2 and chromatin remodelling proteins, with Rb phosphorylation also being critical for these interactions.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> Rb phosphorylation was inhibited at all sites studied, with the observed inhibition being considerably greater for <b>4k</b> than that observed for equivalent concentrations of roscovitine, in keeping with the much better growth inhibition seen for <b>4k</b> compared with roscovitine. Phosphorylation of all Rb sites was abolished with 10 μmol/L of <b>4k</b>, with substantial inhibition being obtained at concentrations as low as 0.1 μmol/L for Thr821, although complete inhibition of Thr821 phosphorylation was not achieved even at high concentrations of <b>4k</b>, which may be a reflection of that fact that in addition to being phosphorylated by CDK2, Thr821 can be phosphorylated by CDK6.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a> Phosphorylation of PP1a at Thr-320 was inhibited in a dose-dependent manner, likely reflecting the inhibition of CDK1 activity by <b>4k</b>. These analyses were reflected in the accumulation of cells in the S and G2/M phases of the cell cycle, with a concomitant reduction in cells in the G1 phase.</div><div class="NLM_p">As expected from the potent inhibition of CDK1, CDK2, and CDK9 by <b>4k</b> and the inhibition of Rb and PolII phosphorylation, the growth of diverse cancer cell lines was inhibited, with GI<sub>50</sub> values ranging between 0.1 and 1.0 μmol/L. This was confirmed by growth studies performed with the NCI60 cancer cell line panel, GI<sub>50</sub> values ranging between 0.1 and 0.5 μmol/L, with the exception of the multidrug resistant NCI/Adr-Res ovarian cancer cell line, which was inhibited somewhat less well (GI<sub>50</sub> = 2.0 μmol/L). The growth of human normal vascular endothelial cells was also inhibited less well than the growth of the cancer lines (GI<sub>50</sub> = 6.3 μmol/L), suggestive of some selectivity for cancer cells over normal cells.</div><div class="NLM_p last">The physicochemical and predictive ADME-Tox properties of <b>4k</b>, including aqueous solubility, cell permeability, and plasma protein binding were consistent with utility for in vivo studies. Pharmacokinetic studies demonstrated good oral bioavailability, which was confirmed by single oral dose administration, followed by collection of PBMC and FACS analysis of RB and PolII phosphorylation after 6 h. Inhibition of Rb Thr-821 phosphorylation was maximal with a dose of 25 mg/kg. Although PolII Ser-2 phosphorylation was decreased in a dose-dependent manner from 10 to 100 mg/kg, PolII levels were also seen to fall at doses of 50 and 100 mg/kg. Importantly, even at doses of 75 and 100 mg/kg, no significant reduction in PolII or Rb phosphorylation was noted 24 h following <b>4k</b> administration, which may be a reflection of the fact that the plasma concentration of <b>4k</b> are likely to be below the concentrations that demonstrate inhibition of Rb and PolII phosphorylation in cell lines beyond 6 h post administration. Nevertheless, single daily ip and oral administration of <b>4k</b> showed tumor growth inhibition in xenograft models at doses of 10 mg/kg ip in MCF-7 xenografts and 25 mg/kg po in HCT116 xenografts. Further, using Rb phosphorylation as an immunohistochemical marker of CDK activity, we have been able to observe that oral <b>4k</b> administration results in reduced Rb phosphorylation in the tumors. This is indicative of a relationship between pharmacodynamic factors and therapeutic outcome for <b>4k</b>.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58423" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58423" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Several selective and broad-specificity CDK inhibitors have now entered clinical trials. Phase I studies show that they can generally be safely administered. Of particular note is PD0332991, a selective CDK4/CDK6 inhibitor, as well as agents with broader selectivity, a few of which have been progressed to phase II studies either as single agents or in combination with chemotherapeutic agents such as cisplatin, gemcitabine, and capecitabine.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Here we have described the identification and preclinical evaluation of a potent orally active CDK inhibitor, which demonstrates selectivity for CDK1, CDK2, CDK5, and CDK9, with moderate inhibition in vitro of CDK7 and which is a poor inhibitor of CDK4 and CDK6. Compound <b>4k</b> selectively exhibited nanomolar enzymatic potency, potently inhibited all cell lines tested, and demonstrated inhibition of phosphorylation of CDK substrates. A pyrazolopyrimidine compound (Dinaciclib; SCH 727965) which is similar to <b>4k</b> in selectively inhibiting CDK1, CDK2, CDK5, and CDK9 with IC<sub>50</sub> values of 1−4 nmol/L, which shows tumor regression in mouse models<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and is well tolerated in patients following IV administration in a phase I setting,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> has recently been described. Our previous description of a CDK7 specific pyrazolopyrimidine-based comound,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> together with the identification of <b>4k</b>, show that pyrazolopyrimidine-based compounds have considerable potential for development as potent CDK inhibitors. Finally, the oral bioavailability of <b>4k</b> highlights it as an important new CDK inhibitor, with potential for clinical development.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Materials and Methods</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46553" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46553" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Synthetic Methods</h3><div class="NLM_p">All manipulations of air or moisture sensitive materials were carried out in oven- or flame-dried glassware under an inert atmosphere of nitrogen or argon. Syringes, which were used to transfer reagents and solvents, were purged with nitrogen prior to use. Reaction solvents were distilled from CaH<sub>2</sub> (CH<sub>2</sub>Cl<sub>2</sub>, PhMe, Et<sub>3</sub>N), Na/Ph<sub>2</sub>CO (THF, Et<sub>2</sub>O), or obtained as dry or anhydrous from Aldrich Chemical Co. (DMF, MeCN) or BDH (EtOH). Other solvents and all reagents were obtained from commercial suppliers and were used as obtained if purity was >98%. All flash column chromatography was carried out on silica gel 60 particle size 0.040−0.063 mm, unless otherwise stated. Thin layer chromatography (TLC) was performed on precoated aluminum backed or glass backed plates and visualized under ultraviolet light (254 nm) or following spraying with potassium permanganate, vanillin, or phosphomolybdic acid (PMA) stains as deemed appropriate. LC-MS analysis was performed using a Waters LCT Premier XE equipped with a Waters Atlantis C18-reverse phase column of length 30 mm, inner diameter 2.1 mm and particle size 3 μm using a mobile phase of water (0.1% formic acid):acetonitrile, monitoring at 254 nm. Compound purity was determined by combustion analysis (elemental analysis) or LC-MS analysis and was confirmed to be >95% for all compounds.</div><div class="NLM_p last">Dichloride <b>1</b> was prepared according to methods described by ref <a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">51</a>.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Benzyl-(5-chloro-3-<i>iso-</i>propylpyrazolo[1,5-<i>a</i>]pyrimidin-7-yl)-amine</h3><div class="NLM_p last">5,7-Dichloro-3-<i>iso</i>-propyl-pyrazolo[1,5-<i>a</i>]pyrimidine (<b>1</b>) (15.5 g, 67.0 mmol) and benzylamine (14.7 mL, 134 mmol) in EtOH (500 mL) were heated at reflux for 16 h. The reaction mixture was cooled to ambient temperature, concentrated in vacuo, and the residue recrystallized from EtOAc. The mother liquor was chromatographed on silica (EtOAc:hexanes 1:8) to yield the title pyrazolo[1,5-<i>a</i>]pyrimidine as a white solid. The combined yield of the crystallized and chromatographed material was 19.3 g, 96%; mp 78−79 °C (EtOAc); TLC Rf 0.16 (EtOAc:hexanes 1:16). IR (neat) 3380, 3239, 1616, 1585 cm<sup>−1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.84 (s, 1H), 7.40−7.32 (m, 5H), 6.88 (m, 1H), 5.91 (s, 1H), 4.55 (m, 2H), 3.28 (sept, <i>J</i> = 6.9 Hz, 1H), 1.33 (d, <i>J</i> = 6.9 Hz, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 150.2, 146.9, 144.2, 141.6, 135.8, 129.1, 128.3, 127.3, 117.0, 84.7, 46.2, 23.5, 23.4. MS <i>m</i>/<i>z</i> (ESI) 301 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>16</sub>H<sub>18</sub>ClN<sub>4</sub><sup>+</sup>, 301.1215; found, 301.1227. Anal. Calcd for C<sub>16</sub>H<sub>17</sub>ClN<sub>4</sub>: C, 63.89; H, 5.70; N, 18.63. Found: C, 63.95; H, 5.78; N, 18.59.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> <i>tert</i>-Butyl-benzyl-(5-chloro-3-<i>iso</i>-propylpyrazolo[1,5-<i>a</i>]pyrimidin-7-yl)-carbamate Monohydrate (<b>2</b>)</h3><div class="NLM_p last">Benzyl-(5-chloro-3-<i>iso</i>-propylpyrazolo[1,5-<i>a</i>]pyrimidin-7-yl)-amine (17.0 g, 56.7 mmol), Boc<sub>2</sub>O (16.1 g, 73.7 mmol), and DMAP (100 mg) in THF (400 mL) were stirred for 20 h at ambient temperature. EtOAc (300 mL) was added, and the organic layer was washed with water (2 × 400 mL) and saturated aqueous NaHCO<sub>3</sub> (400 mL) and dried (Na<sub>2</sub>SO<sub>4</sub>). Concentration in vacuo, chromatography (EtOAc:hexanes 1:8), and recrystallization from EtOAc and hexanes (1: 8) gave carbamate <b>2</b> (22.6 g, 100%) as a pale-yellow solid; mp 100−103 °C (EtOAc); TLC Rf 0.40 (EtOAc:hexanes 1:8). IR (neat) 1612 cm<sup>−1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 8.02 (s, 1H), 7.34−7.21 (m, 5H), 6.48 (s, 1H), 5.03 (s, 2H), 3.31 (sept, <i>J</i> = 6.9 Hz, 1H), 1.52 (s, 2H), 1.39 (s, 9H), 1.37 (d, <i>J</i> = 6.9 Hz, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 152.8, 148.0, 145.1, 144.3, 142.6, 136.8, 128.7, 127.8, 127.8, 118.3, 106.3, 83.0, 51.4, 28.0, 23.6, 23.4. MS <i>m</i>/<i>z</i> (ESI) 401 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>21</sub>H<sub>26</sub>ClN<sub>4</sub>O<sub>2</sub><sup>+</sup>, 401.1739; found, 401.1735. Anal. Calcd for C<sub>21</sub>H<sub>27</sub>ClN<sub>4</sub>O<sub>3</sub>: C, 60.21; H, 6.50; N, 13.37. Found: C, 60.28; H, 6.58; N, 13.43.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Procedure for Buchwald−Hartwig Coupling Reaction</h3><div class="NLM_p last"><i>tert</i>-Butyl-benzyl-(5-chloro-3-<i>iso-</i>propylpyrazolo[1,5-<i>a</i>]pyrimidin-7-yl)-carbamate (1.0 equiv), tris(dibenzylideneacetone)dipalladium (0.05 equiv), 2,2′-bis(diphenylphosphino)-1,1′-binaphthalene (0.15 equiv), and sodium <i>tert</i>-butoxide (1.1 equiv) were suspended in PhMe (0.30 M) and stirred for 15 min. The amine (1.1 equiv) was added and the mixture heated to 95 °C for 16 h and cooled and diluted with EtOAc. The organic phase was washed with water (3×), brine, dried (MgSO<sub>4</sub>), and concentrated in vacuo. Chromatography on silica (EtOAc:hexanes) gave the pure coupled products.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Procedure for the Final Acid Deprotection</h3><div class="NLM_p">AcCl was dissolved in MeOH (5.0 M) with stirring at 0 °C. After 15 min, the solution was warmed to room temperature and stirred for a further 15 min. The ambient was added and the mixture stirred at ambient temperature for 3 h and concentrated in vacuo. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub>, washed with saturated aqueous sodium bicarbonate, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated in vacuo. Crystallization (MeCN or MeOH) or chromatography (CH<sub>2</sub>Cl<sub>2</sub>: MeOH) gave the pure analogues.</div><div class="NLM_p last">Compound <b>5</b> was prepared according to Campbell et al.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (<i>R</i>)-1-(<i>tert</i>-Butyldimethylsilyloxy)-3-buten-2-amine (<b>6</b>)</h3><div class="NLM_p last">Et<sub>3</sub>N (5.00 mL, 35.6 mmol), DMAP (20.0 mg), and t-BuMe<sub>2</sub>SiCl (2.70 g, 17.8 mmol) were added to amino-alcohol <b>5</b> (2.00 g, 16.2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (80 mL). The mixture was stirred overnight at ambient temperature. Water (80 mL) was added, and the mixture was vigorously stirred for 10 min. The organic phase was separated, washed with water (60 mL) and brine (60 mL), and dried (Na<sub>2</sub>SO<sub>4</sub>). Concentration in vacuo gave amine <b>6</b> (2.83 g, 43%) as a yellow oil; TLC Rf 0.55 (EtOAc:hexanes 1:1); [α]<sup>25</sup><sub>D</sub> (<i>c</i> 1.09, CH<sub>2</sub>Cl<sub>2</sub>) + 22.8. IR (neat) 1471, 1254, 1095 cm<sup>−1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 5.80 (m, 1H), 5.14 (m, 2H), 3.60 (m, 1H), 3.42 (m, 2H), 1.61 (m, 2H), 0.89 (s, 9H), 0.05 (s, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ 139.2, 115.1, 67.8, 55.8, 25.9, 18.3, −5.4. MS <i>m</i>/<i>z</i> (CI) 202 (M + H)<sup>+</sup>. HRMS (CI) calcd for C<sub>10</sub>H<sub>24</sub>NOSi<sup>+</sup>, 202.1622; found, 202.1622.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (<i>R</i>)-<i>tert</i>-Butyl Benzyl(5-((1-((<i>tert</i>-butyldimethylsilyl)oxy)but-3-en-2-yl)amino)-3-<i>iso-</i>propylpyrazolo[1,5-<i>a</i>]pyrimidin-7-yl)carbamate <b>(3f)</b></h3><div class="NLM_p last">Synthesized according to the general procedure for Buchwald−Hartwig coupling, <b>2</b> (100 mg, 0.25 mmol), Pd<sub>2</sub>dba<sub>3</sub> (12.0 mg, 0.013 mmol), BINAP (24.0 mg, 0.039 mmol), sodium <i>tert</i>-butoxide (36.0 mg, 0.38 mmol), amine <b>6</b> (58.0 mg, 0.27 mmol), and PhMe (0.80 mL) yielded carbamate <b>3f</b> (72.0 mg, 0.13 mmol, 51%). Purification EtOAc:hexanes (1:10): [α]<sub>D</sub> (c 0.59, CH<sub>2</sub>Cl<sub>2</sub>) + 16.3. IR (neat) 3370, 1722, 1642, 1581, 1516, 1368, 1158, 1107, 837, 777, 699 cm<sup>−1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 7.75 (s, 1H), 7.27 (m, 5H), 5.85 (m, 1H), 5.71 (s, 1H), 5.19 (m, 2H), 4.97 (br s, 1H), 4.95 (br s, 2H), 4.54 (m, 1H), 3.75 (m, 2H), 3.08 (m, 1H), 1.40−1.31 (m, 15H), 0.88 (s, 9H), 0.05 (s, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ 154.0, 153.5, 146.1, 142.8, 141.5, 137.7, 136.4, 128.4, 127.9, 127.4, 116.2, 113.3, 97.2, 82.0, 65.0, 54.6, 51.3, 28.0, 25.9, 23.8, 23.1, 18.3, −5.4. MS <i>m</i>/<i>z</i> (CI) 566 (M + H)<sup>+</sup>. HRMS (CI) calcd for C<sub>31</sub>H<sub>48</sub>N<sub>5</sub>O<sub>3</sub>Si<sup>+</sup>, 566.3526; found, 566.3538.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>tert</i>-Butyl Benzyl(5-(((2<i>S</i>,3<i>S</i>)-1-((<i>tert</i>-butyldimethylsilyl)oxy)-3,4-dihydroxybutan-2-yl)amino)-3-<i>iso-</i>propylpyrazolo[1,5-<i>a</i>]pyrimidin-7-yl)carbamate <b>(3k)</b><i>. tert</i>-Butyl Benzyl(5-(((2<i>S</i>,3<i>R</i>)-1-((<i>tert</i>-butyldimethylsilyl)oxy)-3,4-dihydroxybutan-2-yl)amino)-3-<i>iso</i>-propylpyrazolo[1,5-<i>a</i>]pyrimidin-7-yl)carbamate <b>(3l)</b></h3><div class="NLM_p">OsO<sub>4</sub> (5.40 mL, 15 mol %, 2.5 wt % in <sup>t</sup>BuOH) was added to alkene <b>3f</b> (2.27 g, 4.00 mmol) and NMO H<sub>2</sub>O (0.97 g, 8.3 mmol) in MeCN and H<sub>2</sub>O (4: 1, 80 mL). After 16 h, reaction was quenched by the addition of saturated aqueous Na<sub>2</sub>SO<sub>3</sub> (20 mL). The mixture was stirred for 45 min at ambient temperature, and the aqueous phase was extracted with EtOAc (3 × 200 mL). The combined organic phases were dried (Na<sub>2</sub>SO<sub>4</sub>), concentrated in vacuo, and chromatographed (EtOAc:hexanes 1:20) to yield carbamate <b>3k</b> (1.00 g, 1.67 mmol, 42%) and carbamate <b>3l</b> (800 mg, 1.34 mmol, 33%). <b>3k</b>: IR (neat) 3363, 1721, 1644, 1518 cm<sup>−1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.80 (s, 1H), 7.36−7.27 (m, 5H), 5.72 (s, 1H), 5.24−5.22 (m, 1H), 4.98−4.94 (m, 3H), 4.18−4.11 (m, 1H), 3.95−3.90 (m, 1H), 3.79−3.76 (m, 1H), 3.64−3.57 (m, 3H), 3.10 (hept, <i>J</i> = 6.9 Hz, 1H), 2.84−2.81 (m, 1H), 1.43 (s, 9H), 1.33 (d, <i>J</i> = 6.9 Hz, 6H), 0.93 (s, 9H), 0.13−0.12 (m, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 154.8, 153.4, 141.7, 137.6, 128.5, 127.9, 127.6, 113.8, 97.4, 83.8, 82.5, 70.4, 62.5, 61.8, 53.5, 51.7, 28.0, 25.9, 23.6, 23.5, 23.2, −5.4. MS <i>m</i>/<i>z</i> (CI) 600 (M + H)<sup>+</sup>. HRMS (CI) calcd for C<sub>31</sub>H<sub>50</sub>N<sub>5</sub>O<sub>5</sub>Si<sup>+</sup>, 600.3576; found, 600.3578.</div><div class="NLM_p last"><b>3l</b>: IR (neat) 3361, 1719, 1644, 1518 cm<sup>−1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.77 (s, 1H), 7.32−7.23 (m, 5H), 5.78 (s, 1H), 5.27−5.25 (m, 1H), 4.98−4.89 (m, 2H), 4.41 − 4.31 (m, 2H), 4.14−4.09 (m, 1H), 4.00−3.90 (m, 2H), 3.79−3.75 (m, 1H), 3.61−3.57 (m, 1H), 3.40−3.36 (m, 1H), 3.11−3.04 (m, 1H), 1.40 (s, 9H), 1.32−1.28 (m, 6H), 0.89 (s, 9H), 0.08−0.06 (m, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 141.7, 137.6, 128.5, 127.9, 127.6, 113.8, 97.4, 82.5, 70.4, 62.4, 61.8, 60.4, 53.5, 51.6, 28.0, 25.9, 23.6, −5.4. MS <i>m</i>/<i>z</i> (CI) 600 (M + H)<sup>+</sup>. HRMS (CI) calcd for C<sub>31</sub>H<sub>50</sub>N<sub>5</sub>O<sub>5</sub>Si<sup>+</sup>, 600.3576; found, 600.3574.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (2<i>S</i>,3<i>S</i>)-3-(7-(Benzylamino)-3-iso-propylpyrazolo[1,5-<i>a</i>]pyrimidin-5-ylamino)-1,2,4-butanetriol <b>(4k)</b></h3><div class="NLM_p last">Synthesized according to the general procedure for acidic deprotection. <b>3k</b> (605 mg, 1.01 mmol), HCl/MeOH (50.0 mL). Yield triol <b>4k</b> (310 mg, 0.81 mmol, 79%). Purification crystallization from MeCN: mp 184−186 °C; [α]<sup>25</sup><sub>D</sub> (<i>c</i> 0.20, CH<sub>3</sub>OH) −25.0. IR (neat) 3229, 1639, 1581 cm<sup>−1</sup>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.69 (s, 1H), 7.42−7.27 (m, 5H), 5.32 (s, 1H), 4.56 (s, 2H), 4.10−4.04 (m, 1H), 3.87 (dd, <i>J</i> = 11.4, 4.1 Hz, 1H), 3.84 (dd, <i>J</i> = 11.1, 5.5 Hz), 3.63−3.56 (m, 3H), 3.05 (hept, <i>J</i> = 6.9 Hz, 1H), 1.31 (d, <i>J</i> = 6.9 Hz, 3H), 1.29 (d, <i>J</i> = 6.9 Hz, 3H). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 100 MHz) δ 157.6, 146.9, 144.9, 140.6, 137.7, 128.4, 127.1, 126.6, 112.1, 72.8, 72.0, 63.0, 61.7, 54.3, 45.1, 23.3, 22.6, 22.2. MS <i>m</i>/<i>z</i> (ESI) 386 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>20</sub>H<sub>28</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, 386.2187; found, 386.2181.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (2<i>R</i>,3<i>S</i>)-3-(7-(Benzylamino)-3-iso-propylpyrazolo[1,5-<i>a</i>]pyrimidin-5-ylamino)-1,2,4-butanetriol <b>(4l)</b></h3><div class="NLM_p last">Synthesized according to the general procedure for acidic deprotection. <b>3l</b> (765 mg, 1.28 mmol), HCl/MeOH (50.0 mL). Yield <b>4l</b> (338 mg, 0.86 mmol, 67%). Purification chromatography (EtOAc): [α]<sup>25</sup><sub>D</sub> (<i>c</i> 0.20, CH<sub>3</sub>OH) −60.0. IR (neat) 3307, 1637, 1579 cm<sup>−1</sup>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.68 (s, 1H), 7.40−7.25 (m, 5H), 5.34 (s, 1H), 4.54 (s, 2H), 4.23−4.20 (m, 1H), 3.93−3.89 (ddd, <i>J</i> = 8.3, 5.9, 2.2 Hz, 1H), 3.80 (dd, <i>J</i> = 11.0, 6.2 Hz, 1H), 3.77 (dd, <i>J</i> = 11.0, 7.0 Hz, 1H), 3.52 (dd, <i>J</i> = 11.5, 6.1 Hz, 1H), 3.39 (dd, <i>J</i> = 11.0, 8.7 Hz, 1H), 3.03 (hept, <i>J</i> = 6.9 Hz, 1H), 1.31 (d, <i>J</i> = 6.9 Hz, 3H), 1.29 (d, <i>J</i> = 6.9 Hz, 3H). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 100 MHz) δ158.0, 146.9, 144.5, 140.1, 137.7, 128.3, 127.1, 126.7, 112.0, 72.8, 70.8, 62.2, 62.0, 53.4, 45.1, 23.2, 22.6, 22.2. MS <i>m</i>/<i>z</i> (ESI) 386 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>20</sub>H<sub>28</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, 386.2187; found, 386.2189.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Second Generation Synthesis of <b>4k</b></h3><div id="sec5_11_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (2<i>R</i>,3<i>S</i>)-Diethyl 2-azido-3-hydroxysuccinate <b>(9)</b></h4><div class="NLM_p last">(−)-Diethyl tartrate (10.0 g, 48.5 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (250 mL) was cooled to −5 °C. Et<sub>3</sub>N (13.5 mL, 97.0 mmol) was added, followed by the dropwise addition of SOCl<sub>2</sub> (5.28 mL, 72.7 mmol). After 30 min, the mixture was poured into water and the aqueous layer extracted into CH<sub>2</sub>Cl<sub>2</sub> (3×). The combined organic layers were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated in vacuo to yield the cyclic sulfite which was directly dissolved in DMF (400 mL), and sodium azide (6.30 g, 97.0 mmol) was added. The mixture was stirred for 12 h and then poured into water and extracted into Et<sub>2</sub>O (3×). The combined organic layers were washed with brine, dried (MgSO<sub>4</sub>), and concentrated in vacuo. Chromatography (hexanes:EtOAc 4:1) gave azide <b>9</b> (7.79 g, 33.7 mmol, 70%): [α]<sub>D</sub> (c 1.0, EtOH) −39.4. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 4.66 (dd, <i>J</i> = 5.5, 2.7 Hz, 1H), 4.32 (m, 4H), 3.31 (d, <i>J</i> = 5.5 Hz, 1H), 1.35 (t, <i>J</i> = 7.1 Hz, 3H), 1.34 (t, <i>J</i> 7.1 Hz, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 170.6, 166.9, 71.5, 64.2, 62.6, 62.0, 14.0.</div></div><div id="sec5_11_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>S</i>)-4-((<i>S</i>)-1-Azido-2-(methoxymethoxy)ethyl)-2,2-dimethyl-1,3-dioxolane <b>(11)</b></h4><div class="NLM_p last">Diester <b>9</b> (5.00 g, 21.6 mmol) in EtOH (80.0 mL) was cooled to −10 °C and lithium chloride (909 mg, 21.6 mmol) was added, followed by portionwise addition of sodium borohydride (4.80 g, 130 mmol). The suspension was warmed overnight, recooled to −10 °C, and acidified to pH4 by the dropwise addition of 1 M HCl in H<sub>2</sub>O. The resultant clear solution was concentrated in vacuo to yield crude triol <b>10</b>, which was directly suspended in Me<sub>2</sub>CO (80.0 mL) and 2,2-dimethoxypropane (25.0 mL). <i>p</i>-TsOH.H<sub>2</sub>O (400 mg, 2.1 mmol) was added and the mixture heated to 50 °C for 2.5 h, cooled, and saturated ammonium chloride solution (60.0 mL) was added. The suspension was stirred for 1 h, poured into water, and extracted into Et<sub>2</sub>O (3×). The combined organic layers were washed with brine, dried (MgSO<sub>4</sub>), and concentrated in vacuo. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (25.0 mL), cooled to 0 °C, and <i>N</i>,<i>N</i>-di-<i>iso</i>-propylethylamine (7.51 mL, 43.2 mmol) was added followed by the slow addition of MeOCH<sub>2</sub>Cl (3.26 mL, 43.2 mmol) and the mixture was stirred overnight. The solution was poured into water and extracted into CH<sub>2</sub>Cl<sub>2</sub> (3×). The combined organic layers were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated in vacuo. Chromatography (hexanes:EtOAc 10:1) gave azide <b>11</b> (3.49 g, 15.1 mmol, 70%); [α]<sup>25</sup><sub>D</sub> (<i>c</i> 1.2, CHCl<sub>3</sub>) + 18.6. IR (neat) 3229, 2100, 1373, 1259 cm<sup>−1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 4.68 (s, 2H), 4.14−4.06 (m, 2H), 3.97−3.94 (m, 1H), 3.84−3.78 (m, 1H), 3.71−3.64 (m, 2H), 3.42 (s, 3H), 1.47 (s, 3H), 1.37 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 109.8, 96.7, 74.8, 67.3, 66.6, 63.0, 55.5, 26.5, 25.2. MS <i>m</i>/<i>z</i> (ESI) 249 (M + NH<sub>4</sub>)<sup>+</sup>. HRMS (ESI) calcd for C<sub>9</sub>H<sub>18</sub>N<sub>3</sub>O<sub>4</sub><sup>+</sup>, 232.1297; found, 232.1303.</div></div><div id="sec5_11_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>S</i>)-1-((<i>S</i>)-2,2-Dimethyl-1,3-dioxolan-4-yl)-2-(methoxymethoxy)ethanamine <b>(12)</b></h4><div class="NLM_p last">Azide <b>11</b> (3.49 g, 15.1 mmol) in MeOH (100 mL) and added to Pd/C (10 wt %, 350 mg). The atmosphere was replaced by hydrogen and hydrogen bubbled through the suspension for 1 h. The mixture was filtered through Celite and concentrated in vacuo to yield amine <b>12</b> (3.02 g, 14.7 mmol, 97%). IR (neat) 3330, 1600, 1461 cm<sup>−1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 4.65 (s, 2H), 4.07−4.01 (m, 2H), 3.93−3.87 (m, 1H), 3.66 (dd, <i>J</i> = 9.7, 3.5 Hz, 1H), 3.51 (dd, <i>J</i> = 9.7, 6.2 Hz, 1H), 3.38 (s, 3H), 3.10−3.06 (m, 1H), 1.45 (br. s, 2H), 1.43 (s, 3H), 1.36 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 108.9, 96.7, 77.1, 69.8, 66.3, 55.3, 53.2, 26.6, 25.3. HRMS (ESI) calcd for C<sub>9</sub>H<sub>20</sub>NO<sub>4</sub>, 206.1392; found, 206.1395.</div></div><div id="sec5_11_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (2<i>S</i>,3<i>S</i>)-3-(7-(Benzylamino)-3-<i>iso</i>-propylpyrazolo[1,5-<i>a</i>]pyrimidin-5-ylamino)-1,2,4-butanetriol <b>(4k)</b></h4><div class="NLM_p last">Synthesized according to the general procedure for Buchwald−Hartwig coupling, <b>2</b> (500 mg, 1.25 mmol), Pd<sub>2</sub>dba<sub>3</sub> (57.0 mg, 0.062 mmol), BINAP (117.0 mg, 0.19 mmol), sodium <i>tert</i>-butoxide (132 mg, 1.38 mmol), <b>12</b> (283 mg, 1.38 mmol), and PhMe (5.0 mL). Purification EtOAc:hexanes (1:4). Analytically pure material could not be obtained at this stage. General procedure for acidic deprotection followed. HCl/MeOH (50.0 mL) yield <b>4k</b> (412 mg, 1.07 mmol, 86%). Purification: crystallization from MeCN.</div></div></div><div id="sec5_11_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Expression, Purification, and Crystallography of CDK2 Complexed with <b>4k</b></h3><div class="NLM_p last">A cDNA encoding human CDK2<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> was cloned into a pProEx-HTb vector (Invitrogen) containing a 6×His-SUMO-1 N-terminal tag and expressed in <i>E. coli</i> BL21 (DE3). To cleave the SUMO tag, SuPr-1/Senp2 (Imagenes, Berlin, Germany) was cloned into pET28b (Novagen) with both N- and C-terminal 6×His tags and expressed in <i>E. coli</i> BL21(DE3). After a first nickel affinity purification, 6×His-SUMO-CDK2 was incubated with partially purified SUMO protease at 4 °C overnight. Cleaved CDK2 was separated from the 6×His-SUMO tag and the SUMO protease using a second nickel affinity column and further purified on a Superdex 75 gel filtration column (GE Healthcare). This purification method takes advantage of the fact that the SUMO protease cleaves the SUMO tag without leaving any extra N-terminal residues, which would hinder crystallization. Purified CDK2 was stored at −80 °C in the crystallization buffer (10 mM Hepes pH 7.4, 0.5 mM DTT). Crystallization and ligand soaking conditions were as previously described.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> A 1.8 Å diffraction data set was collected at beamline I02 (Diamond Light Source, Didcot, England) and the structure solved by molecular replacement with Molrep4,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> using the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1HCK">1HCK</a> PDB structure as the search model. <b>4k</b> was fitted automatically using ARP/wARP ligand<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and the structure refined using Refmac5.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Coordinates and structure factors have been deposited to the Protein Data Bank, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NS9">3NS9</a>.</div></div><div id="sec5_11_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> In Vitro Kinase Assays</h3><div class="NLM_p last">Purified recombinant CDK1/cycB1, CDK2/cycE, CDK4/cycD1, CDK5/p35NCK, CDK6/CycD1, CDK7/CycH/MAT1, and CDK9/CycT were purchased from Proqinase GmbH (Freiburg, Germany). Kinase assays were performed according to manufacturer’s protocols, using substrate peptides purchased from Proqinase GmbH. Measurement of the amount of ATP remaining at the end of the reaction, carried out with a luciferase assay (PKLight assay; Cambrex, England), was used to determine inhibition of kinase activity by compounds.</div></div><div id="sec5_11_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Cell Growth Assays</h3><div class="NLM_p last">Cell lines were obtained from the CRUK cell bank facility and were routinely cultured in DMEM supplemented with 10% fetal calf serum (FCS) (First Link, England). Cell growth was assessed using the Sulforhodamine B (SRB) assay, as described.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Human normal umbilical vein endothelial cells (HUVEC) and the appropriate culture media were purchased from Lonza Wokingham Ltd., England, and the cells were cultured as per supplier’s protocols.</div></div><div id="sec5_11_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Flow Cytometry</h3><div class="NLM_p last">HCT116 colon cancer cells were seeded (4 × 10<sup>5</sup>) in 6-well plates in DMEM containing 10% FCS and allowed to adhere for 24 h. Compounds prepared in DMSO were added, and after 24 h incubation, cells were trypsinized, centrifuged at 1100 rpm for 5 min, and resuspended in 5 mL of ice-cold PBS, centrifuged as above, gently resuspended in 2 mL ice-cold 70% ethanol, and incubated at 4 °C for 1 h. Cells were washed twice with 5 mL of ice-cold PBS and resuspended in 100 μL of PBS containing 100 μg/mL RNase (Sigma-Aldrich, England) and 1 mL of 50 μg/mL propidium iodide (Sigma-Aldrich, England) in PBS. Following incubation overnight in the dark at 4 °C and filtering through 70 μm muslin gauze into FACS tubes (Becton-Dickinson, England) to remove cell clumps, stained cells were processed using the RXP cytomics software on a Beckman Coulter Elite ESP (Beckman Coulter, High Wycombe, United Kingdom). The data were analyzed using Flow Jo v7.2.5 (Tree Star Inc., San Calos, CA), and statistical analysis was performed using the unpaired Student’s <i>t</i> test to determine <i>p</i>-values.</div></div><div id="sec5_11_4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Immunoblotting</h3><div class="NLM_p last">Cells (8 ×10<sup>5</sup>), plated in 10 cm plates, were treated with compounds after 24 h. Four hours later, cell lysates were prepared by the addition of 500 μL of RIPA buffer (Sigma-Aldrich, England), containing phosphatase inhibitor cocktail and complete protease inhibitor cocktail, both from Roche Diagnostics, England. Protein concentrations were determined using the BCA protein assay (Thermo-Scientific, England). Immunoblotting was performed as described previously.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Antibody details are available upon request.</div></div><div id="sec5_11_4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> In Vivo Assessment of Molecular Pharmcology</h3><div class="NLM_p last">All procedures were approved by the Imperial College London Animal Ethics Committee. The experiments were done by licensed investigators in accordance with the United Kingdom Home Office’s regulations under the Animal (Scientific Procedures) Act 1986 and were within guidelines set out by the United Kingdom Coordinating Committee for Cancer Research’s Ad hoc Committee on the Welfare of Animals in Experimental Neoplasia.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Seven-week-old female nu/nu-BALB/c athymic nude mice were purchased from Harlan Olac Ltd. (England). <b>4k</b>, prepared in 28% (w/v) PEG300/5% (v/v) dimethylacetamide/10% (w/v) HPB cyclodextrin in H<sub>2</sub>O, was administered by oral gavage. Drug was administered by exact body weight, with the injection volume being not more than 0.2 mL. After 6 h, the mice were anaesthetized and blood collected by cardiac puncture into tubes containing 200 μL of PBS, 100 U of Heparin, and 10 mM EDTA. Blood was mixed with 1 mL of red blood cell lysis solution (Flowgen Bioscience, Nottingham, England) for 15 min at room temperature, followed by centrifugation for 5 min at 1,000 rpm to pellet the peripheral blood mononuclear cells (PBMC). PMBC were washed twice in PBS, and the cells were stained using the Fix and Perm kit (Caltag Laboratories, Burlingame, CA, USA) following the manufacturer’s instructions. Briefly, after washing the PBMCs in PBS, 2 × 10<sup>4</sup>−10<sup>5</sup> cells were fixed using 50 μL of reagent A (fixation medium) for 15 min at room temperature. At the end of the incubation, the cells were washed in PBS, and then 50 μL of reagent B (permeabilization medium) was added together with antibodies for RNA polymerase II (PolII), PolII P-Ser2, RB, or RB P-Thr821 (purchased from Abcam, England) at a dilution of 1:100 for 1 h at room temperature. Cells were washed three times with PBS and were incubated for 1 h with goat antirabbit Alexafluor 488 (Invitrogen, Paisley, England) diluted at 1:200 in PBS in the dark at room temperature. Finally cells were washed in PBS three times and resuspended in 200 μL of PBS and stored at 4 °C for flow cytometric analysis. Labeled cells were processed using the RXP cytomics software on a Beckman Coulter Elite ESP, and the data were analyzed using Flow Jo v7.2.5.</div></div><div id="sec5_11_4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Absorption, Distribution, Metabolism, Elimination and Toxicity (ADME-Tox) and Pharmacokinetic Studies</h3><div class="NLM_p last">Studies were performed under contract by Cerep Inc. (USA), using described methods.<a onclick="showRef(event, 'ref45 ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47 ref48">(45-48)</a></div></div><div id="sec5_11_4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Tumor Xenografts</h3><div class="NLM_p last">HCT116 cells (5 × 10<sup>6</sup>) were injected subcutaneously in not more than 0.1 mL volume into the flank of the animals (female nu/nu-BALB/c athymic nude mice). Tumor measurements were performed twice per week, and volumes were calculated using the formula <sup>1</sup>/<sub>2</sub>[length (mm)] × [width (mm)]<sup>2</sup>. The animals were randomized, and when tumors had reached a volume of 100−200 mm<sup>3</sup>, animals were entered into the different treatment groups and treatment with <b>4k</b> or vehicle control was initiated. Animals were treated with <b>4k</b> prepared as abovedaily by oral gavage for a total of 14 days. At the end of the 14-day treatment period, the mice were sacrificed, and the tumors were fixed by formalin fixation and paraffin embedding. Throughout the 14-day treatment period, animal weights were determined each day and tumor volumes on alternate days. The MCF-7 xenograft study was performed exactly as described previously.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div></div><div id="sec5_11_4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Immunohistochemistry</h3><div class="NLM_p last">Tumors were dissected from mice and fixed in 10% formalin and embedded in paraffin blocks. Immunohistochemical staining was performed as described previously,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> except that antigen retrieval was performed by microwaving for 10 min using 10 mmol/L citrate buffer (pH 6.0). Antibodies used were Rb pThr821 (ab4787) from Abcam (England) or Rb (9309) and Rb pSer807/811 (9308) from New England Biolabs, England. Images were acquired using the Automated Cellular Imaging System (ACIS) (Carl Zeiss Ltd., Welwyn Garden City, England). Cell positivity was determined by counting >1000 cells per section, and the results were tabulated using GraphPad Prism software, with statistical significance being determined using the Student’s <i>t</i> test (GraphPad Prism).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44"><a href="/doi/suppl/10.1021/jm100732t">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55254" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55254" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">In vitro kinase and cell growth inhibition data, cell cycle profiles, and spectral data for <b>4k</b>, as well as additional synthetic methods. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm100732t/suppl_file/jm100732t_si_001.pdf">jm100732t_si_001.pdf (2.06 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm100732t" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56743" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56743" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simak Ali</span> - <span class="hlFld-Affiliation affiliation">Dept of Oncology, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, England</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9ceff5f1fdf7b2fdf0f5dcf5f1ecf9eef5fdf0b2fdffb2e9f7"><span class="__cf_email__" data-cfemail="dcafb5b1bdb7f2bdb0b59cb5b1acb9aeb5bdb0f2bdbff2a9b7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dean A. Heathcote</span> - <span class="hlFld-Affiliation affiliation">Dept of Oncology, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, England</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hetal Patel</span> - <span class="hlFld-Affiliation affiliation">Dept of Oncology, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, England</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sebastian H. B. Kroll</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Imperial College London, London SW7 2AZ, England</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pascale Hazel</span> - <span class="hlFld-Affiliation affiliation">Division of Molecular Biosciences, Imperial College London, London SW7 2AZ, England</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manikandan Periyasamy</span> - <span class="hlFld-Affiliation affiliation">Dept of Oncology, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, England</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary Alikian</span> - <span class="hlFld-Affiliation affiliation">Dept of Oncology, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, England</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Seshu K. Kanneganti</span> - <span class="hlFld-Affiliation affiliation">Dept of Oncology, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, England</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ashutosh S. Jogalekar</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Emory University, Atlanta GA30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bodo Scheiper</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Imperial College London, London SW7 2AZ, England</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marion Barbazanges</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Imperial College London, London SW7 2AZ, England</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andreas Blum</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Imperial College London, London SW7 2AZ, England</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jan Brackow</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Imperial College London, London SW7 2AZ, England</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alekasandra Siwicka</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Imperial College London, London SW7 2AZ, England</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert D. M. Pace</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Imperial College London, London SW7 2AZ, England</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew J. Fuchter</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Imperial College London, London SW7 2AZ, England</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James P. Snyder</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Emory University, Atlanta GA30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dennis C. Liotta</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Emory University, Atlanta GA30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul. S. Freemont</span> - <span class="hlFld-Affiliation affiliation">Division of Molecular Biosciences, Imperial College London, London SW7 2AZ, England</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric O. Aboagye</span> - <span class="hlFld-Affiliation affiliation">Dept of Oncology, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, England</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">R. Charles Coombes</span> - <span class="hlFld-Affiliation affiliation">Dept of Oncology, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, England</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony G. M. Barrett</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Imperial College London, London SW7 2AZ, England</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01878" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01878" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was funded by grants from the Engineering and Physical Sciences Research Council and Cancer Research UK. Our thanks go to the MRC Protein Phosphorylation unit for the 76-kinase screening and to Cerep, Inc. for the ADME-Tox and PK studies. The Developmental Therapeutics Program at NCI carried out the NCI60 screening of <b>4k</b>. We are grateful for support from the NIHR Biomedical Research Centre funding scheme. We also thank the CR-UK and the Dept of Health funded Imperial College Experimental Cancer Medicine Centre (ECMC) grant.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43388" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43388" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 51 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Sherr, C. J.</span><span> </span><span class="NLM_article-title">Cancer cell cycles</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">1672</span><span class="NLM_x">–</span> <span class="NLM_lpage">1677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1996&pages=1672-1677&author=C.+J.+Sherr&title=Cancer+cell+cycles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSherr%26aufirst%3DC.%2BJ.%26atitle%3DCancer%2520cell%2520cycles%26jtitle%3DScience%26date%3D1996%26volume%3D274%26spage%3D1672%26epage%3D1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Morgan, D. O.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinases: engines, clocks, and microprocessors</span> <span class="citation_source-journal">Annu. Rev. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1146%2Fannurev.cellbio.13.1.261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=9442875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADyaK1cXisFSktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1997&pages=261-291&author=D.+O.+Morgan&title=Cyclin-dependent+kinases%3A+engines%2C+clocks%2C+and+microprocessors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-dependent kinases: engines, clocks, and microprocessors</span></div><div class="casAuthors">Morgan, David O.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Cell and Developmental Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">261-291</span>CODEN:
                <span class="NLM_cas:coden">ARDBF8</span>;
        ISSN:<span class="NLM_cas:issn">1081-0706</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 133 refs.  Cyclin-dependent kinases (Cdks) play a well-established role in the regulation of the eukaryotic cell division cycle and have also been implicated in the control of gene transcription and other processes.  Cdk activity is governed by a complex network of regulatory subunits and phosphorylation events whose precise effects on Cdk conformation have been revealed by recent crystallog. studies.  In the cell, these regulatory mechanisms generate an interlinked series of Cdk oscillators that trigger the events of cell division.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDw-roxCwtY7Vg90H21EOLACvtfcHk0limzuqZS-VugQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFSktA%253D%253D&md5=9b9b161d0beaef5e7934bab158906dcd</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.cellbio.13.1.261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.cellbio.13.1.261%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DD.%2BO.%26atitle%3DCyclin-dependent%2520kinases%253A%2520engines%252C%2520clocks%252C%2520and%2520microprocessors%26jtitle%3DAnnu.%2520Rev.%2520Cell%2520Dev.%2520Biol.%26date%3D1997%26volume%3D13%26spage%3D261%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Cell cycle, CDKs and cancer: a changing paradigm</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1038%2Fnrc2602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=19238148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1ans78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=153-166&author=M.+Malumbresauthor=M.+Barbacid&title=Cell+cycle%2C+CDKs+and+cancer%3A+a+changing+paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle, CDKs and cancer: a changing paradigm</span></div><div class="casAuthors">Malumbres, Marcos; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-166</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Tumor-assocd. cell cycle defects are often mediated by alterations in cyclin-dependent kinase (CDK) activity.  Misregulated CDKs induce unscheduled proliferation as well as genomic and chromosomal instability.  According to current models, mammalian CDKs are essential for driving each cell cycle phase, so therapeutic strategies that block CDK activity are unlikely to selectively target tumor cells.  However, recent genetic evidence has revealed that, whereas CDK1 is required for the cell cycle, interphase CDKs are only essential for proliferation of specialized cells.  Emerging evidence suggests that tumor cells may also require specific interphase CDKs for proliferation.  Thus, selective CDK inhibition may provide therapeutic benefit against certain human neoplasias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzlIKlbCPWnLVg90H21EOLACvtfcHk0limzuqZS-VugQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1ans78%253D&md5=2a7eb34b2381e288b3f43ec1bffc0aec</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc2602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2602%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DCell%2520cycle%252C%2520CDKs%2520and%2520cancer%253A%2520a%2520changing%2520paradigm%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D153%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Fu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pestell, R. G.</span><span> </span><span class="NLM_article-title">Minireview: Cyclin D1: normal and abnormal functions</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">5439</span><span class="NLM_x">–</span> <span class="NLM_lpage">5447</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2004&pages=5439-5447&author=M.+Fuauthor=C.+Wangauthor=Z.+Liauthor=T.+Sakamakiauthor=R.+G.+Pestell&title=Minireview%3A+Cyclin+D1%3A+normal+and+abnormal+functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DSakamaki%26aufirst%3DT.%26aulast%3DPestell%26aufirst%3DR.%2BG.%26atitle%3DMinireview%253A%2520Cyclin%2520D1%253A%2520normal%2520and%2520abnormal%2520functions%26jtitle%3DEndocrinology%26date%3D2004%26volume%3D145%26spage%3D5439%26epage%3D5447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">To cycle or not to cycle: a critical decision in cancer</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1038%2F35106065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=11902577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvF2qtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=222-231&author=M.+Malumbresauthor=M.+Barbacid&title=To+cycle+or+not+to+cycle%3A+a+critical+decision+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Milestones in cell division: to cycle or not to cycle: a critical decision in cancer</span></div><div class="casAuthors">Malumbres, Marcos; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">222-231</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Tumor cells undergo uncontrolled proliferation, yet tumors most often originate from adult tissues, in which most cells are quiescent.  So, the proliferative advantage of tumor cells arises from their ability to bypass quiescence.  This can be due to increased mitogenic signaling and/or alterations that lower the threshold required for cell-cycle commitment.  Understanding the mol. mechanisms that underlie this commitment should provide important insights into how normal cells become tumorigenic and how new anticancer strategies can be devised.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI2EOLFB2ULbVg90H21EOLACvtfcHk0ljLrYi5pOulNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvF2qtrg%253D&md5=2bd8961854332a30c814f8ac2f9bd6f4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F35106065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35106065%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DTo%2520cycle%2520or%2520not%2520to%2520cycle%253A%2520a%2520critical%2520decision%2520in%2520cancer%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2001%26volume%3D1%26spage%3D222%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Ortega, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odajima, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotillo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbero, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice</span> <span class="citation_source-journal">Nature Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1038%2Fng1232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=12923533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmslelsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2003&pages=25-31&author=S.+Ortegaauthor=I.+Prietoauthor=J.+Odajimaauthor=A.+Martinauthor=P.+Dubusauthor=R.+Sotilloauthor=J.+L.+Barberoauthor=M.+Malumbresauthor=M.+Barbacid&title=Cyclin-dependent+kinase+2+is+essential+for+meiosis+but+not+for+mitotic+cell+division+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice</span></div><div class="casAuthors">Ortega, Sagrario; Prieto, Ignacio; Odajima, Junko; Martin, Alberto; Dubus, Pierre; Sotillo, Rocio; Barbero, Jose Luis; Malumbres, Marcos; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-31</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We targeted the locus encoding the cyclin-dependent kinase 2 (CDK2) by homologous recombination in mouse embryonic stem (ES) cells.  Embryonic fibroblasts lacking CDK2 proliferate normally and become immortal after continuous passage in culture.  Elimination of a conditional Cdk2 allele in immortal cells does not have a significant effect on proliferation.  Cdk2-/- mice are viable and survive for up to two years, indicating that CDK2 is also dispensable for proliferation and survival of most cell types.  But CDK2 is essential for completion of prophase I during meiotic cell division in male and female germ cells, an unforeseen role for this cell cycle kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5r24x7syf9bVg90H21EOLACvtfcHk0ljLrYi5pOulNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmslelsrw%253D&md5=7f2898209c25b5b663626897ec956a2f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fng1232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1232%26sid%3Dliteratum%253Aachs%26aulast%3DOrtega%26aufirst%3DS.%26aulast%3DPrieto%26aufirst%3DI.%26aulast%3DOdajima%26aufirst%3DJ.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DDubus%26aufirst%3DP.%26aulast%3DSotillo%26aufirst%3DR.%26aulast%3DBarbero%26aufirst%3DJ.%2BL.%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DCyclin-dependent%2520kinase%25202%2520is%2520essential%2520for%2520meiosis%2520but%2520not%2520for%2520mitotic%2520cell%2520division%2520in%2520mice%26jtitle%3DNature%2520Genet.%26date%3D2003%26volume%3D35%26spage%3D25%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Berthet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleem, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tessarollo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaldis, P.</span><span> </span><span class="NLM_article-title">Cdk2 knockout mice are viable</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1775</span><span class="NLM_x">–</span> <span class="NLM_lpage">1785</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1016%2Fj.cub.2003.09.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=14561402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXot12itbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1775-1785&author=C.+Berthetauthor=E.+Aleemauthor=V.+Coppolaauthor=L.+Tessarolloauthor=P.+Kaldis&title=Cdk2+knockout+mice+are+viable"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cdk2 Knockout Mice Are Viable</span></div><div class="casAuthors">Berthet, Cyril; Aleem, Eiman; Coppola, Vincenzo; Tessarollo, Lino; Kaldis, Philipp</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1775-1785</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Background: Cyclin-dependent kinases (Cdks) and their cyclin regulatory subunits control cell growth and division.  Cdk2/cyclin E complexes are thought to be required because they phosphorylate the retinoblastoma protein and drive cells through the G1/S transition into the S phase of the cell cycle.  In addn., Cdk2 assocs. with cyclin A, which itself is essential for cell proliferation during early embryonic development.  Results: In order to study the functions of Cdk2 in vivo, we generated Cdk2 knockout mice.  Surprisingly, these mice are viable, and therefore Cdk2 is not an essential gene in the mouse.  However, Cdk2 is required for germ cell development; both male and female Cdk2-/- mice are sterile.  Immunoppts. of cyclin E1 complexes from Cdk2-/- spleen exts. displayed no activity toward histone H1.  Cyclin A2 complexes were active in primary mouse embryonic fibroblasts (MEFs), embryo exts. and in spleen exts. from young animals.  In contrast, there was little cyclin A2 kinase activity in immortalized MEFs and spleen exts. from adult animals.  Cdk2-/- MEFs proliferate but enter delayed into S phase.  Ectopic expression of Cdk2 in Cdk2-/- MEFs rescued the delayed entry into S phase.  Conclusions: Although Cdk2 is not an essential gene in the mouse, it is required for germ cell development and meiosis.  Loss of Cdk2 affects the timing of S phase, suggesting that Cdk2 is involved in regulating progression through the mitotic cell cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0o-n-kcfSW7Vg90H21EOLACvtfcHk0ljLrYi5pOulNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXot12itbk%253D&md5=8bb2c819e566952895434253f667454c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2003.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2003.09.024%26sid%3Dliteratum%253Aachs%26aulast%3DBerthet%26aufirst%3DC.%26aulast%3DAleem%26aufirst%3DE.%26aulast%3DCoppola%26aufirst%3DV.%26aulast%3DTessarollo%26aufirst%3DL.%26aulast%3DKaldis%26aufirst%3DP.%26atitle%3DCdk2%2520knockout%2520mice%2520are%2520viable%26jtitle%3DCurr.%2520Biol.%26date%3D2003%26volume%3D13%26spage%3D1775%26epage%3D1785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Aleem, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyokawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaldis, P.</span><span> </span><span class="NLM_article-title">Cdc2-cyclin E complexes regulate the G1/S phase transition</span> <span class="citation_source-journal">Nature Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">831</span><span class="NLM_x">–</span> <span class="NLM_lpage">836</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1038%2Fncb1284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=16007079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvVClurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=831-836&author=E.+Aleemauthor=H.+Kiyokawaauthor=P.+Kaldis&title=Cdc2-cyclin+E+complexes+regulate+the+G1%2FS+phase+transition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cdc2-cyclin E complexes regulate the G1/S phase transition</span></div><div class="casAuthors">Aleem, Eiman; Kiyokawa, Hiroaki; Kaldis, Philipp</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">831-836</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The cyclin-dependent kinase inhibitor p27Kip1 is known as a neg. regulator of cell-cycle progression and as a tumor suppressor.  Cdk2 is the main target of p27 and therefore we hypothesized that loss of Cdk2 activity should modify the p27-/- mouse phenotype.  Here, we show that although p27-/- Cdk2-/- mice developed ovary tumors and tumors in the anterior lobe of the pituitary, we failed to detect any functional complementation in p27-/- Cdk2-/- double-knockout mice, indicating a parallel pathway regulated by p27.  We obsd. elevated levels of S phase and mitosis in tissues of p27-/- Cdk2-/- mice concomitantly with elevated Cdc2 activity in p27-/- Cdk2-/- exts. p27 binds to Cdc2, cyclin B1, cyclin A2, or suc1 complexes in wild-type and Cdk2-/- exts.  In addn., cyclin E binds to and activates Cdc2.  Our in vivo results provide strong evidence that Cdc2 may compensate the loss of Cdk2 function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9JLx0kmXSbLVg90H21EOLACvtfcHk0ljfRJK66J43pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvVClurs%253D&md5=a692be69a184476681cc9640f15587ea</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fncb1284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1284%26sid%3Dliteratum%253Aachs%26aulast%3DAleem%26aufirst%3DE.%26aulast%3DKiyokawa%26aufirst%3DH.%26aulast%3DKaldis%26aufirst%3DP.%26atitle%3DCdc2-cyclin%2520E%2520complexes%2520regulate%2520the%2520G1%252FS%2520phase%2520transition%26jtitle%3DNature%2520Cell%2520Biol.%26date%3D2005%26volume%3D7%26spage%3D831%26epage%3D836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Cai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latham, V. M.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span> </span><span class="NLM_article-title">Combined depletion of cell cycle and transcriptional cyclin-dependent kinase activities induces apoptosis in cancer cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">9270</span><span class="NLM_x">–</span> <span class="NLM_lpage">9280</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=9270-9280&author=D.+Caiauthor=V.+M.+Lathamauthor=X.+Zhangauthor=G.+I.+Shapiro&title=Combined+depletion+of+cell+cycle+and+transcriptional+cyclin-dependent+kinase+activities+induces+apoptosis+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DD.%26aulast%3DLatham%26aufirst%3DV.%2BM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26atitle%3DCombined%2520depletion%2520of%2520cell%2520cycle%2520and%2520transcriptional%2520cyclin-dependent%2520kinase%2520activities%2520induces%2520apoptosis%2520in%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D9270%26epage%3D9280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Rane, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mettus, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galbreath, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boden, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia</span> <span class="citation_source-journal">Nature Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1038%2F8751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=10319860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADyaK1MXjtVags7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1999&pages=44-52&author=S.+G.+Raneauthor=P.+Dubusauthor=R.+V.+Mettusauthor=E.+J.+Galbreathauthor=G.+Bodenauthor=E.+P.+Reddyauthor=M.+Barbacid&title=Loss+of+Cdk4+expression+causes+insulin-deficient+diabetes+and+Cdk4+activation+results+in+beta-islet+cell+hyperplasia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia</span></div><div class="casAuthors">Rane, Sushil G.; Dubus, Pierre; Mettus, Richard V.; Galbreath, Elizabeth J.; Boden, Guenther; Reddy, E. Premkumar; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-52</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">To ascertain the role of cyclin-dependent kinase 4 (Cdk4) in vivo, the authors have targeted the mouse Cdk4 locus by homologous recombination to generate two strains of mice, one that lacks Cdk4 expression and one that expresses a Cdk4 mol. with an activating mutation.  Embryonic fibroblasts proliferate normally in the absence of Cdk4 but have a delayed S phase on re-entry into the cell cycle.  Moreover, mice devoid of Cdk4 are viable, but small in size and infertile.  These mice also develop insulin-deficient diabetes due to a redn. in β-islet pancreatic cells.  In contrast, mice expressing a mutant Cdk4 that cannot bind the cell-cycle inhibitor P16INK4a display pancreatic hyperplasia due to abnormal proliferation of β-islet cells.  These results establish Cdk4 as an essential regulator of specific cell types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofmhLD8YQB97Vg90H21EOLACvtfcHk0ljfRJK66J43pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtVags7o%253D&md5=82326fc337b7b1ddabf2cb0fcfd6c288</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F8751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F8751%26sid%3Dliteratum%253Aachs%26aulast%3DRane%26aufirst%3DS.%2BG.%26aulast%3DDubus%26aufirst%3DP.%26aulast%3DMettus%26aufirst%3DR.%2BV.%26aulast%3DGalbreath%26aufirst%3DE.%2BJ.%26aulast%3DBoden%26aufirst%3DG.%26aulast%3DReddy%26aufirst%3DE.%2BP.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DLoss%2520of%2520Cdk4%2520expression%2520causes%2520insulin-deficient%2520diabetes%2520and%2520Cdk4%2520activation%2520results%2520in%2520beta-islet%2520cell%2520hyperplasia%26jtitle%3DNature%2520Genet.%26date%3D1999%26volume%3D22%26spage%3D44%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Tsutsui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesabi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moons, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandolfi, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansel, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyokawa, H.</span><span> </span><span class="NLM_article-title">Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">7011</span><span class="NLM_x">–</span> <span class="NLM_lpage">7019</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1128%2FMCB.19.10.7011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=10490638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADyaK1MXmtlals7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=7011-7019&author=T.+Tsutsuiauthor=B.+Hesabiauthor=D.+S.+Moonsauthor=P.+P.+Pandolfiauthor=K.+S.+Hanselauthor=A.+Koffauthor=H.+Kiyokawa&title=Targeted+disruption+of+CDK4+delays+cell+cycle+entry+with+enhanced+p27%28Kip1%29+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted disruption of CDK4 delays cell cycle entry with enhanced p27Kip1 activity</span></div><div class="casAuthors">Tsutsui, Tateki; Hesabi, Bahar; Moons, David S.; Pandolfi, Pier Paolo; Hansel, Kimberly S.; Koff, Andrew; Kiyokawa, Hiroaki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">7011-7019</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The mechanism by which cyclin-dependent kinase 4 (CDK4) regulates cell cycle progression is not entirely clear.  Cyclin D/CDK4 appears to initiate phosphorylation of retinoblastoma protein (Rb) leading to inactivation of the S-phase-inhibitory action of Rb.  However, cyclin D/CDK4 has been postulated to act in a noncatalytic manner to regulate the cyclin E/CDK2-inhibitory activity of p27Kip1 by sequestration.  In this study we investigated the roles of CDK4 in cell cycle regulation by targeted disruption of the mouse CDK4 gene.  CDK4-/- mice survived embryogenesis and showed growth retardation and reproductive dysfunction assocd. with hypoplastic seminiferous tubules in the testis and perturbed corpus luteum formation in the ovary.  These phenotypes appear to be opposite to those of p27-deficient mice such as gigantism and gonadal hyperplasia.  A majority of CDK4-/- mice developed diabetes mellitus by 6 wk, assocd. with degeneration of pancreatic islets.  Fibroblasts from CDK4-/- mouse embryos proliferated similarly to wild-type embryonic fibroblasts under conditions that promote continuous growth.  However, quiescent CDK4-/- fibroblasts exhibited a substantial (∼6-h) delay in S-phase entry after serum stimulation.  This cell cycle perturbation by CDK4 disruption was assocd. with increased binding of p27 to cyclin E/CDK2 and diminished activation of CDK2 accompanied by impaired Rb phosphorylation.  Importantly, fibroblasts from CDK4-/- p27-/- embryos displayed partially restored kinetics of the G0-S transition, indicating the significance of the sequestration of p27 by CDK4.  These results suggest that at least part of CDK4's participation in the rate-limiting mechanism for the G0-S transition consists of controlling p27 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKIPUccGpY97Vg90H21EOLACvtfcHk0ljfRJK66J43pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtlals7c%253D&md5=bba944ba00b313a19943eaa2acad2301</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1128%2FMCB.19.10.7011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.19.10.7011%26sid%3Dliteratum%253Aachs%26aulast%3DTsutsui%26aufirst%3DT.%26aulast%3DHesabi%26aufirst%3DB.%26aulast%3DMoons%26aufirst%3DD.%2BS.%26aulast%3DPandolfi%26aufirst%3DP.%2BP.%26aulast%3DHansel%26aufirst%3DK.%2BS.%26aulast%3DKoff%26aufirst%3DA.%26aulast%3DKiyokawa%26aufirst%3DH.%26atitle%3DTargeted%2520disruption%2520of%2520CDK4%2520delays%2520cell%2520cycle%2520entry%2520with%2520enhanced%2520p27%2528Kip1%2529%2520activity%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1999%26volume%3D19%26spage%3D7011%26epage%3D7019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotillo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santamaria, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerezo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">493</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2004&pages=493-504&author=M.+Malumbresauthor=R.+Sotilloauthor=D.+Santamariaauthor=J.+Galanauthor=A.+Cerezoauthor=S.+Ortegaauthor=P.+Dubusauthor=M.+Barbacid&title=Mammalian+cells+cycle+without+the+D-type+cyclin-dependent+kinases+Cdk4+and+Cdk6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DSotillo%26aufirst%3DR.%26aulast%3DSantamaria%26aufirst%3DD.%26aulast%3DGalan%26aufirst%3DJ.%26aulast%3DCerezo%26aufirst%3DA.%26aulast%3DOrtega%26aufirst%3DS.%26aulast%3DDubus%26aufirst%3DP.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DMammalian%2520cells%2520cycle%2520without%2520the%2520D-type%2520cyclin-dependent%2520kinases%2520Cdk4%2520and%2520Cdk6%26jtitle%3DCell%26date%3D2004%26volume%3D118%26spage%3D493%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Yu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahnstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagozdzon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyokawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stal, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span> </span><span class="NLM_article-title">Requirement for CDK4 kinase function in breast cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1016%2Fj.ccr.2005.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=16413469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD28XosFersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=23-32&author=Q.+Yuauthor=E.+Sicinskaauthor=Y.+Gengauthor=M.+Ahnstromauthor=A.+Zagozdzonauthor=Y.+Kongauthor=H.+Gardnerauthor=H.+Kiyokawaauthor=L.+N.+Harrisauthor=O.+Stalauthor=P.+Sicinski&title=Requirement+for+CDK4+kinase+function+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement for CDK4 kinase function in breast cancer</span></div><div class="casAuthors">Yu, Qunyan; Sicinska, Ewa; Geng, Yan; Ahnstrom, Marie; Zagozdzon, Agnieszka; Kong, Yinxin; Gardner, Humphrey; Kiyokawa, Hiroaki; Harris, Lyndsay N.; Stal, Olle; Sicinski, Piotr</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-32</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cyclin D1 is overexpressed in the majority of human breast cancers.  The authors previously found that mice lacking cyclin D1 are resistant to mammary carcinomas triggered by the ErbB-2 oncogene.  In this study, the authors investigated which function of cyclin D1 is required for ErbB-2-driven mammary oncogenesis.  The authors report that the ability of cyclin D1 to activate cyclin-dependent kinase CDK4 underlies the crit. role for cyclin D1 in breast cancer formation.  The authors also found that the continued presence of CDK4-assocd. kinase activity is required to maintain breast tumorigenesis.  The authors analyzed primary human breast cancers and found high cyclin D1 levels in a subset (∼25%) of ErbB-2-overexpressing tumors.  The authors propose that this subset of breast cancer patients might benefit from inhibiting CDK4 kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7XtIoi9OqULVg90H21EOLACvtfcHk0limGabVH1SeaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosFersw%253D%253D&md5=de0dbbf7f2463d60b126c201ac6bb7f6</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2005.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2005.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DSicinska%26aufirst%3DE.%26aulast%3DGeng%26aufirst%3DY.%26aulast%3DAhnstrom%26aufirst%3DM.%26aulast%3DZagozdzon%26aufirst%3DA.%26aulast%3DKong%26aufirst%3DY.%26aulast%3DGardner%26aufirst%3DH.%26aulast%3DKiyokawa%26aufirst%3DH.%26aulast%3DHarris%26aufirst%3DL.%2BN.%26aulast%3DStal%26aufirst%3DO.%26aulast%3DSicinski%26aufirst%3DP.%26atitle%3DRequirement%2520for%2520CDK4%2520kinase%2520function%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D23%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Landis, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlyk, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinds, P. W.</span><span> </span><span class="NLM_article-title">Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=13-22&author=M.+W.+Landisauthor=B.+S.+Pawlykauthor=T.+Liauthor=P.+Sicinskiauthor=P.+W.+Hinds&title=Cyclin+D1-dependent+kinase+activity+in+murine+development+and+mammary+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLandis%26aufirst%3DM.%2BW.%26aulast%3DPawlyk%26aufirst%3DB.%2BS.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DSicinski%26aufirst%3DP.%26aulast%3DHinds%26aufirst%3DP.%2BW.%26atitle%3DCyclin%2520D1-dependent%2520kinase%2520activity%2520in%2520murine%2520development%2520and%2520mammary%2520tumorigenesis%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D13%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Reddy, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mettus, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rane, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grana, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litvin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, E. P.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinase 4 expression is essential for neu-induced breast tumorigenesis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">10174</span><span class="NLM_x">–</span> <span class="NLM_lpage">10178</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=10174-10178&author=H.+K.+Reddyauthor=R.+V.+Mettusauthor=S.+G.+Raneauthor=X.+Granaauthor=J.+Litvinauthor=E.+P.+Reddy&title=Cyclin-dependent+kinase+4+expression+is+essential+for+neu-induced+breast+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DH.%2BK.%26aulast%3DMettus%26aufirst%3DR.%2BV.%26aulast%3DRane%26aufirst%3DS.%2BG.%26aulast%3DGrana%26aufirst%3DX.%26aulast%3DLitvin%26aufirst%3DJ.%26aulast%3DReddy%26aufirst%3DE.%2BP.%26atitle%3DCyclin-dependent%2520kinase%25204%2520expression%2520is%2520essential%2520for%2520neu-induced%2520breast%2520tumorigenesis%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D10174%26epage%3D10178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Yu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span> </span><span class="NLM_article-title">Specific protection against breast cancers by cyclin D1 ablation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">411</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1021</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2001&pages=1017-1021&author=Q.+Yuauthor=Y.+Gengauthor=P.+Sicinski&title=Specific+protection+against+breast+cancers+by+cyclin+D1+ablation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DGeng%26aufirst%3DY.%26aulast%3DSicinski%26aufirst%3DP.%26atitle%3DSpecific%2520protection%2520against%2520breast%2520cancers%2520by%2520cyclin%2520D1%2520ablation%26jtitle%3DNature%26date%3D2001%26volume%3D411%26spage%3D1017%26epage%3D1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Is Cyclin D1-CDK4 kinase a bona fide cancer target?</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=2-4&author=M.+Malumbresauthor=M.+Barbacid&title=Is+Cyclin+D1-CDK4+kinase+a+bona+fide+cancer+target%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DIs%2520Cyclin%2520D1-CDK4%2520kinase%2520a%2520bona%2520fide%2520cancer%2520target%253F%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D2%26epage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Roy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adamczewski, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seroz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeulen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tassan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeffer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoeijmakers, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egly, J. M.</span><span> </span><span class="NLM_article-title">The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1093</span><span class="NLM_x">–</span> <span class="NLM_lpage">1101</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1994&pages=1093-1101&author=R.+Royauthor=J.+P.+Adamczewskiauthor=T.+Serozauthor=W.+Vermeulenauthor=J.+P.+Tassanauthor=L.+Schaefferauthor=E.+A.+Niggauthor=J.+H.+Hoeijmakersauthor=J.+M.+Egly&title=The+MO15+cell+cycle+kinase+is+associated+with+the+TFIIH+transcription-DNA+repair+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DR.%26aulast%3DAdamczewski%26aufirst%3DJ.%2BP.%26aulast%3DSeroz%26aufirst%3DT.%26aulast%3DVermeulen%26aufirst%3DW.%26aulast%3DTassan%26aufirst%3DJ.%2BP.%26aulast%3DSchaeffer%26aufirst%3DL.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26aulast%3DHoeijmakers%26aufirst%3DJ.%2BH.%26aulast%3DEgly%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520MO15%2520cell%2520cycle%2520kinase%2520is%2520associated%2520with%2520the%2520TFIIH%2520transcription-DNA%2520repair%2520factor%26jtitle%3DCell%26date%3D1994%26volume%3D79%26spage%3D1093%26epage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Serizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makela, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conaway, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conaway, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. A.</span><span> </span><span class="NLM_article-title">Association of Cdk-activating kinase subunits with transcription factor TFIIH</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x">, </span> <span class="NLM_fpage">280</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=1995&pages=280-282&author=H.+Serizawaauthor=T.+P.+Makelaauthor=J.+W.+Conawayauthor=R.+C.+Conawayauthor=R.+A.+Weinbergauthor=R.+A.+Young&title=Association+of+Cdk-activating+kinase+subunits+with+transcription+factor+TFIIH"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSerizawa%26aufirst%3DH.%26aulast%3DMakela%26aufirst%3DT.%2BP.%26aulast%3DConaway%26aufirst%3DJ.%2BW.%26aulast%3DConaway%26aufirst%3DR.%2BC.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26aulast%3DYoung%26aufirst%3DR.%2BA.%26atitle%3DAssociation%2520of%2520Cdk-activating%2520kinase%2520subunits%2520with%2520transcription%2520factor%2520TFIIH%26jtitle%3DNature%26date%3D1995%26volume%3D374%26spage%3D280%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Fisher, R. P.</span><span> </span><span class="NLM_article-title">Secrets of a double agent: CDK7 in cell-cycle control and transcription</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">5171</span><span class="NLM_x">–</span> <span class="NLM_lpage">5180</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1242%2Fjcs.02718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=16280550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlWru73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2005&pages=5171-5180&author=R.+P.+Fisher&title=Secrets+of+a+double+agent%3A+CDK7+in+cell-cycle+control+and+transcription"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Secrets of a double agent: CDK7 in cell cycle control and transcription</span></div><div class="casAuthors">Fisher, Robert P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5171-5180</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  In metazoans, cyclin-dependent kinase 7 (CDK7) has essential roles in both the cell division cycle and transcription, as a CDK-activating kinase (CAK) and as a component of the general transcription factor TFIIH, resp.  Controversy over its double duty has been resolved, but questions remain.  First, how does CDK7 achieve the dual substrate specificity necessary to perform both roles.  Second, is there a deeper connection implied by the dichotomy of CDK7 function, for example similar mechanisms controlling cell division and gene expression, and/or actual coordination of the two processes.  Enzymol. studies have revealed solns. to the unusual substrate recognition problem, and there is evidence that the distinct functions of CDK7 can be regulated independently.  Finally, despite divergence in their wiring, the CAK-CDK networks of budding yeast, fission yeast and metazoans all link transcriptional regulation with operation of the cell cycle machinery.  This connection might help to ensure that mRNAs encoding effectors of cell division are expressed at the right time in the cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjIga058ymZrVg90H21EOLACvtfcHk0lhQmTyWN0OjZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlWru73F&md5=d97c0b0080a97d0c9692f76f63d364f8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1242%2Fjcs.02718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.02718%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DR.%2BP.%26atitle%3DSecrets%2520of%2520a%2520double%2520agent%253A%2520CDK7%2520in%2520cell-cycle%2520control%2520and%2520transcription%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2005%26volume%3D118%26spage%3D5171%26epage%3D5180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">DePinto, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goelzer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tovar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blain, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevins, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luistro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolinsky, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felix, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heimbrook, D.</span><span> </span><span class="NLM_article-title">In vitro and in vivo activity of R547: a potent and selective cyclin-dependent kinase inhibitor currently in phase I clinical trials</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">2644</span><span class="NLM_x">–</span> <span class="NLM_lpage">2658</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1158%2F1535-7163.MCT-06-0355" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=17121911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1els7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=2644-2658&author=W.+DePintoauthor=X.+J.+Chuauthor=X.+Yinauthor=M.+Smithauthor=K.+Packmanauthor=P.+Goelzerauthor=A.+Loveyauthor=Y.+Chenauthor=H.+Qianauthor=R.+Hamidauthor=Q.+Xiangauthor=C.+Tovarauthor=R.+Blainauthor=T.+Nevinsauthor=B.+Higginsauthor=L.+Luistroauthor=K.+Kolinskyauthor=B.+Felixauthor=S.+Hussainauthor=D.+Heimbrook&title=In+vitro+and+in+vivo+activity+of+R547%3A+a+potent+and+selective+cyclin-dependent+kinase+inhibitor+currently+in+phase+I+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo activity of R547: a potent and selective cyclin-dependent kinase inhibitor currently in phase I clinical trials</span></div><div class="casAuthors">DePinto, Wanda; Chu, Xin-Jie; Yin, Xuefeng; Smith, Melissa; Packman, Kathryn; Goelzer, Petra; Lovey, Allen; Chen, Yingsi; Qian, Hong; Hamid, Rachid; Xiang, Qing; Tovar, Christian; Blain, Roger; Nevins, Tom; Higgins, Brian; Luistro, Leopoldo; Kolinsky, Kenneth; Felix, Bernardo; Hussain, Sazzad; Heimbrook, David</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2644-2658</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The cyclin-dependent protein kinases are key regulators of cell cycle progression.  Aberrant expression or altered activity of distinct cyclin-dependent kinase (CDK) complexes results in escape of cells from cell cycle control, leading to unrestricted cell proliferation.  CDK inhibitors have the potential to induce cell cycle arrest and apoptosis in cancer cells, and identifying small-mol. CDK inhibitors has been a major focus in cancer research.  Several CDK inhibitors are entering the clinic, the most recent being selective CDK2 and CDK4 inhibitors.  We have identified a diaminopyrimidine compd., R547, which is a potent and selective ATP-competitive CDK inhibitor.  In cell-free assays, R547 effectively inhibited CDK1/cyclin B, CDK2/cyclin E, and CDK4/cyclin D1 (Ki = 1-3 nmol/L) and was inactive (Ki > 5000 nmol/L) against a panel of >120 unrelated kinases.  In vitro, R547 effectively inhibited the proliferation of tumor cell lines independent of multidrug resistant status, histol. type, retinoblastoma protein, or p53 status, with IC50s ≤ 0.60 μmol/L.  The growth-inhibitory activity is characterized by a cell cycle block at G1 and G2 phases and induction of apoptosis.  R547 reduced phosphorylation of the cellular retinoblastoma protein at specific CDK phosphorylation sites at the same concns. that induced cell cycle arrest, suggesting a potential pharmacodynamic marker for clin. use.  In vivo, R547 showed antitumor activity in all of the models tested to date, including six human tumor xenografts and an orthotopic syngeneic rat model.  R547 was efficacious with daily oral dosing as well as with once weekly i.v. dosing in established human tumor models and at the targeted efficacious exposures inhibited phosphorylation of the retinoblastoma protein in the tumors.  The selective kinase inhibition profile and the preclin. antitumor activity of R547 suggest that it may be promising for development for use in the treatment of solid tumors.  R547 is currently being evaluated in phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTvfleWG6NybVg90H21EOLACvtfcHk0lhQmTyWN0OjZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1els7nM&md5=ce7c9fc59ec7e500778035b4a9103bf5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0355%26sid%3Dliteratum%253Aachs%26aulast%3DDePinto%26aufirst%3DW.%26aulast%3DChu%26aufirst%3DX.%2BJ.%26aulast%3DYin%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DGoelzer%26aufirst%3DP.%26aulast%3DLovey%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DQian%26aufirst%3DH.%26aulast%3DHamid%26aufirst%3DR.%26aulast%3DXiang%26aufirst%3DQ.%26aulast%3DTovar%26aufirst%3DC.%26aulast%3DBlain%26aufirst%3DR.%26aulast%3DNevins%26aufirst%3DT.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DLuistro%26aufirst%3DL.%26aulast%3DKolinsky%26aufirst%3DK.%26aulast%3DFelix%26aufirst%3DB.%26aulast%3DHussain%26aufirst%3DS.%26aulast%3DHeimbrook%26aufirst%3DD.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520activity%2520of%2520R547%253A%2520a%2520potent%2520and%2520selective%2520cyclin-dependent%2520kinase%2520inhibitor%2520currently%2520in%2520phase%2520I%2520clinical%2520trials%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D2644%26epage%3D2658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodhead, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulstridge, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devine, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Early, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltell, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seavers, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squires, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trewartha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolford, A. J.</span><span> </span><span class="NLM_article-title">Identification of <i>N</i>-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1<i>H</i>-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4986</span><span class="NLM_x">–</span> <span class="NLM_lpage">4999</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800382h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4986-4999&author=P.+G.+Wyattauthor=A.+J.+Woodheadauthor=V.+Berdiniauthor=J.+A.+Boulstridgeauthor=M.+G.+Carrauthor=D.+M.+Crossauthor=D.+J.+Davisauthor=L.+A.+Devineauthor=T.+R.+Earlyauthor=R.+E.+Feltellauthor=E.+J.+Lewisauthor=R.+L.+McMenaminauthor=E.+F.+Navarroauthor=M.+A.+O%E2%80%99Brienauthor=M.+O%E2%80%99Reillyauthor=M.+Reuleauthor=G.+Saxtyauthor=L.+C.+Seaversauthor=D.+M.+Smithauthor=M.+S.+Squiresauthor=G.+Trewarthaauthor=M.+T.+Walkerauthor=A.+J.+Woolford&title=Identification+of+N-%284-piperidinyl%29-4-%282%2C6-dichlorobenzoylamino%29-1H-pyrazole-3-carboxamide+%28AT7519%29%2C+a+novel+cyclin+dependent+kinase+inhibitor+using+fragment-based+X-ray+crystallography+and+structure+based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm800382h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800382h%26sid%3Dliteratum%253Aachs%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DBoulstridge%26aufirst%3DJ.%2BA.%26aulast%3DCarr%26aufirst%3DM.%2BG.%26aulast%3DCross%26aufirst%3DD.%2BM.%26aulast%3DDavis%26aufirst%3DD.%2BJ.%26aulast%3DDevine%26aufirst%3DL.%2BA.%26aulast%3DEarly%26aufirst%3DT.%2BR.%26aulast%3DFeltell%26aufirst%3DR.%2BE.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DMcMenamin%26aufirst%3DR.%2BL.%26aulast%3DNavarro%26aufirst%3DE.%2BF.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%2BA.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DReule%26aufirst%3DM.%26aulast%3DSaxty%26aufirst%3DG.%26aulast%3DSeavers%26aufirst%3DL.%2BC.%26aulast%3DSmith%26aufirst%3DD.%2BM.%26aulast%3DSquires%26aufirst%3DM.%2BS.%26aulast%3DTrewartha%26aufirst%3DG.%26aulast%3DWalker%26aufirst%3DM.%2BT.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.%26atitle%3DIdentification%2520of%2520N-%25284-piperidinyl%2529-4-%25282%252C6-dichlorobenzoylamino%2529-1H-pyrazole-3-carboxamide%2520%2528AT7519%2529%252C%2520a%2520novel%2520cyclin%2520dependent%2520kinase%2520inhibitor%2520using%2520fragment-based%2520X-ray%2520crystallography%2520and%2520structure%2520based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4986%26epage%3D4999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Dickson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G. K.</span><span> </span><span class="NLM_article-title">Development of cell-cycle inhibitors for cancer therapy</span> <span class="citation_source-journal">Curr. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=19370178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A280%3ADC%252BD1M3otVaqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=36-43&author=M.+A.+Dicksonauthor=G.+K.+Schwartz&title=Development+of+cell-cycle+inhibitors+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Development of cell-cycle inhibitors for cancer therapy</span></div><div class="casAuthors">Dickson M A; Schwartz G K</div><div class="citationInfo"><span class="NLM_cas:title">Current oncology (Toronto, Ont.)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">36-43</span>
        ISSN:<span class="NLM_cas:issn">1198-0052</span>.
    </div><div class="casAbstract">The cell cycle governs the transition from quiescence through cell growth to proliferation.  The key parts of the cell cycle machinery are the cyclin-dependent kinases (CDKS) and the regulatory proteins called cyclins.  The CDKS are rational targets for cancer therapy because their expression in cancer cells is often aberrant and their inhibition can induce cell death.  Inhibitors of CDKS can also block transcription.Several drugs targeting the cell cycle have entered clinical trials.  These agents include flavopiridol, indisulam, AZD5438, SNS-032, bryostatin-1, seliciclib, PD 0332991, and SCH 727965.  Phase i studies have demonstrated that these drugs can generally be administered safely.  Phase ii studies have shown little single-agent activity in solid tumors, but combination studies with cytotoxic chemotherapy have been more promising.  In hematologic malignancies, reports have shown encouraging single-agent and combination activity.  Pharmacodynamic studies show that the dose and schedule of these drugs are crucial to permit maximum therapeutic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTgaRuY_68sqszK395ZObgVfW6udTcc2eZFJZh7REIIt7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3otVaqsg%253D%253D&md5=450695393901bd4eee8c4183717b1e42</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDickson%26aufirst%3DM.%2BA.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26atitle%3DDevelopment%2520of%2520cell-cycle%2520inhibitors%2520for%2520cancer%2520therapy%26jtitle%3DCurr.%2520Oncol.%26date%3D2009%26volume%3D16%26spage%3D36%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Ali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heathcote, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroll, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jogalekar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheiper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brackow, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siwicka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchter, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Periyasamy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolhurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanneganti, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aboagye, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span> </span><span class="NLM_article-title">The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">6208</span><span class="NLM_x">–</span> <span class="NLM_lpage">6215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=6208-6215&author=S.+Aliauthor=D.+A.+Heathcoteauthor=S.+H.+Krollauthor=A.+S.+Jogalekarauthor=B.+Scheiperauthor=H.+Patelauthor=J.+Brackowauthor=A.+Siwickaauthor=M.+J.+Fuchterauthor=M.+Periyasamyauthor=R.+S.+Tolhurstauthor=S.+K.+Kannegantiauthor=J.+P.+Snyderauthor=D.+C.+Liottaauthor=E.+O.+Aboagyeauthor=A.+G.+Barrettauthor=R.+C.+Coombes&title=The+development+of+a+selective+cyclin-dependent+kinase+inhibitor+that+shows+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DS.%26aulast%3DHeathcote%26aufirst%3DD.%2BA.%26aulast%3DKroll%26aufirst%3DS.%2BH.%26aulast%3DJogalekar%26aufirst%3DA.%2BS.%26aulast%3DScheiper%26aufirst%3DB.%26aulast%3DPatel%26aufirst%3DH.%26aulast%3DBrackow%26aufirst%3DJ.%26aulast%3DSiwicka%26aufirst%3DA.%26aulast%3DFuchter%26aufirst%3DM.%2BJ.%26aulast%3DPeriyasamy%26aufirst%3DM.%26aulast%3DTolhurst%26aufirst%3DR.%2BS.%26aulast%3DKanneganti%26aufirst%3DS.%2BK.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DAboagye%26aufirst%3DE.%2BO.%26aulast%3DBarrett%26aufirst%3DA.%2BG.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26atitle%3DThe%2520development%2520of%2520a%2520selective%2520cyclin-dependent%2520kinase%2520inhibitor%2520that%2520shows%2520antitumor%2520activity%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D6208%26epage%3D6215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Parry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanahan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabhavalkar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiswell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seghezzi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paruch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doll, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomeir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windsor, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oft, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschmeier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, E. M.</span><span> </span><span class="NLM_article-title">Dinaciclib (SCH 727965), a novel and potent cyclin-dependent kinase inhibitor</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2344</span><span class="NLM_x">–</span> <span class="NLM_lpage">2353</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1158%2F1535-7163.MCT-10-0324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=20663931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVOjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=2344-2353&author=D.+Parryauthor=T.+Guziauthor=F.+Shanahanauthor=N.+Davisauthor=D.+Prabhavalkarauthor=D.+Wiswellauthor=W.+Seghezziauthor=K.+Paruchauthor=M.+P.+Dwyerauthor=R.+Dollauthor=A.+Nomeirauthor=W.+Windsorauthor=T.+Fischmannauthor=Y.+Wangauthor=M.+Oftauthor=T.+Chenauthor=P.+Kirschmeierauthor=E.+M.+Lees&title=Dinaciclib+%28SCH+727965%29%2C+a+novel+and+potent+cyclin-dependent+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor</span></div><div class="casAuthors">Parry, David; Guzi, Timothy; Shanahan, Frances; Davis, Nicole; Prabhavalkar, Deepa; Wiswell, Derek; Seghezzi, Wolfgang; Paruch, Kamil; Dwyer, Michael P.; Doll, Ronald; Nomeir, Amin; Windsor, William; Fischmann, Thierry; Wang, Yaolin; Oft, Martin; Chen, Taiying; Kirschmeier, Paul; Lees, Emma M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2344-2353</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cyclin-dependent kinases (CDK) are key pos. regulators of cell cycle progression and attractive targets in oncol.  SCH 727965 inhibits CDK2, CDK5, CDK1, and CDK9 activity in vitro with IC50 values of 1, 1, 3, and 4 nmol/L, resp.  SCH 727965 was selected as a clin. candidate using a functional screen in vivo that integrated both efficacy and safety parameters.  Compared with flavopiridol, SCH 727965 exhibits superior activity with an improved therapeutic index.  In cell-based assays, SCH 727965 completely suppressed retinoblastoma phosphorylation, which correlated with apoptosis onset and total inhibition of bromodeoxyuridine incorporation in >100 tumor cell lines of diverse origin and background.  Moreover, short exposures to SCH 727965 were sufficient for long-lasting cellular effects.  SCH 727965 induced regression of established solid tumors in a range of mouse models following intermittent scheduling of doses below the maximally tolerated level.  This was assocd. with modulation of pharmacodynamic biomarkers in skin punch biopsies and rapidly reversible, mechanism-based effects on hematol. parameters.  These results suggest that SCH 727965 is a potent and selective CDK inhibitor and a novel cytotoxic agent.  Mol Cancer Ther; 9(8); 2344-53.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxn1NtmEAh7LVg90H21EOLACvtfcHk0lixK6VwVX1VlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVOjtrw%253D&md5=bd2d30fdfdca0f2bceb3f5c0b44b8630</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-0324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-0324%26sid%3Dliteratum%253Aachs%26aulast%3DParry%26aufirst%3DD.%26aulast%3DGuzi%26aufirst%3DT.%26aulast%3DShanahan%26aufirst%3DF.%26aulast%3DDavis%26aufirst%3DN.%26aulast%3DPrabhavalkar%26aufirst%3DD.%26aulast%3DWiswell%26aufirst%3DD.%26aulast%3DSeghezzi%26aufirst%3DW.%26aulast%3DParuch%26aufirst%3DK.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DDoll%26aufirst%3DR.%26aulast%3DNomeir%26aufirst%3DA.%26aulast%3DWindsor%26aufirst%3DW.%26aulast%3DFischmann%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DOft%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DKirschmeier%26aufirst%3DP.%26aulast%3DLees%26aufirst%3DE.%2BM.%26atitle%3DDinaciclib%2520%2528SCH%2520727965%2529%252C%2520a%2520novel%2520and%2520potent%2520cyclin-dependent%2520kinase%2520inhibitor%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D2344%26epage%3D2353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittaker, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClue, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrie, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelland, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">In vitro and in vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine and CYC202</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">4875</span><span class="NLM_x">–</span> <span class="NLM_lpage">4887</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1158%2F1078-0432.CCR-04-2264" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=16000586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvVGgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=4875-4887&author=F.+I.+Raynaudauthor=S.+R.+Whittakerauthor=P.+M.+Fischerauthor=S.+McClueauthor=M.+I.+Waltonauthor=S.+E.+Barrieauthor=M.+D.+Garrettauthor=P.+Rogersauthor=S.+J.+Clarkeauthor=L.+R.+Kellandauthor=M.+Valentiauthor=L.+Bruntonauthor=S.+Ecclesauthor=D.+P.+Laneauthor=P.+Workman&title=In+vitro+and+in+vivo+pharmacokinetic-pharmacodynamic+relationships+for+the+trisubstituted+aminopurine+cyclin-dependent+kinase+inhibitors+olomoucine%2C+bohemine+and+CYC202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and In vivo Pharmacokinetic-Pharmacodynamic Relationships for the Trisubstituted Aminopurine Cyclin-Dependent Kinase Inhibitors Olomoucine, Bohemine and CYC202</span></div><div class="casAuthors">Raynaud, Florence I.; Whittaker, Steven R.; Fischer, Peter M.; McClue, Steven; Walton, Michael I.; Barrie, S. Elaine; Garrett, Michelle D.; Rogers, Paul; Clarke, Simon J.; Kelland, Lloyd R.; Valenti, Melanie; Brunton, Lisa; Eccles, Suzanne; Lane, David P.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4875-4887</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: To investigate pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine, and CYC202 (R-roscovitine; seliciclib) in the HCT116 human colon carcinoma model.  Exptl. Design: The in vitro activity of the agents was detd. in a human tumor panel using the sulforhodamine B assay.  The concn. and time dependence was established in HCT116 cells.  Mol. biomarkers, including RB phosphorylation and cyclin expression, were assessed by Western blotting.  Pharmacokinetic properties were characterized in mice following anal. by liq. chromatog.-tandem mass spectrometry.  Based on these studies, a dosing regimen was developed for CYC202 that allowed therapeutic exposures in the HCT116 tumor xenograft.  RESULTS: The antitumor potency of the agents in vitro was in the order olomoucine (IC50, 56 μmol/L) < bohemine (IC50, 27 μmol/L) < CYC202 (IC50, 15 μmol/L), corresponding to their activities as cyclin-dependent kinase inhibitors.  Antitumor activity increased with exposure time up to 16 h.  The agents caused inhibition of RB and RNA polymerase II phosphorylation and depletion of cyclins.  They exhibited relatively rapid clearance following administration to mice.  CYC202 displayed the slowest clearance from plasma and the highest tumor uptake, with oral bioavailability of 86%.  Oral dosing of CYC202 gave active concns. in the tumor, modulation of pharmacodynamic markers, and inhibition of tumor growth.  CONCLUSIONS: CYC202 showed therapeutic activity on human cancer cell lines in vitro and on xenografts.  Pharmacodynamic markers are altered in vitro and in vivo, consistent with the inhibition of cyclin-dependent kinases.  Such markers may be potentially useful in the clin. development of CYC202 and other cyclin-dependent kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF8GDYVKzb7rVg90H21EOLACvtfcHk0lhnP6zdn9Z2pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvVGgsLw%253D&md5=ecb8798ef675b44ea4ab5403940ce6ad</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-2264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-2264%26sid%3Dliteratum%253Aachs%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DWhittaker%26aufirst%3DS.%2BR.%26aulast%3DFischer%26aufirst%3DP.%2BM.%26aulast%3DMcClue%26aufirst%3DS.%26aulast%3DWalton%26aufirst%3DM.%2BI.%26aulast%3DBarrie%26aufirst%3DS.%2BE.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DRogers%26aufirst%3DP.%26aulast%3DClarke%26aufirst%3DS.%2BJ.%26aulast%3DKelland%26aufirst%3DL.%2BR.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DBrunton%26aufirst%3DL.%26aulast%3DEccles%26aufirst%3DS.%26aulast%3DLane%26aufirst%3DD.%2BP.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520pharmacokinetic-pharmacodynamic%2520relationships%2520for%2520the%2520trisubstituted%2520aminopurine%2520cyclin-dependent%2520kinase%2520inhibitors%2520olomoucine%252C%2520bohemine%2520and%2520CYC202%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D4875%26epage%3D4887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">Vicinal diol cyclic sulfates. Like epoxides only more reactive</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">7538</span><span class="NLM_x">–</span> <span class="NLM_lpage">7539</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00230a045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=1988&pages=7538-7539&author=Y.+Gaoauthor=K.+B.+Sharpless&title=Vicinal+diol+cyclic+sulfates.+Like+epoxides+only+more+reactive"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fja00230a045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00230a045%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DVicinal%2520diol%2520cyclic%2520sulfates.%2520Like%2520epoxides%2520only%2520more%2520reactive%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1988%26volume%3D110%26spage%3D7538%26epage%3D7539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Calderón, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyagüez, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Mayoralas, A.</span><span> </span><span class="NLM_article-title">Synthesis of Azasugars through a Proline-Catalyzed Reaction</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">6258</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo060568b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=6258&author=F.+Calder%C3%B3nauthor=E.+G.+Doyag%C3%BCezauthor=A.+Fern%C3%A1ndez-Mayoralas&title=Synthesis+of+Azasugars+through+a+Proline-Catalyzed+Reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjo060568b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo060568b%26sid%3Dliteratum%253Aachs%26aulast%3DCalder%25C3%25B3n%26aufirst%3DF.%26aulast%3DDoyag%25C3%25BCez%26aufirst%3DE.%2BG.%26aulast%3DFern%25C3%25A1ndez-Mayoralas%26aufirst%3DA.%26atitle%3DSynthesis%2520of%2520Azasugars%2520through%2520a%2520Proline-Catalyzed%2520Reaction%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D6258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Kollonitsch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabor, V.</span><span> </span><span class="NLM_article-title">New and known complex borohydrides and some of their applications in organic syntheses</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1954</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1038%2F173125a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADyaG2MXhtFKqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=1954&pages=125-126&author=J.+Kollonitschauthor=O.+Fuchsauthor=V.+Gabor&title=New+and+known+complex+borohydrides+and+some+of+their+applications+in+organic+syntheses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">New and known complex borohydrides and some of their applications in organic syntheses</span></div><div class="casAuthors">Kollonitsch, Janos; Fuchs, Oszkar; Gabor, Valeria</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1954</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">125-6</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">NaBH4 (I) and LiCl at -10° in abs. alc. yielded LiBH4 (II) in 85-90% conversion.  II in alc. showed no decompn. in 2-4 hrs. at 0°.  Alc. solns. of Ca(BH4)2 (III) and Mg(BH4)2 (IV) were prepd. similarly at -50° to -20° in 80% conversion.  III and IV are much more sensitive to H2O than II, have reducing properties similar to those of alkali borohydrides, reduce dehydroandrosterone to androstene in good yield at -5° (as does II), do not effect nitro groups, carboxyl groups, or double bonds, and give nearly neutral solns., which can reduce alkali-sensitive compds. such as sugar derivs.  I and LiI in tetrahydrofuran with p-O2NC6H4CO2Et gave 80% p-O2NC6H4CH2OH, with II postulated as the intermediate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMuvlLWTwDDbVg90H21EOLACvtfcHk0lhnP6zdn9Z2pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG2MXhtFKqug%253D%253D&md5=087e499564fd73e8745154e6659a0a52</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2F173125a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F173125a0%26sid%3Dliteratum%253Aachs%26aulast%3DKollonitsch%26aufirst%3DJ.%26aulast%3DFuchs%26aufirst%3DO.%26aulast%3DGabor%26aufirst%3DV.%26atitle%3DNew%2520and%2520known%2520complex%2520borohydrides%2520and%2520some%2520of%2520their%2520applications%2520in%2520organic%2520syntheses%26jtitle%3DNature%26date%3D1954%26volume%3D173%26spage%3D125%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">De Azevedo, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leclerc, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havlicek, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strnad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span> </span><span class="NLM_article-title">Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">243</span><span class="NLM_x">, </span> <span class="NLM_fpage">518</span><span class="NLM_x">–</span> <span class="NLM_lpage">526</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1111%2Fj.1432-1033.1997.0518a.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=9030780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADyaK2sXhtVWiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=243&publication_year=1997&pages=518-526&author=W.+F.+De+Azevedoauthor=S.+Leclercauthor=L.+Meijerauthor=L.+Havlicekauthor=M.+Strnadauthor=S.+H.+Kim&title=Inhibition+of+cyclin-dependent+kinases+by+purine+analogues%3A+crystal+structure+of+human+cdk2+complexed+with+roscovitine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of cyclin-dependent kinases by purine analogs. Crystal structure of human cdk2 complexed with roscovitine</span></div><div class="casAuthors">De Azevedo, Walter Filgueira; Leclerc, Sophie; Meijer, Laurent; Havlicek, Libor; Strnad, Miroslav; Kim, Sung Hou</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">243</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">518-526</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Cyclin-dependent kinases (cdk) control the cell division cycle (cdc).  These kinases and their regulators are frequently deregulated in human tumors.  A potent inhibitor of cdks, roscovitine [2-(1-ethyl-2-hydro-xyethylamino)-6-benzylamino-9-isopropylpurine], was identified by screening a series of C2,N6,N9-substituted adenines on purified cdc2/cyclin B.  Roscovitine displays high efficiency and high selectivity (Meijer, L., Borgne, A., Mulner, O., Chong, J. P. J., Blow, J. J., Inagaki, N., Inagaki, M., Delcros, J. G. & Moulinoux, J. P. (1997) Eur. J. Biochem. 243, 527-536).  It behaves as a competitive inhibitor for ATP binding to cdc2.  We detd. the crystal structure of a complex between cdk2 and roscovitine at 0.24-nm (2.4 Å) resoln. and refined to an Rfactor of 0.18.  The purine portion of the inhibitor binds to the adenine binding pocket of cdk2.  The position of the benzyl ring group of the inhibitor enables the inhibitor to make contacts with the enzyme not obsd. in the ATP-complex structure.  Anal. of the position of this benzyl ring explains the specificity of roscovitine in inhibiting cdk2.  The structure also reveals that the (R)-stereoisomer of roscovitine is bound to cdk2.  The (R)-isomer is about twice as potent in inhibiting cdc2/cyclin B than the (S)-isomer.  Results from structure/activity studies and from anal. of the cdk2/roscovitine complex crystal structure should allow the design of even more potent cdk inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK34z2RUbiELVg90H21EOLACvtfcHk0liuWfV_DiWLQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtVWiu7s%253D&md5=65e91c4860cdf1c1982576402c387f5e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1997.0518a.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1997.0518a.x%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BAzevedo%26aufirst%3DW.%2BF.%26aulast%3DLeclerc%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DHavlicek%26aufirst%3DL.%26aulast%3DStrnad%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DS.%2BH.%26atitle%3DInhibition%2520of%2520cyclin-dependent%2520kinases%2520by%2520purine%2520analogues%253A%2520crystal%2520structure%2520of%2520human%2520cdk2%2520complexed%2520with%2520roscovitine%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1997%26volume%3D243%26spage%3D518%26epage%3D526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Tetsu, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, F.</span><span> </span><span class="NLM_article-title">Proliferation of cancer cells despite CDK2 inhibition</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=233-245&author=O.+Tetsuauthor=F.+McCormick&title=Proliferation+of+cancer+cells+despite+CDK2+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTetsu%26aufirst%3DO.%26aulast%3DMcCormick%26aufirst%3DF.%26atitle%3DProliferation%2520of%2520cancer%2520cells%2520despite%2520CDK2%2520inhibition%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D3%26spage%3D233%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Genovese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caputi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claudio, P. P.</span><span> </span><span class="NLM_article-title">Cell cycle control and beyond: emerging roles for the retinoblastoma gene family</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">5201</span><span class="NLM_x">–</span> <span class="NLM_lpage">5209</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=5201-5209&author=C.+Genoveseauthor=D.+Traniauthor=M.+Caputiauthor=P.+P.+Claudio&title=Cell+cycle+control+and+beyond%3A+emerging+roles+for+the+retinoblastoma+gene+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGenovese%26aufirst%3DC.%26aulast%3DTrani%26aufirst%3DD.%26aulast%3DCaputi%26aufirst%3DM.%26aulast%3DClaudio%26aufirst%3DP.%2BP.%26atitle%3DCell%2520cycle%2520control%2520and%2520beyond%253A%2520emerging%2520roles%2520for%2520the%2520retinoblastoma%2520gene%2520family%26jtitle%3DOncogene%26date%3D2006%26volume%3D25%26spage%3D5201%26epage%3D5209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Giacinti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, A.</span><span> </span><span class="NLM_article-title">RB and cell cycle progression</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">5220</span><span class="NLM_x">–</span> <span class="NLM_lpage">5227</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=5220-5227&author=C.+Giacintiauthor=A.+Giordano&title=RB+and+cell+cycle+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiacinti%26aufirst%3DC.%26aulast%3DGiordano%26aufirst%3DA.%26atitle%3DRB%2520and%2520cell%2520cycle%2520progression%26jtitle%3DOncogene%26date%3D2006%26volume%3D25%26spage%3D5220%26epage%3D5227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Zarkowska, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mittnacht, S.</span><span> </span><span class="NLM_article-title">Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">12738</span><span class="NLM_x">–</span> <span class="NLM_lpage">12746</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=12738-12746&author=T.+Zarkowskaauthor=S.+Mittnacht&title=Differential+phosphorylation+of+the+retinoblastoma+protein+by+G1%2FS+cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZarkowska%26aufirst%3DT.%26aulast%3DMittnacht%26aufirst%3DS.%26atitle%3DDifferential%2520phosphorylation%2520of%2520the%2520retinoblastoma%2520protein%2520by%2520G1%252FS%2520cyclin-dependent%2520kinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D12738%26epage%3D12746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Takaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukasawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki-Takahashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitagawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, H.</span><span> </span><span class="NLM_article-title">Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1093%2Fjb%2Fmvi050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=15809340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlt1CmsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2005&pages=381-386&author=T.+Takakiauthor=K.+Fukasawaauthor=I.+Suzuki-Takahashiauthor=K.+Sembaauthor=M.+Kitagawaauthor=Y.+Tayaauthor=H.+Hirai&title=Preferences+for+phosphorylation+sites+in+the+retinoblastoma+protein+of+D-type+cyclin-dependent+kinases%2C+Cdk4+and+Cdk6%2C+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro</span></div><div class="casAuthors">Takaki, Tohru; Fukasawa, Kazuhiro; Suzuki-Takahashi, Ikuko; Semba, Kentaro; Kitagawa, Masatoshi; Taya, Yoichi; Hirai, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">381-386</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">D-type cyclin-dependent kinases (Cdk4 and Cdk6) regulate the G1 to S phase progression of the mammalian cell cycle.  It has been suggested that Cdk4 and Cdk6 may have distinct functions in vivo, even though they are indistinguishable biochem.  Here we show that although these Cdks phosphorylate multiple residues in pRB, they do so with different residue selectivities in vitro; Thr821 and Thr826 are preferentially phosphorylated by Cdk6 and Cdk4, resp.  This raises the possibility different substrate specificities lead to their different roles in the regulation of cellular events.  Furthermore, our results indicate the new concept that Cdk itself contributes to substrate recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnX0lrugo4WbVg90H21EOLACvtfcHk0lgy0YV7HBJc8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlt1CmsLo%253D&md5=f0ea5bb1671c6a4764d85fab7cdfdb6f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvi050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvi050%26sid%3Dliteratum%253Aachs%26aulast%3DTakaki%26aufirst%3DT.%26aulast%3DFukasawa%26aufirst%3DK.%26aulast%3DSuzuki-Takahashi%26aufirst%3DI.%26aulast%3DSemba%26aufirst%3DK.%26aulast%3DKitagawa%26aufirst%3DM.%26aulast%3DTaya%26aufirst%3DY.%26aulast%3DHirai%26aufirst%3DH.%26atitle%3DPreferences%2520for%2520phosphorylation%2520sites%2520in%2520the%2520retinoblastoma%2520protein%2520of%2520D-type%2520cyclin-dependent%2520kinases%252C%2520Cdk4%2520and%2520Cdk6%252C%2520in%2520vitro%26jtitle%3DJ.%2520Biochem.%26date%3D2005%26volume%3D137%26spage%3D381%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Campbell, A. D.; Raynham, T. M.; Taylor, R. J. K.</span><span> </span><span class="NLM_article-title">Pyrazolopyrimidine compounds and their use in medicine</span>.  <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">1998</span><span class="NLM_x">, </span> <span class="NLM_fpage">1707</span>− <span class="NLM_lpage">1709</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1055%2Fs-1998-4504" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1998&publication_year=1998&pages=1707-1709&author=A.+D.+Campbell&author=T.+M.+Raynham&author=R.+J.+K.+Taylor&title=Pyrazolopyrimidine+compounds+and+their+use+in+medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1055%2Fs-1998-4504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1998-4504%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DA.%2BD.%26atitle%3DPyrazolopyrimidine%2520compounds%2520and%2520their%2520use%2520in%2520medicine%26jtitle%3DSynthesis%26date%3D1998%26volume%3D1998%26spage%3D1707%26epage%3D1709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washbrook, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egly, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S.</span><span> </span><span class="NLM_article-title">Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=127-137&author=D.+Chenauthor=T.+Riedlauthor=E.+Washbrookauthor=P.+E.+Paceauthor=R.+C.+Coombesauthor=J.+M.+Eglyauthor=S.+Ali&title=Activation+of+estrogen+receptor+alpha+by+S118+phosphorylation+involves+a+ligand-dependent+interaction+with+TFIIH+and+participation+of+CDK7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DD.%26aulast%3DRiedl%26aufirst%3DT.%26aulast%3DWashbrook%26aufirst%3DE.%26aulast%3DPace%26aufirst%3DP.%2BE.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26aulast%3DEgly%26aufirst%3DJ.%2BM.%26aulast%3DAli%26aufirst%3DS.%26atitle%3DActivation%2520of%2520estrogen%2520receptor%2520alpha%2520by%2520S118%2520phosphorylation%2520involves%2520a%2520ligand-dependent%2520interaction%2520with%2520TFIIH%2520and%2520participation%2520of%2520CDK7%26jtitle%3DMol.%2520Cell%26date%3D2000%26volume%3D6%26spage%3D127%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">McNae, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kontipidis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worrall, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walkinshaw, M. D.</span><span> </span><span class="NLM_article-title">Studying protein−ligand interactions using protein crystallography</span> <span class="citation_source-journal">Crystallogr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1080%2F08893110500078639" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtVWmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=61-71&author=I.+W.+McNaeauthor=D.+Kanauthor=G.+Kontipidisauthor=A.+Pattersonauthor=P.+Taylorauthor=L.+Worrallauthor=M.+D.+Walkinshaw&title=Studying+protein%E2%88%92ligand+interactions+using+protein+crystallography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Studying protein-ligand interactions using protein crystallography</span></div><div class="casAuthors">McNae, Iain W.; Kan, Daphne; Kontopidis, George; Patterson, Alan; Taylor, Paul; Worrall, Liam; Walkinshaw, Malcolm D.</div><div class="citationInfo"><span class="NLM_cas:title">Crystallography Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-71</span>CODEN:
                <span class="NLM_cas:coden">CRRVEN</span>;
        ISSN:<span class="NLM_cas:issn">0889-311X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein X-ray crystallog. is now a relatively high-throughput technique that plays a major role in structure-based drug design programs where the method of soaking small org. ligands into protein crystals is used to confirm or identify binding modes.  In this review, we discuss some exptl. approaches for 'soaking-in' ligands into protein crystals where the major problem is poor soly. of the ligand.  We also provide examples showing how crystal soaking can be used as a technique for establishing ligand binding strength: Kc (the apparent ligand-protein dissocn. const. in the crystal), which for some proteins at least, is found to be very similar to the soln. Kd.  Kinetic effects are also found to be important and the rate at which ligands soak into crystals is shown to vary by orders of magnitude from 10-1 to 107 s depending on the system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIx5SpvuGj67Vg90H21EOLACvtfcHk0lgy0YV7HBJc8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtVWmsrk%253D&md5=ce7b163b0a2fe7047e11c12546e64258</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1080%2F08893110500078639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F08893110500078639%26sid%3Dliteratum%253Aachs%26aulast%3DMcNae%26aufirst%3DI.%2BW.%26aulast%3DKan%26aufirst%3DD.%26aulast%3DKontipidis%26aufirst%3DG.%26aulast%3DPatterson%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DWorrall%26aufirst%3DL.%26aulast%3DWalkinshaw%26aufirst%3DM.%2BD.%26atitle%3DStudying%2520protein%25E2%2588%2592ligand%2520interactions%2520using%2520protein%2520crystallography%26jtitle%3DCrystallogr.%2520Rev.%26date%3D2005%26volume%3D11%26spage%3D61%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Lebedev, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span> </span><span class="NLM_article-title">Model preparation in MOLREP and examples of model improvement using X-ray data</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=33-39&author=A.+A.+Lebedevauthor=A.+A.+Vaginauthor=G.+N.+Murshudov&title=Model+preparation+in+MOLREP+and+examples+of+model+improvement+using+X-ray+data"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26atitle%3DModel%2520preparation%2520in%2520MOLREP%2520and%2520examples%2520of%2520model%2520improvement%2520using%2520X-ray%2520data%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2008%26volume%3D64%26spage%3D33%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Zwart, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamzin, V. S.</span><span> </span><span class="NLM_article-title">Modelling bound ligands in protein crystal structures</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2230</span><span class="NLM_x">–</span> <span class="NLM_lpage">2239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2230-2239&author=P.+H.+Zwartauthor=G.+G.+Langerauthor=V.+S.+Lamzin&title=Modelling+bound+ligands+in+protein+crystal+structures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZwart%26aufirst%3DP.%2BH.%26aulast%3DLanger%26aufirst%3DG.%2BG.%26aulast%3DLamzin%26aufirst%3DV.%2BS.%26atitle%3DModelling%2520bound%2520ligands%2520in%2520protein%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2230%26epage%3D2239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebedev, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potterton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span> </span><span class="NLM_article-title">REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2184</span><span class="NLM_x">–</span> <span class="NLM_lpage">2195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1107%2FS0907444904023510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=15572771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2184-2195&author=A.+A.+Vaginauthor=R.+A.+Steinerauthor=A.+A.+Lebedevauthor=L.+Pottertonauthor=S.+McNicholasauthor=F.+Longauthor=G.+N.+Murshudov&title=REFMAC5+dictionary%3A+organization+of+prior+chemical+knowledge+and+guidelines+for+its+use"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use</span></div><div class="casAuthors">Vagin, Alexei A.; Steiner, Roberto A.; Lebedev, Andrey A.; Potterton, Liz; McNicholas, Stuart; Long, Fei; Murshudov, Garib N.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2184-2195</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">One of the most important aspects of macromol. structure refinement is the use of prior chem. knowledge.  Bond lengths, bond angles and other chem. properties are used in restrained refinement as subsidiary conditions.  This contribution describes the organization and some aspects of the use of the flexible and human/machine-readable dictionary of prior chem. knowledge used by the max.-likelihood macromol.-refinement program REFMAC5.  The dictionary stores information about monomers which represent the constitutive building blocks of biol. macromols. (amino acids, nucleic acids and saccharides) and about numerous org./inorg. compds. commonly found in macromol. crystallog.  It also describes the modifications the building blocks undergo as a result of chem. reactions and the links required for polymer formation.  More than 2000 monomer entries, 100 modification entries and 200 link entries are currently available.  Algorithms and tools for updating and adding new entries to the dictionary have also been developed and are presented here.  In many cases, the REFMAC5 dictionary allows entirely automatic generation of restraints within REFMAC5 refinement runs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRjDd-k3YHGrVg90H21EOLACvtfcHk0ljC48vKt65b6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73F&md5=005910422c5fb72fe2434c39b5321bf4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS0907444904023510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904023510%26sid%3Dliteratum%253Aachs%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPotterton%26aufirst%3DL.%26aulast%3DMcNicholas%26aufirst%3DS.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26atitle%3DREFMAC5%2520dictionary%253A%2520organization%2520of%2520prior%2520chemical%2520knowledge%2520and%2520guidelines%2520for%2520its%2520use%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2184%26epage%3D2195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Skehan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storeng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vistica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bokesch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span> </span><span class="NLM_article-title">New colorimetric cytotoxicity assay for anticancer-drug screening</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1093%2Fjnci%2F82.13.1107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=2359136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADyaK3cXltVylsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1990&pages=1107-1112&author=P.+Skehanauthor=R.+Storengauthor=D.+Scudieroauthor=A.+Monksauthor=J.+McMahonauthor=D.+Visticaauthor=J.+T.+Warrenauthor=H.+Bokeschauthor=S.+Kenneyauthor=M.+R.+Boyd&title=New+colorimetric+cytotoxicity+assay+for+anticancer-drug+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">New colorimetric cytotoxicity assay for anticancer-drug screening</span></div><div class="casAuthors">Skehan, Philip; Storeng, Ritsa; Scudiero, Dominic; Monks, Anne; McMahon, James; Vistica, David; Warren, Jonathan T.; Bokesch, Heidi; Kenney, Susan; Boyd, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1107-12</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">A rapid, sensitive, and inexpensive method was developed for measuring the cellular protein content of adherent and suspension cultures in 96-well microtiter plates.  The method is suitable for ordinary lab. purposes and for very large-scale applications, such as the National Cancer Institute's disease-oriented in vitro anticancer-drug discovery screen, which requires the use of several million culture wells per yr.  Cultures fixed with trichloroacetic acid were stained for 30 min with 0.4% (wt/vol) sulforhodamine B (SRB) dissolved in 1% acetic acid.  Unbound dye was removed by four washes with 1% acetic acid, and protein-bound dye was extd. with 10 mM unbuffered Tris base [tris(hydroxymethyl)aminomethane] for detn. of optical d. in a computer-interfaced, 96-well microtiter plate reader.  The SRB assay results were linear with the no. of cells and with values for cellular protein measured by both the Lowry and Bradford assays at densities ranging from sparse subconfluence to multilayered supraconfluence.  The signal-to-noise ratio at 564 nm was approx. 1.5 with 1,000 cells per well.  The sensitivity of the SRB assay compared favorably with sensitivities of several fluorescence assays and was superior to those of both the Lowry and Bradford assays and to those of 20 other visible dyes.  The SRB assay provides a colorimetric end point that is nondestructive, indefinitely stable, and visible to the naked eye.  It provides a sensitive measure of drug-induced cytotoxicity, is useful in quantitating clonogenicity, and is well suited to high-vol., automated drug screening.  SRB fluoresces strongly with laser excitation at 488 nm and can be measured quant. at the single-cell level by static fluorescence cytometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA1MIZ3rkcqLVg90H21EOLACvtfcHk0ljC48vKt65b6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXltVylsL8%253D&md5=d7bc1784a1f181842d2999efa7fa870c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F82.13.1107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F82.13.1107%26sid%3Dliteratum%253Aachs%26aulast%3DSkehan%26aufirst%3DP.%26aulast%3DStoreng%26aufirst%3DR.%26aulast%3DScudiero%26aufirst%3DD.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DMcMahon%26aufirst%3DJ.%26aulast%3DVistica%26aufirst%3DD.%26aulast%3DWarren%26aufirst%3DJ.%2BT.%26aulast%3DBokesch%26aufirst%3DH.%26aulast%3DKenney%26aufirst%3DS.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DNew%2520colorimetric%2520cytotoxicity%2520assay%2520for%2520anticancer-drug%2520screening%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1990%26volume%3D82%26spage%3D1107%26epage%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Lopez-Garcia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Periyasamy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kindle, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heery, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buluwela, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamalati, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S.</span><span> </span><span class="NLM_article-title">ZNF366 is an estrogen receptor corepressor that acts through CtBP and histone deacetylases</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">6126</span><span class="NLM_x">–</span> <span class="NLM_lpage">6136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=6126-6136&author=J.+Lopez-Garciaauthor=M.+Periyasamyauthor=R.+S.+Thomasauthor=M.+Christianauthor=M.+Leaoauthor=P.+Jatauthor=K.+B.+Kindleauthor=D.+M.+Heeryauthor=M.+G.+Parkerauthor=L.+Buluwelaauthor=T.+Kamalatiauthor=S.+Ali&title=ZNF366+is+an+estrogen+receptor+corepressor+that+acts+through+CtBP+and+histone+deacetylases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Garcia%26aufirst%3DJ.%26aulast%3DPeriyasamy%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DR.%2BS.%26aulast%3DChristian%26aufirst%3DM.%26aulast%3DLeao%26aufirst%3DM.%26aulast%3DJat%26aufirst%3DP.%26aulast%3DKindle%26aufirst%3DK.%2BB.%26aulast%3DHeery%26aufirst%3DD.%2BM.%26aulast%3DParker%26aufirst%3DM.%2BG.%26aulast%3DBuluwela%26aufirst%3DL.%26aulast%3DKamalati%26aufirst%3DT.%26aulast%3DAli%26aufirst%3DS.%26atitle%3DZNF366%2520is%2520an%2520estrogen%2520receptor%2520corepressor%2520that%2520acts%2520through%2520CtBP%2520and%2520histone%2520deacetylases%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2006%26volume%3D34%26spage%3D6126%26epage%3D6136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balmain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNally, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohas, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchison, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierrepoint, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlatt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straughan, D. W.</span><span> </span><span class="NLM_article-title">UKCCCR guidelines for the welfare of animals in experimental neoplasia</span> <span class="citation_source-journal">Lab. Anim.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1258%2F002367788780746467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=3172698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A280%3ADyaL1M%252Fht1ymtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1988&pages=195-201&author=P.+Workmanauthor=A.+Balmainauthor=J.+A.+Hickmanauthor=N.+J.+McNallyauthor=A.+M.+Rohasauthor=N.+A.+Mitchisonauthor=C.+G.+Pierrepointauthor=R.+Raymondauthor=C.+Rowlattauthor=T.+C.+Stephensauthor=J.+Wallaceauthor=D.+W.+Straughan&title=UKCCCR+guidelines+for+the+welfare+of+animals+in+experimental+neoplasia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">UKCCCR guidelines for the welfare of animals in experimental neoplasia</span></div><div class="casAuthors">Workman P; Balmain A; Hickman J A; McNally N J; Rohas A M; Mitchison N A; Pierrepoint C G; Raymond R; Rowlatt C; Stephens T C</div><div class="citationInfo"><span class="NLM_cas:title">Laboratory animals</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">195-201</span>
        ISSN:<span class="NLM_cas:issn">0023-6772</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSpbCFa3IXp3kcLvDNbOD4DfW6udTcc2ebI0ASj0yFJCbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M%252Fht1ymtA%253D%253D&md5=632d4a2f5869b721721884546190da34</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1258%2F002367788780746467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1258%252F002367788780746467%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DBalmain%26aufirst%3DA.%26aulast%3DHickman%26aufirst%3DJ.%2BA.%26aulast%3DMcNally%26aufirst%3DN.%2BJ.%26aulast%3DRohas%26aufirst%3DA.%2BM.%26aulast%3DMitchison%26aufirst%3DN.%2BA.%26aulast%3DPierrepoint%26aufirst%3DC.%2BG.%26aulast%3DRaymond%26aufirst%3DR.%26aulast%3DRowlatt%26aufirst%3DC.%26aulast%3DStephens%26aufirst%3DT.%2BC.%26aulast%3DWallace%26aufirst%3DJ.%26aulast%3DStraughan%26aufirst%3DD.%2BW.%26atitle%3DUKCCCR%2520guidelines%2520for%2520the%2520welfare%2520of%2520animals%2520in%2520experimental%2520neoplasia%26jtitle%3DLab.%2520Anim.%26date%3D1988%26volume%3D22%26spage%3D195%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Banker, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. A.</span><span> </span><span class="NLM_article-title">Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">974</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1002%2Fjps.10332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=12712416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1ehsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2003&pages=967-974&author=M.+J.+Bankerauthor=T.+H.+Clarkauthor=J.+A.+Williams&title=Development+and+validation+of+a+96-well+equilibrium+dialysis+apparatus+for+measuring+plasma+protein+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding</span></div><div class="casAuthors">Banker, Michael J.; Clark, Tracey H.; Williams, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">967-974</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A 96-well equil. dialysis block was designed and constructed that is compatible with most std. 96-well format lab. supplies and instruments.  The unique design of the dialysis app. allows one to dispense and aspirate from either or both the sample and dialyzate sides from the top of the app., which is not possible with systems currently on the market.  This feature permits the investigator to analyze a large no. of samples, time points, or replicates in the same expt.  The novel alignment of the dialysis membrane vertically in the well maximizes the surface-to-vol. ratio, eliminates problems assocd. with trapped air pockets, and allows one to add or remove samples independently or all at once.  Furthermore, the design of the app. allows both the sample and dialyzate sides of the dialysis well to be accessible by robotic systems, so assays can be readily automated.  Teflon construction is used to minimize nonspecific binding of test samples to the app.  The device is reusable, easily assembled, and can be shaken in controlled temp. environments to decrease the time required to reach equil. as well as facilitate dissoln. of test compds.  Plasma protein binding values obtained for 10 diverse compds. using std. dialysis equipment and the 96-well dialysis block validates this method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp9qyX_9tHHrVg90H21EOLACvtfcHk0lgWWSlNUsXz1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1ehsrs%253D&md5=0948f0a11373c57be06be9e0d604ad40</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2Fjps.10332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.10332%26sid%3Dliteratum%253Aachs%26aulast%3DBanker%26aufirst%3DM.%2BJ.%26aulast%3DClark%26aufirst%3DT.%2BH.%26aulast%3DWilliams%26aufirst%3DJ.%2BA.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%252096-well%2520equilibrium%2520dialysis%2520apparatus%2520for%2520measuring%2520plasma%2520protein%2520binding%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2003%26volume%3D92%26spage%3D967%26epage%3D974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Gres, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julian, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourrie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meunier, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roques, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulenc, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabre, G.</span><span> </span><span class="NLM_article-title">Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">726</span><span class="NLM_x">–</span> <span class="NLM_lpage">733</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1998&pages=726-733&author=M.+C.+Gresauthor=B.+Julianauthor=M.+Bourrieauthor=V.+Meunierauthor=C.+Roquesauthor=M.+Bergerauthor=X.+Boulencauthor=Y.+Bergerauthor=G.+Fabre&title=Correlation+between+oral+drug+absorption+in+humans%2C+and+apparent+drug+permeability+in+TC-7+cells%2C+a+human+epithelial+intestinal+cell+line%3A+comparison+with+the+parental+Caco-2+cell+line"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGres%26aufirst%3DM.%2BC.%26aulast%3DJulian%26aufirst%3DB.%26aulast%3DBourrie%26aufirst%3DM.%26aulast%3DMeunier%26aufirst%3DV.%26aulast%3DRoques%26aufirst%3DC.%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DBoulenc%26aufirst%3DX.%26aulast%3DBerger%26aufirst%3DY.%26aulast%3DFabre%26aufirst%3DG.%26atitle%3DCorrelation%2520between%2520oral%2520drug%2520absorption%2520in%2520humans%252C%2520and%2520apparent%2520drug%2520permeability%2520in%2520TC-7%2520cells%252C%2520a%2520human%2520epithelial%2520intestinal%2520cell%2520line%253A%2520comparison%2520with%2520the%2520parental%2520Caco-2%2520cell%2520line%26jtitle%3DPharm.%2520Res.%26date%3D1998%26volume%3D15%26spage%3D726%26epage%3D733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Kuhnz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gieschen, H.</span><span> </span><span class="NLM_article-title">Predicting the oral bioavailability of 19-nortestosterone progestins in vivo from their metabolic stability in human liver microsomal preparations in vitro</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1120</span><span class="NLM_x">–</span> <span class="NLM_lpage">1127</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1998&pages=1120-1127&author=W.+Kuhnzauthor=H.+Gieschen&title=Predicting+the+oral+bioavailability+of+19-nortestosterone+progestins+in+vivo+from+their+metabolic+stability+in+human+liver+microsomal+preparations+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuhnz%26aufirst%3DW.%26aulast%3DGieschen%26aufirst%3DH.%26atitle%3DPredicting%2520the%2520oral%2520bioavailability%2520of%252019-nortestosterone%2520progestins%2520in%2520vivo%2520from%2520their%2520metabolic%2520stability%2520in%2520human%2520liver%2520microsomal%2520preparations%2520in%2520vitro%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1998%26volume%3D26%26spage%3D1120%26epage%3D1127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Deliv. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1016%2FS0169-409X%2800%2900129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=11259830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2001&pages=3-26&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-26</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is greater than 500 and the calcd. Log P (CLogP) is greater than 5 (or MlogP >4.15).  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYDqa02g16urVg90H21EOLACvtfcHk0lgWWSlNUsXz1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D&md5=c60bb89da68f051c0ee7ac4c0468a0e4</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2800%2900129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252800%252900129-0%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Deliv.%2520Rev.%26date%3D2001%26volume%3D46%26spage%3D3%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Sarwar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peston, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinnett, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madden, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lykkesfeldt, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shousha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S.</span><span> </span><span class="NLM_article-title">Phosphorylation of ER{alpha} at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ER{alpha} phosphorylation in breast cancer progression</span> <span class="citation_source-journal">Endocr.-Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">851</span><span class="NLM_x">–</span> <span class="NLM_lpage">861</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=851-861&author=N.+Sarwarauthor=J.+S.+Kimauthor=J.+Jiangauthor=D.+Pestonauthor=H.+D.+Sinnettauthor=P.+Maddenauthor=J.+M.+Geeauthor=R.+I.+Nicholsonauthor=A.+E.+Lykkesfeldtauthor=S.+Shoushaauthor=R.+C.+Coombesauthor=S.+Ali&title=Phosphorylation+of+ER%7Balpha%7D+at+serine+118+in+primary+breast+cancer+and+in+tamoxifen-resistant+tumours+is+indicative+of+a+complex+role+for+ER%7Balpha%7D+phosphorylation+in+breast+cancer+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarwar%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DPeston%26aufirst%3DD.%26aulast%3DSinnett%26aufirst%3DH.%2BD.%26aulast%3DMadden%26aufirst%3DP.%26aulast%3DGee%26aufirst%3DJ.%2BM.%26aulast%3DNicholson%26aufirst%3DR.%2BI.%26aulast%3DLykkesfeldt%26aufirst%3DA.%2BE.%26aulast%3DShousha%26aufirst%3DS.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26aulast%3DAli%26aufirst%3DS.%26atitle%3DPhosphorylation%2520of%2520ER%257Balpha%257D%2520at%2520serine%2520118%2520in%2520primary%2520breast%2520cancer%2520and%2520in%2520tamoxifen-resistant%2520tumours%2520is%2520indicative%2520of%2520a%2520complex%2520role%2520for%2520ER%257Balpha%257D%2520phosphorylation%2520in%2520breast%2520cancer%2520progression%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D2006%26volume%3D13%26spage%3D851%26epage%3D861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Liscovitch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravid, D.</span><span> </span><span class="NLM_article-title">A case study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">245</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">352</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1016%2Fj.canlet.2006.01.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=16504380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1enuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=245&publication_year=2007&pages=350-352&author=M.+Liscovitchauthor=D.+Ravid&title=A+case+study+in+misidentification+of+cancer+cell+lines%3A+MCF-7%2FAdrR+cells+%28re-designated+NCI%2FADR-RES%29+are+derived+from+OVCAR-8+human+ovarian+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">A case study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells</span></div><div class="casAuthors">Liscovitch, Mordechai; Ravid, Dana</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">245</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">350-352</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Multidrug-resistant MCF-7 breast adenocarcinoma cells (originally named MCF-7/AdrR cells and later re-designated NCI/ADR-RES) have served as an important and widely used research tool during the last two decades.  However, the real identity of these cells has been in doubt since 1998 and has since been debated.  The origin of NCI/ADR-RES cells has now been revealed by SNP and karyotypic analyses, carried out at the Sanger Institute and the NCI, resp.  The results of these analyses, recently posted on the Web, show that NCI/ADR-RES cells are derived from OVCAR-8 ovarian adenocarcinoma cells.  The case of NCI/ADR-RES cells highlights a wide-spread problem of cell line cross-contamination and misidentification.  Fortunately, this is a tractable problem that can be avoided by scrupulous genotyping of cell stocks and adoption of a few simple rules in cell culture practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr51zv6pSfF_bVg90H21EOLACvtfcHk0lh20o-evYis_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1enuw%253D%253D&md5=0d460541e164f6fb5b2abaf6bc573b51</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2006.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2006.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DLiscovitch%26aufirst%3DM.%26aulast%3DRavid%26aufirst%3DD.%26atitle%3DA%2520case%2520study%2520in%2520misidentification%2520of%2520cancer%2520cell%2520lines%253A%2520MCF-7%252FAdrR%2520cells%2520%2528re-designated%2520NCI%252FADR-RES%2529%2520are%2520derived%2520from%2520OVCAR-8%2520human%2520ovarian%2520carcinoma%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2007%26volume%3D245%26spage%3D350%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Parratt, M.; Bower, J. F.; Williamson, D.; Cansfield, A.</span><span> </span><span class="NLM_article-title">Pyrazolopyrimidine compounds and their use in medicine</span>. Patent WO2004/087707A1,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+Parratt&author=J.+F.+Bower&author=D.+Williamson&author=A.+Cansfield&title=Pyrazolopyrimidine+compounds+and+their+use+in+medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DParratt%26aufirst%3DM.%26atitle%3DPyrazolopyrimidine%2520compounds%2520and%2520their%2520use%2520in%2520medicine%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 51 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Sarah Diab, Mingfeng Yu, <span class="NLM_string-name hlFld-ContribAuthor">Shudong Wang</span>. </span><span class="cited-content_cbyCitation_article-title">CDK7 Inhibitors in Cancer Therapy: The Sweet Smell of Success?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (14)
                                     , 7458-7474. <a href="https://doi.org/10.1021/acs.jmedchem.9b01985" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01985</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01985%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCDK7%252BInhibitors%252Bin%252BCancer%252BTherapy%25253A%252BThe%252BSweet%252BSmell%252Bof%252BSuccess%25253F%26aulast%3DDiab%26aufirst%3DSarah%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D29112019%26date%3D19032020%26date%3D09032020%26volume%3D63%26issue%3D14%26spage%3D7458%26epage%3D7474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yang Wang, Xing Chen, Yaoyao Yan, Xiaochen Zhu, Mingming Liu, <span class="NLM_string-name hlFld-ContribAuthor">Xinhua Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and SARs of 5-Chloro-N4-phenyl-N2-(pyridin-2-yl)pyrimidine-2,4-diamine Derivatives as Oral Available and Dual CDK 6 and 9 Inhibitors with Potent Antitumor Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (6)
                                     , 3327-3347. <a href="https://doi.org/10.1021/acs.jmedchem.9b02121" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02121%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BSARs%252Bof%252B5-Chloro-N4-phenyl-N2-%252528pyridin-2-yl%252529pyrimidine-2%25252C4-diamine%252BDerivatives%252Bas%252BOral%252BAvailable%252Band%252BDual%252BCDK%252B6%252Band%252B9%252BInhibitors%252Bwith%252BPotent%252BAntitumor%252BActivity%26aulast%3DWang%26aufirst%3DYang%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D20122019%26date%3D12032020%26date%3D04032020%26volume%3D63%26issue%3D6%26spage%3D3327%26epage%3D3347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Solomon Tadesse, Elizabeth C. Caldon, Wayne Tilley, <span class="NLM_string-name hlFld-ContribAuthor">Shudong Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclin-Dependent Kinase 2 Inhibitors in Cancer Therapy: An Update. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (9)
                                     , 4233-4251. <a href="https://doi.org/10.1021/acs.jmedchem.8b01469" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01469</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01469%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCyclin-Dependent%252BKinase%252B2%252BInhibitors%252Bin%252BCancer%252BTherapy%25253A%252BAn%252BUpdate%26aulast%3DTadesse%26aufirst%3DSolomon%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D20092018%26date%3D20122018%26date%3D13122018%26volume%3D62%26issue%3D9%26spage%3D4233%26epage%3D4251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jianzhong Chen, Xingyu Wang, John Z. H. Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Tong Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of Substituents in Different Positions of Aminothiazole Hinge-Binding Scaffolds on Inhibitor–CDK2 Association Probed by Interaction Entropy Method. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2018,</strong> <em>3 </em>
                                    (12)
                                     , 18052-18064. <a href="https://doi.org/10.1021/acsomega.8b02354" title="DOI URL">https://doi.org/10.1021/acsomega.8b02354</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b02354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b02354%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DEffect%252Bof%252BSubstituents%252Bin%252BDifferent%252BPositions%252Bof%252BAminothiazole%252BHinge-Binding%252BScaffolds%252Bon%252BInhibitor%2525E2%252580%252593CDK2%252BAssociation%252BProbed%252Bby%252BInteraction%252BEntropy%252BMethod%26aulast%3DChen%26aufirst%3DJianzhong%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D11092018%26date%3D15112018%26volume%3D3%26issue%3D12%26spage%3D18052%26epage%3D18064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yue  Wang</span>, <span class="hlFld-ContribAuthor ">Yanle  Zhi</span>, <span class="hlFld-ContribAuthor ">Qiaomei  Jin</span>, <span class="hlFld-ContribAuthor ">Shuai  Lu</span>, <span class="hlFld-ContribAuthor ">Guowu  Lin</span>, <span class="hlFld-ContribAuthor ">Haoliang  Yuan</span>, <span class="hlFld-ContribAuthor ">Taotao  Yang</span>, <span class="hlFld-ContribAuthor ">Zhanwei  Wang</span>, <span class="hlFld-ContribAuthor ">Chao  Yao</span>, <span class="hlFld-ContribAuthor ">Jun  Ling</span>, <span class="hlFld-ContribAuthor ">Hao  Guo</span>, <span class="hlFld-ContribAuthor ">Tonghui  Li</span>, <span class="hlFld-ContribAuthor ">Jianlin  Jin</span>, <span class="hlFld-ContribAuthor ">Baoquan  Li</span>, <span class="hlFld-ContribAuthor ">Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Yadong  Chen</span>, and <span class="hlFld-ContribAuthor ">Tao  Lu</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrazole-3-carboxamide (FN-1501), an FLT3- and CDK-Kinase Inhibitor with Potentially High Efficiency against Acute Myelocytic Leukemia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (4)
                                     , 1499-1518. <a href="https://doi.org/10.1021/acs.jmedchem.7b01261" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01261</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01261%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B4-%252528%2525287H-Pyrrolo%25255B2%25252C3-d%25255Dpyrimidin-4-yl%252529amino%252529-N-%2525284-%252528%2525284-methylpiperazin-1-yl%252529methyl%252529phenyl%252529-1H-pyrazole-3-carboxamide%252B%252528FN-1501%252529%25252C%252Ban%252BFLT3-%252Band%252BCDK-Kinase%252BInhibitor%252Bwith%252BPotentially%252BHigh%252BEfficiency%252Bagainst%252BAcute%252BMyelocytic%252BLeukemia%26aulast%3DWang%26aufirst%3DYue%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D24082017%26date%3D12022018%26date%3D22022018%26date%3D22012018%26volume%3D61%26issue%3D4%26spage%3D1499%26epage%3D1518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yogesh A.  Sonawane</span>, <span class="hlFld-ContribAuthor ">Margaret A.  Taylor</span>, <span class="hlFld-ContribAuthor ">John Victor  Napoleon</span>, <span class="hlFld-ContribAuthor ">Sandeep  Rana</span>, <span class="hlFld-ContribAuthor ">Jacob I.  Contreras</span>, and <span class="hlFld-ContribAuthor ">Amarnath  Natarajan</span>  . </span><span class="cited-content_cbyCitation_article-title">Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (19)
                                     , 8667-8684. <a href="https://doi.org/10.1021/acs.jmedchem.6b00150" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00150</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00150%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCyclin%252BDependent%252BKinase%252B9%252BInhibitors%252Bfor%252BCancer%252BTherapy%26aulast%3DSonawane%26aufirst%3DYogesh%2BA.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D29012016%26date%3D03062016%26date%3D13102016%26date%3D12052016%26volume%3D59%26issue%3D19%26spage%3D8667%26epage%3D8684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomáš  Gucký</span>, <span class="hlFld-ContribAuthor ">Radek  Jorda</span>, <span class="hlFld-ContribAuthor ">Marek  Zatloukal</span>, <span class="hlFld-ContribAuthor ">Václav  Bazgier</span>, <span class="hlFld-ContribAuthor ">Karel  Berka</span>, <span class="hlFld-ContribAuthor ">Eva  Řezníčková</span>, <span class="hlFld-ContribAuthor ">Tibor  Béres</span>, <span class="hlFld-ContribAuthor ">Miroslav  Strnad</span>, and <span class="hlFld-ContribAuthor ">Vladimír  Kryštof</span>  . </span><span class="cited-content_cbyCitation_article-title">A Novel Series of Highly Potent 2,6,9-Trisubstituted Purine Cyclin-Dependent Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (15)
                                     , 6234-6247. <a href="https://doi.org/10.1021/jm4006884" title="DOI URL">https://doi.org/10.1021/jm4006884</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4006884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4006884%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BNovel%252BSeries%252Bof%252BHighly%252BPotent%252B2%25252C6%25252C9-Trisubstituted%252BPurine%252BCyclin-Dependent%252BKinase%252BInhibitors%26aulast%3DGuck%25C3%25BD%26aufirst%3DTom%25C3%25A1%25C5%25A1%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D09052013%26date%3D24072013%26date%3D08082013%26date%3D06072013%26volume%3D56%26issue%3D15%26spage%3D6234%26epage%3D6247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Radek  Jorda</span>, <span class="hlFld-ContribAuthor ">Libor  Havlíček</span>, <span class="hlFld-ContribAuthor ">Iain W.  McNae</span>, <span class="hlFld-ContribAuthor ">Malcolm D.  Walkinshaw</span>, <span class="hlFld-ContribAuthor ">Jiří  Voller</span>, <span class="hlFld-ContribAuthor ">Antonín  Šturc</span>, <span class="hlFld-ContribAuthor ">Jana  Navrátilová</span>, <span class="hlFld-ContribAuthor ">Marek  Kuzma</span>, <span class="hlFld-ContribAuthor ">Martin  Mistrík</span>, <span class="hlFld-ContribAuthor ">Jiří  Bártek</span>, <span class="hlFld-ContribAuthor ">Miroslav  Strnad</span>, and <span class="hlFld-ContribAuthor ">Vladimír  Kryštof</span>  . </span><span class="cited-content_cbyCitation_article-title">Pyrazolo[4,3-d]pyrimidine Bioisostere of Roscovitine: Evaluation of a Novel Selective Inhibitor of Cyclin-Dependent Kinases with Antiproliferative Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (8)
                                     , 2980-2993. <a href="https://doi.org/10.1021/jm200064p" title="DOI URL">https://doi.org/10.1021/jm200064p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200064p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200064p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyrazolo%25255B4%25252C3-d%25255Dpyrimidine%252BBioisostere%252Bof%252BRoscovitine%25253A%252BEvaluation%252Bof%252Ba%252BNovel%252BSelective%252BInhibitor%252Bof%252BCyclin-Dependent%252BKinases%252Bwith%252BAntiproliferative%252BActivity%26aulast%3DJorda%26aufirst%3DRadek%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D21012011%26date%3D06042011%26date%3D28042011%26date%3D21032011%26volume%3D54%26issue%3D8%26spage%3D2980%26epage%3D2993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhonglei  He</span>, <span class="hlFld-ContribAuthor ">Clara  Charleton</span>, <span class="hlFld-ContribAuthor ">Robert  Devine</span>, <span class="hlFld-ContribAuthor ">Mark  Kelada</span>, <span class="hlFld-ContribAuthor ">John.  Walsh</span>, <span class="hlFld-ContribAuthor ">Gillian E.  Conway</span>, <span class="hlFld-ContribAuthor ">Sebnem  Gunes</span>, <span class="hlFld-ContribAuthor ">Julie Rose  Mae Mondala</span>, <span class="hlFld-ContribAuthor ">Furong  Tian</span>, <span class="hlFld-ContribAuthor ">Brijesh  Tiwari</span>, <span class="hlFld-ContribAuthor ">Gemma K.  Kinsella</span>, <span class="hlFld-ContribAuthor ">Renee  Malone</span>, <span class="hlFld-ContribAuthor ">Denis  O'Shea</span>, <span class="hlFld-ContribAuthor ">Michael  Devereux</span>, <span class="hlFld-ContribAuthor ">Wenxin  Wang</span>, <span class="hlFld-ContribAuthor ">Patrick J.  Cullen</span>, <span class="hlFld-ContribAuthor ">John C.  Stephens</span>, <span class="hlFld-ContribAuthor ">James F.  Curtin</span>. </span><span class="cited-content_cbyCitation_article-title">Enhanced pyrazolopyrimidinones cytotoxicity against glioblastoma cells activated by ROS-Generating cold atmospheric plasma. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>3 </em>, 113736. <a href="https://doi.org/10.1016/j.ejmech.2021.113736" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113736</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113736%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEnhanced%252Bpyrazolopyrimidinones%252Bcytotoxicity%252Bagainst%252Bglioblastoma%252Bcells%252Bactivated%252Bby%252BROS-Generating%252Bcold%252Batmospheric%252Bplasma%26aulast%3DHe%26aufirst%3DZhonglei%26date%3D2021%26volume%3D3%26spage%3D113736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.S.  Liang</span>, <span class="hlFld-ContribAuthor ">X.G.  Liu</span>, <span class="hlFld-ContribAuthor ">Y.X.  Cui</span>, <span class="hlFld-ContribAuthor ">S.L.  Zhang</span>, <span class="hlFld-ContribAuthor ">Q.G.  Zhang</span>, <span class="hlFld-ContribAuthor ">J.Z.  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular mechanism concerning conformational changes of CDK2 mediated by binding of inhibitors using molecular dynamics simulations and principal component analysis. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2021,</strong> <em>32 </em>
                                    (7)
                                     , 573-594. <a href="https://doi.org/10.1080/1062936X.2021.1934896" title="DOI URL">https://doi.org/10.1080/1062936X.2021.1934896</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2021.1934896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2021.1934896%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DMolecular%252Bmechanism%252Bconcerning%252Bconformational%252Bchanges%252Bof%252BCDK2%252Bmediated%252Bby%252Bbinding%252Bof%252Binhibitors%252Busing%252Bmolecular%252Bdynamics%252Bsimulations%252Band%252Bprincipal%252Bcomponent%252Banalysis%26aulast%3DLiang%26aufirst%3DS.S.%26date%3D2021%26date%3D2021%26volume%3D32%26issue%3D7%26spage%3D573%26epage%3D594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Ming  Cai</span>, <span class="hlFld-ContribAuthor ">Liang  Shao</span>, <span class="hlFld-ContribAuthor ">Jihong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Protein Kinases Degradation by PROTACs. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.3389/fchem.2021.679120" title="DOI URL">https://doi.org/10.3389/fchem.2021.679120</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2021.679120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2021.679120%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DTargeting%252BProtein%252BKinases%252BDegradation%252Bby%252BPROTACs%26aulast%3DYu%26aufirst%3DFei%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ghaneya S.  Hassan</span>, <span class="hlFld-ContribAuthor ">Hanan H.  Georgey</span>, <span class="hlFld-ContribAuthor ">Esraa Z.  Mohammed</span>, <span class="hlFld-ContribAuthor ">Riham F.  George</span>, <span class="hlFld-ContribAuthor ">Walaa R.  Mahmoud</span>, <span class="hlFld-ContribAuthor ">Farghaly A.  Omar</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanistic selectivity investigation and 2D-QSAR study of some new antiproliferative pyrazoles and pyrazolopyridines as potential CDK2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>218 </em>, 113389. <a href="https://doi.org/10.1016/j.ejmech.2021.113389" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113389%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMechanistic%252Bselectivity%252Binvestigation%252Band%252B2D-QSAR%252Bstudy%252Bof%252Bsome%252Bnew%252Bantiproliferative%252Bpyrazoles%252Band%252Bpyrazolopyridines%252Bas%252Bpotential%252BCDK2%252Binhibitors%26aulast%3DHassan%26aufirst%3DGhaneya%2BS.%26date%3D2021%26volume%3D218%26spage%3D113389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elsherbiny H.  El-Sayed</span>, <span class="hlFld-ContribAuthor ">Khaled S.  Mohamed</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Anti-inflammatory Evaluation of Some New Pyrazole, Pyrimidine, Pyrazolo[1,5-
              a
              ]Pyrimidine, Imidazo[1,2-
              b
              ]Pyrazole and Pyrazolo[5,1-
              b
              ]Quinazoline Derivatives Containing Indane Moiety. </span><span class="cited-content_cbyCitation_journal-name">Polycyclic Aromatic Compounds</span><span> <strong>2021,</strong> <em>41 </em>
                                    (5)
                                     , 1077-1093. <a href="https://doi.org/10.1080/10406638.2019.1653941" title="DOI URL">https://doi.org/10.1080/10406638.2019.1653941</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10406638.2019.1653941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10406638.2019.1653941%26sid%3Dliteratum%253Aachs%26jtitle%3DPolycyclic%2520Aromatic%2520Compounds%26atitle%3DSynthesis%252Band%252BAnti-inflammatory%252BEvaluation%252Bof%252BSome%252BNew%252BPyrazole%25252C%252BPyrimidine%25252C%252BPyrazolo%25255B1%25252C5-%252Ba%252B%25255DPyrimidine%25252C%252BImidazo%25255B1%25252C2-%252Bb%252B%25255DPyrazole%252Band%252BPyrazolo%25255B5%25252C1-%252Bb%252B%25255DQuinazoline%252BDerivatives%252BContaining%252BIndane%252BMoiety%26aulast%3DEl-Sayed%26aufirst%3DElsherbiny%2BH.%26date%3D2021%26date%3D2019%26volume%3D41%26issue%3D5%26spage%3D1077%26epage%3D1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aisha A.  Alsfouk</span>, <span class="hlFld-ContribAuthor ">Hanan M.  Alshibl</span>, <span class="hlFld-ContribAuthor ">Najla A.  Altwaijry</span>, <span class="hlFld-ContribAuthor ">Bshra A.  Alsfouk</span>, <span class="hlFld-ContribAuthor ">Ebtehal S.  Al-Abdullah</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of seliciclib derivatives as potent and selective CDK9 inhibitors for prostate cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Monatshefte für Chemie - Chemical Monthly</span><span> <strong>2021,</strong> <em>152 </em>
                                    (1)
                                     , 109-120. <a href="https://doi.org/10.1007/s00706-020-02727-x" title="DOI URL">https://doi.org/10.1007/s00706-020-02727-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00706-020-02727-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00706-020-02727-x%26sid%3Dliteratum%253Aachs%26jtitle%3DMonatshefte%2520f%25C3%25BCr%2520Chemie%2520-%2520Chemical%2520Monthly%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bseliciclib%252Bderivatives%252Bas%252Bpotent%252Band%252Bselective%252BCDK9%252Binhibitors%252Bfor%252Bprostate%252Bcancer%252Btherapy%26aulast%3DAlsfouk%26aufirst%3DAisha%2BA.%26date%3D2021%26date%3D2021%26volume%3D152%26issue%3D1%26spage%3D109%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael J.V.  da Silva</span>, <span class="hlFld-ContribAuthor ">Andrey P.  Jacomini</span>, <span class="hlFld-ContribAuthor ">Mariana C.  Figueiredo</span>, <span class="hlFld-ContribAuthor ">Davi F.  Back</span>, <span class="hlFld-ContribAuthor ">Mary A.  Foglio</span>, <span class="hlFld-ContribAuthor ">Ana L.T.G.  Ruiz</span>, <span class="hlFld-ContribAuthor ">Fávero R.  Paula</span>, <span class="hlFld-ContribAuthor ">Fernanda A.  Rosa</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient synthesis and antitumor evaluation of 4-aminomethyl-N-arylpyrazoles: Discovery of potent and selective agents for ovarian cancer. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>29 </em>, 115835. <a href="https://doi.org/10.1016/j.bmc.2020.115835" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115835</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115835%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DEfficient%252Bsynthesis%252Band%252Bantitumor%252Bevaluation%252Bof%252B4-aminomethyl-N-arylpyrazoles%25253A%252BDiscovery%252Bof%252Bpotent%252Band%252Bselective%252Bagents%252Bfor%252Bovarian%252Bcancer%26aulast%3Dda%2BSilva%26aufirst%3DMichael%2BJ.V.%26date%3D2021%26volume%3D29%26spage%3D115835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingfei  Wu</span>, <span class="hlFld-ContribAuthor ">Jianfei  Han</span>, <span class="hlFld-ContribAuthor ">Zhicheng  Liu</span>, <span class="hlFld-ContribAuthor ">Yilong  Zhang</span>, <span class="hlFld-ContribAuthor ">Cheng  Huang</span>, <span class="hlFld-ContribAuthor ">Jun  Li</span>, <span class="hlFld-ContribAuthor ">Zeng  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of novel CDK 9 inhibitors based on virtual screening, molecular dynamics simulation, and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Life Sciences</span><span> <strong>2020,</strong> <em>258 </em>, 118228. <a href="https://doi.org/10.1016/j.lfs.2020.118228" title="DOI URL">https://doi.org/10.1016/j.lfs.2020.118228</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lfs.2020.118228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lfs.2020.118228%26sid%3Dliteratum%253Aachs%26jtitle%3DLife%2520Sciences%26atitle%3DIdentification%252Bof%252Bnovel%252BCDK%252B9%252Binhibitors%252Bbased%252Bon%252Bvirtual%252Bscreening%25252C%252Bmolecular%252Bdynamics%252Bsimulation%25252C%252Band%252Bbiological%252Bevaluation%26aulast%3DWu%26aufirst%3DMingfei%26date%3D2020%26volume%3D258%26spage%3D118228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bharat  Goel</span>, <span class="hlFld-ContribAuthor ">Nancy  Tripathi</span>, <span class="hlFld-ContribAuthor ">Nivedita  Bhardwaj</span>, <span class="hlFld-ContribAuthor ">Shreyans K.  Jain</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule CDK Inhibitors for the Therapeutic Management of Cancer. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (17)
                                     , 1535-1563. <a href="https://doi.org/10.2174/1568026620666200516152756" title="DOI URL">https://doi.org/10.2174/1568026620666200516152756</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026620666200516152756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026620666200516152756%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecule%252BCDK%252BInhibitors%252Bfor%252Bthe%252BTherapeutic%252BManagement%252Bof%252BCancer%26aulast%3DGoel%26aufirst%3DBharat%26date%3D2020%26volume%3D20%26issue%3D17%26spage%3D1535%26epage%3D1563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Özal  MUTLU</span>. </span><span class="cited-content_cbyCitation_article-title">Assessment of mitogen-activated protein kinases as therapeutic targets for the treatment of babesiosis and theileriosis. </span><span class="cited-content_cbyCitation_journal-name">TURKISH JOURNAL OF VETERINARY AND ANIMAL SCIENCES</span><span> <strong>2020,</strong> <em>44 </em>
                                    (3)
                                     , 702-713. <a href="https://doi.org/10.3906/vet-2002-20" title="DOI URL">https://doi.org/10.3906/vet-2002-20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3906/vet-2002-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3906%2Fvet-2002-20%26sid%3Dliteratum%253Aachs%26jtitle%3DTURKISH%2520JOURNAL%2520OF%2520VETERINARY%2520AND%2520ANIMAL%2520SCIENCES%26atitle%3DAssessment%252Bof%252Bmitogen-activated%252Bprotein%252Bkinases%252Bas%252Btherapeutic%252Btargets%252Bfor%252Bthe%252Btreatment%252Bof%252Bbabesiosis%252Band%252Btheileriosis%26aulast%3DMUTLU%26aufirst%3D%25C3%2596zal%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D3%26spage%3D702%26epage%3D713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R. Nishanth  Rao</span>, <span class="hlFld-ContribAuthor ">Kaushik  Chanda</span>. </span><span class="cited-content_cbyCitation_article-title">An assessment study of known pyrazolopyrimidines: Chemical methodology and cellular activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>99 </em>, 103801. <a href="https://doi.org/10.1016/j.bioorg.2020.103801" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103801</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103801%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DAn%252Bassessment%252Bstudy%252Bof%252Bknown%252Bpyrazolopyrimidines%25253A%252BChemical%252Bmethodology%252Band%252Bcellular%252Bactivity%26aulast%3DRao%26aufirst%3DR.%2BNishanth%26date%3D2020%26volume%3D99%26spage%3D103801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianzhong  Chen</span>, <span class="hlFld-ContribAuthor ">Laixue  Pang</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Lifei  Wang</span>, <span class="hlFld-ContribAuthor ">John Z. H.  Zhang</span>, <span class="hlFld-ContribAuthor ">Tong  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Decoding molecular mechanism of inhibitor bindings to CDK2 using molecular dynamics simulations and binding free energy calculations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>38 </em>
                                    (4)
                                     , 985-996. <a href="https://doi.org/10.1080/07391102.2019.1591304" title="DOI URL">https://doi.org/10.1080/07391102.2019.1591304</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2019.1591304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2019.1591304%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DDecoding%252Bmolecular%252Bmechanism%252Bof%252Binhibitor%252Bbindings%252Bto%252BCDK2%252Busing%252Bmolecular%252Bdynamics%252Bsimulations%252Band%252Bbinding%252Bfree%252Benergy%252Bcalculations%26aulast%3DChen%26aufirst%3DJianzhong%26date%3D2020%26date%3D2019%26volume%3D38%26issue%3D4%26spage%3D985%26epage%3D996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuou  Teng</span>, <span class="hlFld-ContribAuthor ">Kui  Lu</span>, <span class="hlFld-ContribAuthor ">Qian  Zhang</span>, <span class="hlFld-ContribAuthor ">Lianbo  Zhao</span>, <span class="hlFld-ContribAuthor ">Yuna  Huang</span>, <span class="hlFld-ContribAuthor ">Angela Maria  Ingarra</span>, <span class="hlFld-ContribAuthor ">Hervé  Galons</span>, <span class="hlFld-ContribAuthor ">Tingshen  Li</span>, <span class="hlFld-ContribAuthor ">Shanshan  Cui</span>, <span class="hlFld-ContribAuthor ">Peng  Yu</span>, <span class="hlFld-ContribAuthor ">Nassima  Oumata</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the development of cyclin-dependent kinase 7 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>183 </em>, 111641. <a href="https://doi.org/10.1016/j.ejmech.2019.111641" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111641</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111641%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bdevelopment%252Bof%252Bcyclin-dependent%252Bkinase%252B7%2525C2%2525A0inhibitors%26aulast%3DTeng%26aufirst%3DYuou%26date%3D2019%26volume%3D183%26spage%3D111641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mai  Maher</span>, <span class="hlFld-ContribAuthor ">Asmaa E.  Kassab</span>, <span class="hlFld-ContribAuthor ">Ashraf F.  Zaher</span>, <span class="hlFld-ContribAuthor ">Zeinab  Mahmoud</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Anti-Cancer Agents in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (11)
                                     , 1368-1381. <a href="https://doi.org/10.2174/1871520619666190417153350" title="DOI URL">https://doi.org/10.2174/1871520619666190417153350</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1871520619666190417153350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1871520619666190417153350%26sid%3Dliteratum%253Aachs%26jtitle%3DAnti-Cancer%2520Agents%2520in%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BPyrazolo%25255B3%25252C4-d%25255Dpyrimidines%252Bas%252BPotential%252BCytotoxic%252BAgents%25253A%252BDesign%25252C%252BSynthesis%25252C%252BMolecular%252BDocking%252Band%252BCDK2%252BInhibition%26aulast%3DMaher%26aufirst%3DMai%26date%3D2019%26volume%3D19%26issue%3D11%26spage%3D1368%26epage%3D1381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad  Faisal</span>, <span class="hlFld-ContribAuthor ">Aamer  Saeed</span>, <span class="hlFld-ContribAuthor ">Sarwat  Hussain</span>, <span class="hlFld-ContribAuthor ">Parsa  Dar</span>, <span class="hlFld-ContribAuthor ">Fayaz Ali  Larik</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments in synthetic chemistry and biological activities of pyrazole derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Sciences</span><span> <strong>2019,</strong> <em>131 </em>
                                    (8)
                                     <a href="https://doi.org/10.1007/s12039-019-1646-1" title="DOI URL">https://doi.org/10.1007/s12039-019-1646-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12039-019-1646-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12039-019-1646-1%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Sciences%26atitle%3DRecent%252Bdevelopments%252Bin%252Bsynthetic%252Bchemistry%252Band%252Bbiological%252Bactivities%252Bof%252Bpyrazole%252Bderivatives%26aulast%3DFaisal%26aufirst%3DMuhammad%26date%3D2019%26date%3D2019%26volume%3D131%26issue%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin  Diethelm-Varela</span>, <span class="hlFld-ContribAuthor ">Yong  Ai</span>, <span class="hlFld-ContribAuthor ">Dongdong  Liang</span>, <span class="hlFld-ContribAuthor ">Fengtian  Xue</span>. </span><span class="cited-content_cbyCitation_article-title">Nitrogen Mustards as Anticancer Chemotherapies: Historic Perspective, Current Developments and Future Trends. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (9)
                                     , 691-712. <a href="https://doi.org/10.2174/1568026619666190401100519" title="DOI URL">https://doi.org/10.2174/1568026619666190401100519</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190401100519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190401100519%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DNitrogen%252BMustards%252Bas%252BAnticancer%252BChemotherapies%25253A%252BHistoric%252BPerspective%25252C%252BCurrent%252BDevelopments%252Band%252BFuture%252BTrends%26aulast%3DDiethelm-Varela%26aufirst%3DBenjamin%26date%3D2019%26volume%3D19%26issue%3D9%26spage%3D691%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Priscylla Andrade  Volkart</span>, <span class="hlFld-ContribAuthor ">Gabriela  Bitencourt-Ferreira</span>, <span class="hlFld-ContribAuthor ">André Arigony  Souto</span>, <span class="hlFld-ContribAuthor ">Walter Filgueira  de Azevedo</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclin-Dependent Kinase 2 in Cellular Senescence and Cancer. A Structural and Functional Review. </span><span class="cited-content_cbyCitation_journal-name">Current Drug Targets</span><span> <strong>2019,</strong> <em>20 </em>
                                    (7)
                                     , 716-726. <a href="https://doi.org/10.2174/1389450120666181204165344" title="DOI URL">https://doi.org/10.2174/1389450120666181204165344</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389450120666181204165344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389450120666181204165344%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Drug%2520Targets%26atitle%3DCyclin-Dependent%252BKinase%252B2%252Bin%252BCellular%252BSenescence%252Band%252BCancer.%252BA%252BStructural%252Band%252BFunctional%252BReview%26aulast%3DVolkart%26aufirst%3DPriscylla%2BAndrade%26date%3D2019%26volume%3D20%26issue%3D7%26spage%3D716%26epage%3D726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiyan  Cheng</span>, <span class="hlFld-ContribAuthor ">Zhiheng  Yang</span>, <span class="hlFld-ContribAuthor ">Suhua  Wang</span>, <span class="hlFld-ContribAuthor ">Ying  Li</span>, <span class="hlFld-ContribAuthor ">Han  Wei</span>, <span class="hlFld-ContribAuthor ">Xin  Tian</span>, <span class="hlFld-ContribAuthor ">Quancheng  Kan</span>. </span><span class="cited-content_cbyCitation_article-title">Recent development of CDK inhibitors: An overview of CDK/inhibitor co-crystal structures. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>164 </em>, 615-639. <a href="https://doi.org/10.1016/j.ejmech.2019.01.003" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.01.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.01.003%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bdevelopment%252Bof%252BCDK%252Binhibitors%25253A%252BAn%252Boverview%252Bof%252BCDK%25252Finhibitor%252Bco-crystal%252Bstructures%26aulast%3DCheng%26aufirst%3DWeiyan%26date%3D2019%26volume%3D164%26spage%3D615%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-Zhe  Wu</span>, <span class="hlFld-ContribAuthor ">Hua-Zhou  Ying</span>, <span class="hlFld-ContribAuthor ">Lei  Xu</span>, <span class="hlFld-ContribAuthor ">Gang  Cheng</span>, <span class="hlFld-ContribAuthor ">Jing  Chen</span>, <span class="hlFld-ContribAuthor ">Yong-Zhou  Hu</span>, <span class="hlFld-ContribAuthor ">Tao  Liu</span>, <span class="hlFld-ContribAuthor ">Xiao-Wu  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and molecular docking study of 3
              H
              -imidazole[4,5-
              c
              ]pyridine derivatives as CDK2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2018,</strong> <em>351 </em>
                                    (6)
                                     , 1700381. <a href="https://doi.org/10.1002/ardp.201700381" title="DOI URL">https://doi.org/10.1002/ardp.201700381</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201700381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201700381%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bmolecular%252Bdocking%252Bstudy%252Bof%252B3%252BH%252B-imidazole%25255B4%25252C5-%252Bc%252B%25255Dpyridine%252Bderivatives%252Bas%252BCDK2%252Binhibitors%26aulast%3DWu%26aufirst%3DYi-Zhe%26date%3D2018%26date%3D2018%26volume%3D351%26issue%3D6%26spage%3D1700381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hetal  Patel</span>, <span class="hlFld-ContribAuthor ">Manikandan  Periyasamy</span>, <span class="hlFld-ContribAuthor ">Georgina P.  Sava</span>, <span class="hlFld-ContribAuthor ">Alexander  Bondke</span>, <span class="hlFld-ContribAuthor ">Brian W.  Slafer</span>, <span class="hlFld-ContribAuthor ">Sebastian H. B.  Kroll</span>, <span class="hlFld-ContribAuthor ">Marion  Barbazanges</span>, <span class="hlFld-ContribAuthor ">Richard  Starkey</span>, <span class="hlFld-ContribAuthor ">Silvia  Ottaviani</span>, <span class="hlFld-ContribAuthor ">Alison  Harrod</span>, <span class="hlFld-ContribAuthor ">Eric O.  Aboagye</span>, <span class="hlFld-ContribAuthor ">Laki  Buluwela</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Fuchter</span>, <span class="hlFld-ContribAuthor ">Anthony G. M.  Barrett</span>, <span class="hlFld-ContribAuthor ">R. Charles  Coombes</span>, <span class="hlFld-ContribAuthor ">Simak  Ali</span>. </span><span class="cited-content_cbyCitation_article-title">ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2018,</strong> <em>17 </em>
                                    (6)
                                     , 1156-1166. <a href="https://doi.org/10.1158/1535-7163.MCT-16-0847" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-16-0847</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-16-0847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-16-0847%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DICEC0942%25252C%252Ban%252BOrally%252BBioavailable%252BSelective%252BInhibitor%252Bof%252BCDK7%252Bfor%252BCancer%252BTreatment%26aulast%3DPatel%26aufirst%3DHetal%26date%3D2018%26date%3D2018%26volume%3D17%26issue%3D6%26spage%3D1156%26epage%3D1166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pascale  Hazel</span>, <span class="hlFld-ContribAuthor ">Sebastian H. B.  Kroll</span>, <span class="hlFld-ContribAuthor ">Alexander  Bondke</span>, <span class="hlFld-ContribAuthor ">Marion  Barbazanges</span>, <span class="hlFld-ContribAuthor ">Hetal  Patel</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Fuchter</span>, <span class="hlFld-ContribAuthor ">R Charles  Coombes</span>, <span class="hlFld-ContribAuthor ">Simak  Ali</span>, <span class="hlFld-ContribAuthor ">Anthony G. M.  Barrett</span>, <span class="hlFld-ContribAuthor ">Paul S.  Freemont</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitor Selectivity for Cyclin-Dependent Kinase 7: A Structural, Thermodynamic, and Modelling Study. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2017,</strong> <em>12 </em>
                                    (5)
                                     , 372-380. <a href="https://doi.org/10.1002/cmdc.201600535" title="DOI URL">https://doi.org/10.1002/cmdc.201600535</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201600535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201600535%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DInhibitor%252BSelectivity%252Bfor%252BCyclin-Dependent%252BKinase%2525E2%252580%2525857%25253A%252BA%2525E2%252580%252585Structural%25252C%252BThermodynamic%25252C%252Band%252BModelling%252BStudy%26aulast%3DHazel%26aufirst%3DPascale%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D5%26spage%3D372%26epage%3D380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammed M.A.  Hawash</span>, <span class="hlFld-ContribAuthor ">Deniz Cansen  Kahraman</span>, <span class="hlFld-ContribAuthor ">Fikriye  Eren</span>, <span class="hlFld-ContribAuthor ">Rengul  Cetin Atalay</span>, <span class="hlFld-ContribAuthor ">Sultan Nacak  Baytas</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel pyrazolic chalcone derivatives as novel hepatocellular carcinoma therapeutics. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>129 </em>, 12-26. <a href="https://doi.org/10.1016/j.ejmech.2017.02.002" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.02.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.02.002%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bpyrazolic%252Bchalcone%252Bderivatives%252Bas%252Bnovel%252Bhepatocellular%252Bcarcinoma%252Btherapeutics%26aulast%3DHawash%26aufirst%3DMohammed%2BM.A.%26date%3D2017%26volume%3D129%26spage%3D12%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srinivasulu  Cherukupalli</span>, <span class="hlFld-ContribAuthor ">Rajshekhar  Karpoormath</span>, <span class="hlFld-ContribAuthor ">Balakumar  Chandrasekaran</span>, <span class="hlFld-ContribAuthor ">Girish. A.  Hampannavar</span>, <span class="hlFld-ContribAuthor ">Neeta  Thapliyal</span>, <span class="hlFld-ContribAuthor ">Venkata Narayana  Palakollu</span>. </span><span class="cited-content_cbyCitation_article-title">An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>126 </em>, 298-352. <a href="https://doi.org/10.1016/j.ejmech.2016.11.019" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.11.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.11.019%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Binsight%252Bon%252Bsynthetic%252Band%252Bmedicinal%252Baspects%252Bof%252Bpyrazolo%25255B1%25252C5-a%25255Dpyrimidine%252Bscaffold%26aulast%3DCherukupalli%26aufirst%3DSrinivasulu%26date%3D2017%26volume%3D126%26spage%3D298%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caroline M.  Robb</span>, <span class="hlFld-ContribAuthor ">Jacob I.  Contreras</span>, <span class="hlFld-ContribAuthor ">Smit  Kour</span>, <span class="hlFld-ContribAuthor ">Margaret A.  Taylor</span>, <span class="hlFld-ContribAuthor ">Mohammad  Abid</span>, <span class="hlFld-ContribAuthor ">Yogesh A.  Sonawane</span>, <span class="hlFld-ContribAuthor ">Muhammad  Zahid</span>, <span class="hlFld-ContribAuthor ">Daryl J.  Murry</span>, <span class="hlFld-ContribAuthor ">Amarnath  Natarajan</span>, <span class="hlFld-ContribAuthor ">Sandeep  Rana</span>. </span><span class="cited-content_cbyCitation_article-title">Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC). </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2017,</strong> <em>53 </em>
                                    (54)
                                     , 7577-7580. <a href="https://doi.org/10.1039/C7CC03879H" title="DOI URL">https://doi.org/10.1039/C7CC03879H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7CC03879H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7CC03879H%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DChemically%252Binduced%252Bdegradation%252Bof%252BCDK9%252Bby%252Ba%252Bproteolysis%252Btargeting%252Bchimera%252B%252528PROTAC%252529%26aulast%3DRobb%26aufirst%3DCaroline%2BM.%26date%3D2017%26date%3D2017%26volume%3D53%26issue%3D54%26spage%3D7577%26epage%3D7580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chandrakant  Bagul</span>, <span class="hlFld-ContribAuthor ">Garikapati Koteswara  Rao</span>, <span class="hlFld-ContribAuthor ">Venkata Krishna Kanth  Makani</span>, <span class="hlFld-ContribAuthor ">Jaki R.  Tamboli</span>, <span class="hlFld-ContribAuthor ">Manika  Pal-Bhadra</span>, <span class="hlFld-ContribAuthor ">Ahmed  Kamal</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of chalcone-linked pyrazolo[1,5-a]pyrimidines as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (9)
                                     , 1810-1816. <a href="https://doi.org/10.1039/C7MD00193B" title="DOI URL">https://doi.org/10.1039/C7MD00193B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00193B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00193B%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bchalcone-linked%252Bpyrazolo%25255B1%25252C5-a%25255Dpyrimidines%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DBagul%26aufirst%3DChandrakant%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D9%26spage%3D1810%26epage%3D1816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nasser S.M.  Ismail</span>, <span class="hlFld-ContribAuthor ">Ghada M.E.  Ali</span>, <span class="hlFld-ContribAuthor ">Diaa A.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Amira M.  Elmetwali</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal attributes of pyrazolo[1,5-a]pyrimidine based scaffold derivatives targeting kinases as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Future Journal of Pharmaceutical Sciences</span><span> <strong>2016,</strong> <em>2 </em>
                                    (2)
                                     , 60-70. <a href="https://doi.org/10.1016/j.fjps.2016.08.004" title="DOI URL">https://doi.org/10.1016/j.fjps.2016.08.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.fjps.2016.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.fjps.2016.08.004%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DMedicinal%252Battributes%252Bof%252Bpyrazolo%25255B1%25252C5-a%25255Dpyrimidine%252Bbased%252Bscaffold%252Bderivatives%252Btargeting%252Bkinases%252Bas%252Banticancer%252Bagents%26aulast%3DIsmail%26aufirst%3DNasser%2BS.M.%26date%3D2016%26volume%3D2%26issue%3D2%26spage%3D60%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">SOMESHWAR  DESHMUKH</span>, <span class="hlFld-ContribAuthor ">KUNAL  DINGORE</span>, <span class="hlFld-ContribAuthor ">VISHWAS  GAIKWAD</span>, <span class="hlFld-ContribAuthor ">MADHUKAR  JACHAK</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient synthesis of pyrazolo[1,5-a]pyrimidines and evaluation of their antimicrobial activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Sciences</span><span> <strong>2016,</strong> <em>128 </em>
                                    (9)
                                     , 1459-1468. <a href="https://doi.org/10.1007/s12039-016-1141-x" title="DOI URL">https://doi.org/10.1007/s12039-016-1141-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12039-016-1141-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12039-016-1141-x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Sciences%26atitle%3DAn%252Befficient%252Bsynthesis%252Bof%252Bpyrazolo%25255B1%25252C5-a%25255Dpyrimidines%252Band%252Bevaluation%252Bof%252Btheir%252Bantimicrobial%252Bactivity%26aulast%3DDESHMUKH%26aufirst%3DSOMESHWAR%26date%3D2016%26date%3D2016%26volume%3D128%26issue%3D9%26spage%3D1459%26epage%3D1468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingxia  Zhao</span>, <span class="hlFld-ContribAuthor ">Hongyu  Ren</span>, <span class="hlFld-ContribAuthor ">Jin  Chang</span>, <span class="hlFld-ContribAuthor ">Diqin  Zhang</span>, <span class="hlFld-ContribAuthor ">Yating  Yang</span>, <span class="hlFld-ContribAuthor ">Yong  He</span>, <span class="hlFld-ContribAuthor ">Chuanmin  Qi</span>, <span class="hlFld-ContribAuthor ">Huabei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel pyrazolo[1,5-a]pyrimidine derivatives bearing nitrogen mustard moiety and evaluation of their antitumor activity in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>119 </em>, 183-196. <a href="https://doi.org/10.1016/j.ejmech.2016.04.068" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.04.068</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.04.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.04.068%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252Bpyrazolo%25255B1%25252C5-a%25255Dpyrimidine%252Bderivatives%252Bbearing%252Bnitrogen%252Bmustard%252Bmoiety%252Band%252Bevaluation%252Bof%252Btheir%252Bantitumor%252Bactivity%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%26aulast%3DZhao%26aufirst%3DMingxia%26date%3D2016%26volume%3D119%26spage%3D183%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Asterios I.  Grigoroudis</span>, <span class="hlFld-ContribAuthor ">George  Kontopidis</span>. </span><span class="cited-content_cbyCitation_article-title">Preparation of CDK/Cyclin Inhibitor Complexes for Structural Determination. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 29-45. <a href="https://doi.org/10.1007/978-1-4939-2926-9_4" title="DOI URL">https://doi.org/10.1007/978-1-4939-2926-9_4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-2926-9_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-2926-9_4%26sid%3Dliteratum%253Aachs%26atitle%3DPreparation%252Bof%252BCDK%25252FCyclin%252BInhibitor%252BComplexes%252Bfor%252BStructural%252BDetermination%26aulast%3DGrigoroudis%26aufirst%3DAsterios%2BI.%26date%3D2016%26spage%3D29%26epage%3D45%26pub%3DSpringer%2520New%2520York%26atitle%3DCyclin-Dependent%252BKinase%252B%252528CDK%252529%252BInhibitors%26aulast%3DOrz%25C3%25A1ez%26aufirst%3DMar%26date%3D2016%26volume%3D1336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ibtissam  Bassoude</span>, <span class="hlFld-ContribAuthor ">Zahira  Tber</span>, <span class="hlFld-ContribAuthor ">El Mokhtar  Essassi</span>, <span class="hlFld-ContribAuthor ">Gérald  Guillaumet</span>, <span class="hlFld-ContribAuthor ">Sabine  Berteina-Raboin</span>. </span><span class="cited-content_cbyCitation_article-title">A one-pot process for the microwave-assisted synthesis of 7-substituted pyrazolo[1,5-a]pyrimidine. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (4)
                                     , 3301-3306. <a href="https://doi.org/10.1039/C5RA23417D" title="DOI URL">https://doi.org/10.1039/C5RA23417D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA23417D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA23417D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DA%252Bone-pot%252Bprocess%252Bfor%252Bthe%252Bmicrowave-assisted%252Bsynthesis%252Bof%252B7-substituted%252Bpyrazolo%25255B1%25252C5-a%25255Dpyrimidine%26aulast%3DBassoude%26aufirst%3DIbtissam%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D4%26spage%3D3301%26epage%3D3306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laurent Le  Corre</span>, <span class="hlFld-ContribAuthor ">Lotfi  Tak-Tak</span>, <span class="hlFld-ContribAuthor ">Arthur  Guillard</span>, <span class="hlFld-ContribAuthor ">Guillaume  Prestat</span>, <span class="hlFld-ContribAuthor ">Christine  Gravier-Pelletier</span>, <span class="hlFld-ContribAuthor ">Patricia  Busca</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave-assisted preparation of 4-amino-3-cyano-5-methoxycarbonyl-N-arylpyrazoles as building blocks for the diversity-oriented synthesis of pyrazole-based polycyclic scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2015,</strong> <em>13 </em>
                                    (2)
                                     , 409-423. <a href="https://doi.org/10.1039/C4OB01951B" title="DOI URL">https://doi.org/10.1039/C4OB01951B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4OB01951B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4OB01951B%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DMicrowave-assisted%252Bpreparation%252Bof%252B4-amino-3-cyano-5-methoxycarbonyl-N-arylpyrazoles%252Bas%252Bbuilding%252Bblocks%252Bfor%252Bthe%252Bdiversity-oriented%252Bsynthesis%252Bof%252Bpyrazole-based%252Bpolycyclic%252Bscaffolds%26aulast%3DCorre%26aufirst%3DLaurent%2BLe%26date%3D2015%26date%3D2015%26volume%3D13%26issue%3D2%26spage%3D409%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandrine  Houzé</span>, <span class="hlFld-ContribAuthor ">Nha-Thu  Hoang</span>, <span class="hlFld-ContribAuthor ">Olivier  Lozach</span>, <span class="hlFld-ContribAuthor ">Jacques  Le Bras</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Hervé  Galons</span>, <span class="hlFld-ContribAuthor ">Luc  Demange</span>. </span><span class="cited-content_cbyCitation_article-title">Several Human Cyclin-Dependent Kinase Inhibitors, Structurally Related to Roscovitine, As New Anti-Malarial Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2014,</strong> <em>19 </em>
                                    (9)
                                     , 15237-15257. <a href="https://doi.org/10.3390/molecules190915237" title="DOI URL">https://doi.org/10.3390/molecules190915237</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules190915237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules190915237%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSeveral%252BHuman%252BCyclin-Dependent%252BKinase%252BInhibitors%25252C%252BStructurally%252BRelated%252Bto%252BRoscovitine%25252C%252BAs%252BNew%252BAnti-Malarial%252BAgents%26aulast%3DHouz%25C3%25A9%26aufirst%3DSandrine%26date%3D2014%26date%3D2014%26volume%3D19%26issue%3D9%26spage%3D15237%26epage%3D15257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Petr  Cankař</span>, <span class="hlFld-ContribAuthor ">Lukáš  Jedinák</span>, <span class="hlFld-ContribAuthor ">Vladimír  Kryštof</span>, <span class="hlFld-ContribAuthor ">Zdeněk  Trávníček</span>. </span><span class="cited-content_cbyCitation_article-title">Multicomponent and Regioselective Synthesis of Dihydropyrazolo[1,5-a]pyrimidines from Aromatic Aldehydes, Meldrum’s Acid, and Aminopyrazole CAN508. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2014,</strong> <em>89 </em>
                                    (8)
                                     , 1892. <a href="https://doi.org/10.3987/COM-14-13026" title="DOI URL">https://doi.org/10.3987/COM-14-13026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-14-13026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-14-13026%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DMulticomponent%252Band%252BRegioselective%252BSynthesis%252Bof%252BDihydropyrazolo%25255B1%25252C5-a%25255Dpyrimidines%252Bfrom%252BAromatic%252BAldehydes%25252C%252BMeldrum%2525E2%252580%252599s%252BAcid%25252C%252Band%252BAminopyrazole%252BCAN508%26aulast%3DCanka%25C5%2599%26aufirst%3DPetr%26date%3D2014%26volume%3D89%26issue%3D8%26spage%3D1892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shivaji S.  Kadam</span>, <span class="hlFld-ContribAuthor ">Lukáš  Maier</span>, <span class="hlFld-ContribAuthor ">Ioannis  Kostakis</span>, <span class="hlFld-ContribAuthor ">Nicole  Pouli</span>, <span class="hlFld-ContribAuthor ">Jaromír  Toušek</span>, <span class="hlFld-ContribAuthor ">Marek  Nečas</span>, <span class="hlFld-ContribAuthor ">Panagiotis  Marakos</span>, <span class="hlFld-ContribAuthor ">Radek  Marek</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Tautomerism of Substituted Pyrazolo[4,3-
              c
              ]pyrazoles. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>2013 </em>
                                    (30)
                                     , 6811-6822. <a href="https://doi.org/10.1002/ejoc.201300606" title="DOI URL">https://doi.org/10.1002/ejoc.201300606</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201300606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201300606%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Band%252BTautomerism%252Bof%252BSubstituted%252BPyrazolo%25255B4%25252C3-%252Bc%252B%25255Dpyrazoles%26aulast%3DKadam%26aufirst%3DShivaji%2BS.%26date%3D2013%26date%3D2013%26volume%3D2013%26issue%3D30%26spage%3D6811%26epage%3D6822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M  Kaliszczak</span>, <span class="hlFld-ContribAuthor ">H  Patel</span>, <span class="hlFld-ContribAuthor ">S H B  Kroll</span>, <span class="hlFld-ContribAuthor ">L  Carroll</span>, <span class="hlFld-ContribAuthor ">G  Smith</span>, <span class="hlFld-ContribAuthor ">S  Delaney</span>, <span class="hlFld-ContribAuthor ">D A  Heathcote</span>, <span class="hlFld-ContribAuthor ">A  Bondke</span>, <span class="hlFld-ContribAuthor ">M J  Fuchter</span>, <span class="hlFld-ContribAuthor ">R C  Coombes</span>, <span class="hlFld-ContribAuthor ">A G M  Barrett</span>, <span class="hlFld-ContribAuthor ">S  Ali</span>, <span class="hlFld-ContribAuthor ">E O  Aboagye</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a cyclin-dependent kinase inhibitor devoid of ABC transporter-dependent drug resistance. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Cancer</span><span> <strong>2013,</strong> <em>109 </em>
                                    (9)
                                     , 2356-2367. <a href="https://doi.org/10.1038/bjc.2013.584" title="DOI URL">https://doi.org/10.1038/bjc.2013.584</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/bjc.2013.584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fbjc.2013.584%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Cancer%26atitle%3DDevelopment%252Bof%252Ba%252Bcyclin-dependent%252Bkinase%252Binhibitor%252Bdevoid%252Bof%252BABC%252Btransporter-dependent%252Bdrug%252Bresistance%26aulast%3DKaliszczak%26aufirst%3DM%26date%3D2013%26date%3D2013%26volume%3D109%26issue%3D9%26spage%3D2356%26epage%3D2367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luc  Demange</span>, <span class="hlFld-ContribAuthor ">Olivier  Lozach</span>, <span class="hlFld-ContribAuthor ">Yoan  Ferandin</span>, <span class="hlFld-ContribAuthor ">Nha Thu  Hoang</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Hervé  Galons</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of new potent inhibitors of CK1 and CDK5, two kinases involved in Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2013,</strong> <em>22 </em>
                                    (7)
                                     , 3247-3258. <a href="https://doi.org/10.1007/s00044-012-0334-1" title="DOI URL">https://doi.org/10.1007/s00044-012-0334-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-012-0334-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-012-0334-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bnew%252Bpotent%252Binhibitors%252Bof%252BCK1%252Band%252BCDK5%25252C%252Btwo%252Bkinases%252Binvolved%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DDemange%26aufirst%3DLuc%26date%3D2013%26date%3D2012%26volume%3D22%26issue%3D7%26spage%3D3247%26epage%3D3258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alfredo  De Biasio</span>, <span class="hlFld-ContribAuthor ">Ramón  Campos-Olivas</span>, <span class="hlFld-ContribAuthor ">Ricardo  Sánchez</span>, <span class="hlFld-ContribAuthor ">Jorge P.  López-Alonso</span>, <span class="hlFld-ContribAuthor ">David  Pantoja-Uceda</span>, <span class="hlFld-ContribAuthor ">Nekane  Merino</span>, <span class="hlFld-ContribAuthor ">Maider  Villate</span>, <span class="hlFld-ContribAuthor ">Jose M.  Martin-Garcia</span>, <span class="hlFld-ContribAuthor ">Francisco  Castillo</span>, <span class="hlFld-ContribAuthor ">Irene  Luque</span>, <span class="hlFld-ContribAuthor ">Francisco J.  Blanco</span>, . </span><span class="cited-content_cbyCitation_article-title">Proliferating Cell Nuclear Antigen (PCNA) Interactions in Solution Studied by NMR. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2012,</strong> <em>7 </em>
                                    (11)
                                     , e48390. <a href="https://doi.org/10.1371/journal.pone.0048390" title="DOI URL">https://doi.org/10.1371/journal.pone.0048390</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0048390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0048390%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DProliferating%252BCell%252BNuclear%252BAntigen%252B%252528PCNA%252529%252BInteractions%252Bin%252BSolution%252BStudied%252Bby%252BNMR%26aulast%3DDe%2BBiasio%26aufirst%3DAlfredo%26date%3D2012%26date%3D2012%26volume%3D7%26issue%3D11%26spage%3De48390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sunil Kumar  Tripathi</span>, <span class="hlFld-ContribAuthor ">Sanjeev Kumar  Singh</span>, <span class="hlFld-ContribAuthor ">Poonam  Singh</span>, <span class="hlFld-ContribAuthor ">Palanisamy  Chellaperumal</span>, <span class="hlFld-ContribAuthor ">Karnati Konda  Reddy</span>, <span class="hlFld-ContribAuthor ">Chandrabose  Selvaraj</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the selectivity of a ligand complex with CDK2/CDK1: a molecular dynamics simulation approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Recognition</span><span> <strong>2012,</strong> <em>25 </em>
                                    (10)
                                     , 504-512. <a href="https://doi.org/10.1002/jmr.2216" title="DOI URL">https://doi.org/10.1002/jmr.2216</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jmr.2216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjmr.2216%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Recognition%26atitle%3DExploring%252Bthe%252Bselectivity%252Bof%252Ba%252Bligand%252Bcomplex%252Bwith%252BCDK2%25252FCDK1%25253A%252Ba%252Bmolecular%252Bdynamics%252Bsimulation%252Bapproach%26aulast%3DTripathi%26aufirst%3DSunil%2BKumar%26date%3D2012%26date%3D2012%26volume%3D25%26issue%3D10%26spage%3D504%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. A.  Petrov</span>, <span class="hlFld-ContribAuthor ">A. N.  Kasatochkin</span>, <span class="hlFld-ContribAuthor ">E. E.  Emelina</span>. </span><span class="cited-content_cbyCitation_article-title">Study of regioselectivity of reactions between 3(5)-aminopyrazoles and 2-acetylcycloalkanones. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2012,</strong> <em>48 </em>
                                    (8)
                                     , 1111-1120. <a href="https://doi.org/10.1134/S1070428012080131" title="DOI URL">https://doi.org/10.1134/S1070428012080131</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428012080131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428012080131%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DStudy%252Bof%252Bregioselectivity%252Bof%252Breactions%252Bbetween%252B3%2525285%252529-aminopyrazoles%252Band%252B2-acetylcycloalkanones%26aulast%3DPetrov%26aufirst%3DA.%2BA.%26date%3D2012%26date%3D2012%26volume%3D48%26issue%3D8%26spage%3D1111%26epage%3D1120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingli  Xu</span>, <span class="hlFld-ContribAuthor ">Hang  Liu</span>, <span class="hlFld-ContribAuthor ">Guixia  Li</span>, <span class="hlFld-ContribAuthor ">Yong  He</span>, <span class="hlFld-ContribAuthor ">Rui  Ding</span>, <span class="hlFld-ContribAuthor ">Xiao  Wang</span>, <span class="hlFld-ContribAuthor ">Man  Feng</span>, <span class="hlFld-ContribAuthor ">Shuting  Zhang</span>, <span class="hlFld-ContribAuthor ">Yurong  Chen</span>, <span class="hlFld-ContribAuthor ">Shilei  Li</span>, <span class="hlFld-ContribAuthor ">Mingxia  Zhao</span>, <span class="hlFld-ContribAuthor ">Yingruo  Li</span>, <span class="hlFld-ContribAuthor ">Chuanmin  Qi</span>, <span class="hlFld-ContribAuthor ">Yonghong  Dang</span>. </span><span class="cited-content_cbyCitation_article-title">18F-labeled Pyrazolo[1,5-a]pyrimidine Derivatives: Synthesis from 2,4-Dinitrobenzamide and Tosylate Precursors and Comparative Biological Evaluation for Tumor Imaging with Positron Emission Tomography. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2012,</strong> <em>17 </em>
                                    (4)
                                     , 3774-3793. <a href="https://doi.org/10.3390/molecules17043774" title="DOI URL">https://doi.org/10.3390/molecules17043774</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules17043774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules17043774%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3D18F-labeled%252BPyrazolo%25255B1%25252C5-a%25255Dpyrimidine%252BDerivatives%25253A%252BSynthesis%252Bfrom%252B2%25252C4-Dinitrobenzamide%252Band%252BTosylate%252BPrecursors%252Band%252BComparative%252BBiological%252BEvaluation%252Bfor%252BTumor%252BImaging%252Bwith%252BPositron%252BEmission%252BTomography%26aulast%3DXu%26aufirst%3DJingli%26date%3D2012%26date%3D2012%26volume%3D17%26issue%3D4%26spage%3D3774%26epage%3D3793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Józefa  Węsierska-Gądek</span>, <span class="hlFld-ContribAuthor ">Matthias P  Kramer</span>. </span><span class="cited-content_cbyCitation_article-title">The impact of CDK inhibition in human malignancies associated with pronounced defects in apoptosis: advantages of multi-targeting small molecules. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2012,</strong> <em>4 </em>
                                    (4)
                                     , 395-424. <a href="https://doi.org/10.4155/fmc.12.12" title="DOI URL">https://doi.org/10.4155/fmc.12.12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.12.12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.12.12%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bimpact%252Bof%252BCDK%252Binhibition%252Bin%252Bhuman%252Bmalignancies%252Bassociated%252Bwith%252Bpronounced%252Bdefects%252Bin%252Bapoptosis%25253A%252Badvantages%252Bof%252Bmulti-targeting%252Bsmall%252Bmolecules%26aulast%3DW%25C4%2599sierska-G%25C4%2585dek%26aufirst%3DJ%25C3%25B3zefa%26date%3D2012%26volume%3D4%26issue%3D4%26spage%3D395%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingli  Xu</span>, <span class="hlFld-ContribAuthor ">Hang  Liu</span>, <span class="hlFld-ContribAuthor ">Guixia  Li</span>, <span class="hlFld-ContribAuthor ">Yong  He</span>, <span class="hlFld-ContribAuthor ">Rui  Ding</span>, <span class="hlFld-ContribAuthor ">Xiao  Wang</span>, <span class="hlFld-ContribAuthor ">Man  Feng</span>, <span class="hlFld-ContribAuthor ">Shuting  Zhang</span>, <span class="hlFld-ContribAuthor ">Yurong  Chen</span>, <span class="hlFld-ContribAuthor ">Shilei  Li</span>, <span class="hlFld-ContribAuthor ">Mingxia  Zhao</span>, <span class="hlFld-ContribAuthor ">Chuanmin  Qi</span>, <span class="hlFld-ContribAuthor ">Yonghong  Dang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel F-18 labeled pyrazolo[1,5-a]pyrimidine derivatives: Potential PET imaging agents for tumor detection. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (16)
                                     , 4736-4741. <a href="https://doi.org/10.1016/j.bmcl.2011.06.072" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.06.072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.06.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.06.072%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252BF-18%252Blabeled%252Bpyrazolo%25255B1%25252C5-a%25255Dpyrimidine%252Bderivatives%25253A%252BPotential%252BPET%252Bimaging%252Bagents%252Bfor%252Btumor%252Bdetection%26aulast%3DXu%26aufirst%3DJingli%26date%3D2011%26volume%3D21%26issue%3D16%26spage%3D4736%26epage%3D4741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael M.  Miller</span>, <span class="hlFld-ContribAuthor ">Albert J.  DelMonte</span>. </span><span class="cited-content_cbyCitation_article-title">Six-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 371-402. <a href="https://doi.org/10.1016/B978-0-08-096805-6.00013-9" title="DOI URL">https://doi.org/10.1016/B978-0-08-096805-6.00013-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-096805-6.00013-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-096805-6.00013-9%26sid%3Dliteratum%253Aachs%26atitle%3DSix-Membered%252BRing%252BSystems%26aulast%3DMiller%26aufirst%3DMichael%2BM.%26date%3D2011%26spage%3D371%26epage%3D402%26pub%3DElsevier%26date%3D2011%26volume%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/medium/jm-2010-00732t_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100732t&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/medium/jm-2010-00732t_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of some CDK inhibitors currently in clinical evaluation. See text for references.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100732t&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/medium/jm-2010-00732t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Pyrazolopyrimidines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100732t&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) BnNH<sub>2</sub>, EtOH, reflux, 16 h, 95%; (b) Boc<sub>2</sub>O, THF, cat. DMAP, 25 °C, 20 h, 96%; (c) amine, Pd<sub>2</sub>(dba)<sub>3</sub>, <i>rac</i>-BINAP, NaO<sup>t</sup>Bu, 100 °C, 16 h, 40−99%; (d) MeOH, HCl, 25 °C, 3 h, 67−99%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/medium/jm-2010-00732t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. First Generation Synthesis of 4k and 4l<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100732t&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <i>t</i>-BuMe<sub>2</sub>SiCl, Et<sub>3</sub>N, cat. DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 25 °C, 16 h, 99%; (b) <b>2</b>, Pd<sub>2</sub>(dba)<sub>3</sub>, <i>rac</i>-BINAP, NaO<sup>t</sup>Bu, 100 °C, 16 h, 43%; (c) cat. OsO<sub>4</sub>, NMO, MeCN, H<sub>2</sub>O, 25 °C, 45 min, <b>3k</b> 42%, <b>3l</b> 33%; (d) MeOH, HCl, 25 °C, 3 h, <b>4k</b> 79%, <b>4l</b> 67%.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/medium/jm-2010-00732t_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structure of <b>4k</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100732t&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/medium/jm-2010-00732t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0008.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Second Generation Synthesis of 4k<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100732t&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) SOCl<sub>2</sub>, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 1 h; (b) NaN<sub>3</sub>, DMF, 12 h, 70% (2 steps); (c) NaBH<sub>4</sub>,LiCl, EtOH, 0 °C, 12 h; (d) (MeO)<sub>2</sub>CMe<sub>2</sub>, TsOH, Me<sub>2</sub>CO, 50 °C, 3 h; (e) MOMCl,<i>i</i>Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 12 h, 70% (3 steps); (f) H<sub>2</sub>, Pd/C, MeOH, 1 h, 97%; (g) <b>2</b>,Pd<sub>2</sub>(dba)<sub>3</sub>, <i>rac</i>-BINAP, NaO<sup>t</sup>Bu, 100 °C, 16 h, 95%; (h) MeOH, HCl, 25 °C, 3 h, 90%.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/medium/jm-2010-00732t_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structure of <b>4k</b> bound to CDK2. (A) Shown is the <b>4k</b> difference electron density map after refinement, contored at 2.9σ. (B) <b>4k</b> binding site in CDK2 is shown with hydrogen bonding interactions depicted as dashed lines. Water-mediated interactions are also shown. Carbon atoms are colored in cyan, nitrogen in blue, and oxygen in red. Water molecules are represented as red crosses. (C) Roscovitine binding site in CDK2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2A4L">2A4L</a>), as (B). (D) Summary of CDK2-<b>4k</b> data collection and refinement statistics.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100732t&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/medium/jm-2010-00732t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>4k</b> treatment of HCT116 cells leads to cancer cell growth inhibition, cell cycle arrest, and inhibition of CDK substrate phosphorylation. (A) Growth inhibition profiles for the NCI 60 cancer cell panel. For details of the growth profiles of the individual cell lines see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. (B) Effect of <b>4k</b> on cell cycle kinetics. <b>4k</b> at the concentrations shown was added to HCT116 cells for 24 h prior to fixation, staining with propidium iodide (PI), and flow cytometric analysis. The percentage of cells in the sub-G1 (apoptosis), G1, S-phase, and G2/M, as determined from three independent experiments, are shown. Error bars represent the standard errors of the mean (SEM). <i>P</i>-Values were determined using Student’s <i>t</i> test, in which comparison between the DMSO control, and <b>4k</b> treatment at each concentration was carried out. Asterisks (*) denote <i>p</i> < 0.05. (C−E) Molecular pharmacology of <b>4k</b> on HCT116 cells. Cell lysates prepared from HCT116 cells treated with <b>4k</b> or roscovitine for 4 or 24 h were immunoblotted for various proteins or phosphorylated forms, as labeled.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100732t&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/medium/jm-2010-00732t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>4k</b> inhibits growth in human breast tumor xenografts. (A) Randomized MCF-7 tumor bearing mice were injected intraperitoneally twice daily with vehicle (control, <i>n</i> = 11) or with 5 or 10 mg/kg of <b>4k</b>, giving a total daily dose of 10 mg/kg/day (<i>n</i> = 8) or 20 mg/kg/day (<i>n</i> = 9), respectively, over a period of 14 days. The change in tumor volume was determined for each animal, as tumor volume relative to the tumor volume of each animal at day 1. The line graphs show the mean tumor volumes for the animals in each treatment group. (B) Shown are the weights of the animals used over the time course of the study. Error bars represent the standard errors of the mean.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100732t&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/medium/jm-2010-00732t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Pharmacokinetic determination of <b>4k</b> levels. The mean plasma concentration of <b>4k</b> over time was determined for four mice at each time point following <b>4k</b> administration. Error bars represent the standard errors of the mean.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100732t&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/medium/jm-2010-00732t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Oral administration of <b>4k</b> inhibits cyclin-dependent kinase substrate phosphorylation in mouse peripheral blood mononuclear cells. Mouse PBMCs were collected 6 h following dosing of female nude mice by oral gavage at the dose levels shown. PBMCs were incubated with the appropriate primary antibodies, followed by fluorescently labeled secondary antibodies and flow cytometric analysis (<i>n</i> = 4, except for the 100 mg/kg dose where <i>n</i> = 3) to determine the status of (A) Rb, (B) Rb phosphorylated at threonine-821 (Rb Thr821), (C) RNA polymerase II Ser-2 phosphorylation (PolII Ser-2), and (D) total PolII. Error bars represent the standard errors of the mean. <i>P</i>-Values were determined using Student’s <i>t</i> test; # represents <i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100732t&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/medium/jm-2010-00732t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Oral administration of <b>4k</b> inhibits human tumor xenografts. (A) Female nude mice bearing HCT116 tumor xenografts were dosed by oral gavage with vehicle (<i>n</i> = 8) or <b>4k</b> at a concentration of 25 mg/kg (<i>n</i> = 6). (B) The weights of the animals used over the time course of the study are shown. Error bars represent the standard errors of the mean. <i>P</i>-Values were determined using Student’s <i>t</i> test; # represents <i>p</i> < 0.05, * represents <i>p</i> < 0.01, and ** represents <i>p</i> < 0.001. (C) Shown are representative images for tumor xenografts immunostained using antibodies for Rb, Rb pSer807/811, and Rb pThr821. (D) One thousand nuclei were scored for determining percentage of stained cells in sections from each tumor. The results of the scoring are shown as box plots. Student’s <i>t</i> test analysis showed that pSer807/811 and pThr821 staining was significantly different (<i>p</i> < 0.005) between the vehicle and <b>4k</b> treatment groups, whereas there was no significant difference in levels of total Rb.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100732t/production/images/large/jm-2010-00732t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100732t&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i45">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33055" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33055" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 51 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Sherr, C. J.</span><span> </span><span class="NLM_article-title">Cancer cell cycles</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">1672</span><span class="NLM_x">–</span> <span class="NLM_lpage">1677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1996&pages=1672-1677&author=C.+J.+Sherr&title=Cancer+cell+cycles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSherr%26aufirst%3DC.%2BJ.%26atitle%3DCancer%2520cell%2520cycles%26jtitle%3DScience%26date%3D1996%26volume%3D274%26spage%3D1672%26epage%3D1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Morgan, D. O.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinases: engines, clocks, and microprocessors</span> <span class="citation_source-journal">Annu. Rev. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1146%2Fannurev.cellbio.13.1.261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=9442875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADyaK1cXisFSktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1997&pages=261-291&author=D.+O.+Morgan&title=Cyclin-dependent+kinases%3A+engines%2C+clocks%2C+and+microprocessors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-dependent kinases: engines, clocks, and microprocessors</span></div><div class="casAuthors">Morgan, David O.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Cell and Developmental Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">261-291</span>CODEN:
                <span class="NLM_cas:coden">ARDBF8</span>;
        ISSN:<span class="NLM_cas:issn">1081-0706</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 133 refs.  Cyclin-dependent kinases (Cdks) play a well-established role in the regulation of the eukaryotic cell division cycle and have also been implicated in the control of gene transcription and other processes.  Cdk activity is governed by a complex network of regulatory subunits and phosphorylation events whose precise effects on Cdk conformation have been revealed by recent crystallog. studies.  In the cell, these regulatory mechanisms generate an interlinked series of Cdk oscillators that trigger the events of cell division.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDw-roxCwtY7Vg90H21EOLACvtfcHk0lhpJn6j_9ib_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFSktA%253D%253D&md5=9b9b161d0beaef5e7934bab158906dcd</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.cellbio.13.1.261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.cellbio.13.1.261%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DD.%2BO.%26atitle%3DCyclin-dependent%2520kinases%253A%2520engines%252C%2520clocks%252C%2520and%2520microprocessors%26jtitle%3DAnnu.%2520Rev.%2520Cell%2520Dev.%2520Biol.%26date%3D1997%26volume%3D13%26spage%3D261%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Cell cycle, CDKs and cancer: a changing paradigm</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1038%2Fnrc2602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=19238148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1ans78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=153-166&author=M.+Malumbresauthor=M.+Barbacid&title=Cell+cycle%2C+CDKs+and+cancer%3A+a+changing+paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle, CDKs and cancer: a changing paradigm</span></div><div class="casAuthors">Malumbres, Marcos; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-166</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Tumor-assocd. cell cycle defects are often mediated by alterations in cyclin-dependent kinase (CDK) activity.  Misregulated CDKs induce unscheduled proliferation as well as genomic and chromosomal instability.  According to current models, mammalian CDKs are essential for driving each cell cycle phase, so therapeutic strategies that block CDK activity are unlikely to selectively target tumor cells.  However, recent genetic evidence has revealed that, whereas CDK1 is required for the cell cycle, interphase CDKs are only essential for proliferation of specialized cells.  Emerging evidence suggests that tumor cells may also require specific interphase CDKs for proliferation.  Thus, selective CDK inhibition may provide therapeutic benefit against certain human neoplasias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzlIKlbCPWnLVg90H21EOLACvtfcHk0lhpJn6j_9ib_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1ans78%253D&md5=2a7eb34b2381e288b3f43ec1bffc0aec</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc2602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2602%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DCell%2520cycle%252C%2520CDKs%2520and%2520cancer%253A%2520a%2520changing%2520paradigm%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D153%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Fu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pestell, R. G.</span><span> </span><span class="NLM_article-title">Minireview: Cyclin D1: normal and abnormal functions</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">5439</span><span class="NLM_x">–</span> <span class="NLM_lpage">5447</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2004&pages=5439-5447&author=M.+Fuauthor=C.+Wangauthor=Z.+Liauthor=T.+Sakamakiauthor=R.+G.+Pestell&title=Minireview%3A+Cyclin+D1%3A+normal+and+abnormal+functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DSakamaki%26aufirst%3DT.%26aulast%3DPestell%26aufirst%3DR.%2BG.%26atitle%3DMinireview%253A%2520Cyclin%2520D1%253A%2520normal%2520and%2520abnormal%2520functions%26jtitle%3DEndocrinology%26date%3D2004%26volume%3D145%26spage%3D5439%26epage%3D5447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">To cycle or not to cycle: a critical decision in cancer</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1038%2F35106065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=11902577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvF2qtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=222-231&author=M.+Malumbresauthor=M.+Barbacid&title=To+cycle+or+not+to+cycle%3A+a+critical+decision+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Milestones in cell division: to cycle or not to cycle: a critical decision in cancer</span></div><div class="casAuthors">Malumbres, Marcos; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">222-231</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Tumor cells undergo uncontrolled proliferation, yet tumors most often originate from adult tissues, in which most cells are quiescent.  So, the proliferative advantage of tumor cells arises from their ability to bypass quiescence.  This can be due to increased mitogenic signaling and/or alterations that lower the threshold required for cell-cycle commitment.  Understanding the mol. mechanisms that underlie this commitment should provide important insights into how normal cells become tumorigenic and how new anticancer strategies can be devised.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI2EOLFB2ULbVg90H21EOLACvtfcHk0lhpJn6j_9ib_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvF2qtrg%253D&md5=2bd8961854332a30c814f8ac2f9bd6f4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F35106065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35106065%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DTo%2520cycle%2520or%2520not%2520to%2520cycle%253A%2520a%2520critical%2520decision%2520in%2520cancer%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2001%26volume%3D1%26spage%3D222%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Ortega, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odajima, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotillo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbero, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice</span> <span class="citation_source-journal">Nature Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1038%2Fng1232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=12923533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmslelsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2003&pages=25-31&author=S.+Ortegaauthor=I.+Prietoauthor=J.+Odajimaauthor=A.+Martinauthor=P.+Dubusauthor=R.+Sotilloauthor=J.+L.+Barberoauthor=M.+Malumbresauthor=M.+Barbacid&title=Cyclin-dependent+kinase+2+is+essential+for+meiosis+but+not+for+mitotic+cell+division+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice</span></div><div class="casAuthors">Ortega, Sagrario; Prieto, Ignacio; Odajima, Junko; Martin, Alberto; Dubus, Pierre; Sotillo, Rocio; Barbero, Jose Luis; Malumbres, Marcos; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-31</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We targeted the locus encoding the cyclin-dependent kinase 2 (CDK2) by homologous recombination in mouse embryonic stem (ES) cells.  Embryonic fibroblasts lacking CDK2 proliferate normally and become immortal after continuous passage in culture.  Elimination of a conditional Cdk2 allele in immortal cells does not have a significant effect on proliferation.  Cdk2-/- mice are viable and survive for up to two years, indicating that CDK2 is also dispensable for proliferation and survival of most cell types.  But CDK2 is essential for completion of prophase I during meiotic cell division in male and female germ cells, an unforeseen role for this cell cycle kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5r24x7syf9bVg90H21EOLACvtfcHk0lgC0FOTFm7GKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmslelsrw%253D&md5=7f2898209c25b5b663626897ec956a2f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fng1232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1232%26sid%3Dliteratum%253Aachs%26aulast%3DOrtega%26aufirst%3DS.%26aulast%3DPrieto%26aufirst%3DI.%26aulast%3DOdajima%26aufirst%3DJ.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DDubus%26aufirst%3DP.%26aulast%3DSotillo%26aufirst%3DR.%26aulast%3DBarbero%26aufirst%3DJ.%2BL.%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DCyclin-dependent%2520kinase%25202%2520is%2520essential%2520for%2520meiosis%2520but%2520not%2520for%2520mitotic%2520cell%2520division%2520in%2520mice%26jtitle%3DNature%2520Genet.%26date%3D2003%26volume%3D35%26spage%3D25%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Berthet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleem, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tessarollo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaldis, P.</span><span> </span><span class="NLM_article-title">Cdk2 knockout mice are viable</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1775</span><span class="NLM_x">–</span> <span class="NLM_lpage">1785</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1016%2Fj.cub.2003.09.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=14561402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXot12itbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1775-1785&author=C.+Berthetauthor=E.+Aleemauthor=V.+Coppolaauthor=L.+Tessarolloauthor=P.+Kaldis&title=Cdk2+knockout+mice+are+viable"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cdk2 Knockout Mice Are Viable</span></div><div class="casAuthors">Berthet, Cyril; Aleem, Eiman; Coppola, Vincenzo; Tessarollo, Lino; Kaldis, Philipp</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1775-1785</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Background: Cyclin-dependent kinases (Cdks) and their cyclin regulatory subunits control cell growth and division.  Cdk2/cyclin E complexes are thought to be required because they phosphorylate the retinoblastoma protein and drive cells through the G1/S transition into the S phase of the cell cycle.  In addn., Cdk2 assocs. with cyclin A, which itself is essential for cell proliferation during early embryonic development.  Results: In order to study the functions of Cdk2 in vivo, we generated Cdk2 knockout mice.  Surprisingly, these mice are viable, and therefore Cdk2 is not an essential gene in the mouse.  However, Cdk2 is required for germ cell development; both male and female Cdk2-/- mice are sterile.  Immunoppts. of cyclin E1 complexes from Cdk2-/- spleen exts. displayed no activity toward histone H1.  Cyclin A2 complexes were active in primary mouse embryonic fibroblasts (MEFs), embryo exts. and in spleen exts. from young animals.  In contrast, there was little cyclin A2 kinase activity in immortalized MEFs and spleen exts. from adult animals.  Cdk2-/- MEFs proliferate but enter delayed into S phase.  Ectopic expression of Cdk2 in Cdk2-/- MEFs rescued the delayed entry into S phase.  Conclusions: Although Cdk2 is not an essential gene in the mouse, it is required for germ cell development and meiosis.  Loss of Cdk2 affects the timing of S phase, suggesting that Cdk2 is involved in regulating progression through the mitotic cell cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0o-n-kcfSW7Vg90H21EOLACvtfcHk0lgC0FOTFm7GKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXot12itbk%253D&md5=8bb2c819e566952895434253f667454c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2003.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2003.09.024%26sid%3Dliteratum%253Aachs%26aulast%3DBerthet%26aufirst%3DC.%26aulast%3DAleem%26aufirst%3DE.%26aulast%3DCoppola%26aufirst%3DV.%26aulast%3DTessarollo%26aufirst%3DL.%26aulast%3DKaldis%26aufirst%3DP.%26atitle%3DCdk2%2520knockout%2520mice%2520are%2520viable%26jtitle%3DCurr.%2520Biol.%26date%3D2003%26volume%3D13%26spage%3D1775%26epage%3D1785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Aleem, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyokawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaldis, P.</span><span> </span><span class="NLM_article-title">Cdc2-cyclin E complexes regulate the G1/S phase transition</span> <span class="citation_source-journal">Nature Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">831</span><span class="NLM_x">–</span> <span class="NLM_lpage">836</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1038%2Fncb1284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=16007079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvVClurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=831-836&author=E.+Aleemauthor=H.+Kiyokawaauthor=P.+Kaldis&title=Cdc2-cyclin+E+complexes+regulate+the+G1%2FS+phase+transition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cdc2-cyclin E complexes regulate the G1/S phase transition</span></div><div class="casAuthors">Aleem, Eiman; Kiyokawa, Hiroaki; Kaldis, Philipp</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">831-836</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The cyclin-dependent kinase inhibitor p27Kip1 is known as a neg. regulator of cell-cycle progression and as a tumor suppressor.  Cdk2 is the main target of p27 and therefore we hypothesized that loss of Cdk2 activity should modify the p27-/- mouse phenotype.  Here, we show that although p27-/- Cdk2-/- mice developed ovary tumors and tumors in the anterior lobe of the pituitary, we failed to detect any functional complementation in p27-/- Cdk2-/- double-knockout mice, indicating a parallel pathway regulated by p27.  We obsd. elevated levels of S phase and mitosis in tissues of p27-/- Cdk2-/- mice concomitantly with elevated Cdc2 activity in p27-/- Cdk2-/- exts. p27 binds to Cdc2, cyclin B1, cyclin A2, or suc1 complexes in wild-type and Cdk2-/- exts.  In addn., cyclin E binds to and activates Cdc2.  Our in vivo results provide strong evidence that Cdc2 may compensate the loss of Cdk2 function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9JLx0kmXSbLVg90H21EOLACvtfcHk0lgC0FOTFm7GKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvVClurs%253D&md5=a692be69a184476681cc9640f15587ea</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fncb1284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1284%26sid%3Dliteratum%253Aachs%26aulast%3DAleem%26aufirst%3DE.%26aulast%3DKiyokawa%26aufirst%3DH.%26aulast%3DKaldis%26aufirst%3DP.%26atitle%3DCdc2-cyclin%2520E%2520complexes%2520regulate%2520the%2520G1%252FS%2520phase%2520transition%26jtitle%3DNature%2520Cell%2520Biol.%26date%3D2005%26volume%3D7%26spage%3D831%26epage%3D836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Cai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latham, V. M.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span> </span><span class="NLM_article-title">Combined depletion of cell cycle and transcriptional cyclin-dependent kinase activities induces apoptosis in cancer cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">9270</span><span class="NLM_x">–</span> <span class="NLM_lpage">9280</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=9270-9280&author=D.+Caiauthor=V.+M.+Lathamauthor=X.+Zhangauthor=G.+I.+Shapiro&title=Combined+depletion+of+cell+cycle+and+transcriptional+cyclin-dependent+kinase+activities+induces+apoptosis+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DD.%26aulast%3DLatham%26aufirst%3DV.%2BM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26atitle%3DCombined%2520depletion%2520of%2520cell%2520cycle%2520and%2520transcriptional%2520cyclin-dependent%2520kinase%2520activities%2520induces%2520apoptosis%2520in%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D9270%26epage%3D9280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Rane, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mettus, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galbreath, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boden, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia</span> <span class="citation_source-journal">Nature Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1038%2F8751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=10319860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADyaK1MXjtVags7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1999&pages=44-52&author=S.+G.+Raneauthor=P.+Dubusauthor=R.+V.+Mettusauthor=E.+J.+Galbreathauthor=G.+Bodenauthor=E.+P.+Reddyauthor=M.+Barbacid&title=Loss+of+Cdk4+expression+causes+insulin-deficient+diabetes+and+Cdk4+activation+results+in+beta-islet+cell+hyperplasia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia</span></div><div class="casAuthors">Rane, Sushil G.; Dubus, Pierre; Mettus, Richard V.; Galbreath, Elizabeth J.; Boden, Guenther; Reddy, E. Premkumar; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-52</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">To ascertain the role of cyclin-dependent kinase 4 (Cdk4) in vivo, the authors have targeted the mouse Cdk4 locus by homologous recombination to generate two strains of mice, one that lacks Cdk4 expression and one that expresses a Cdk4 mol. with an activating mutation.  Embryonic fibroblasts proliferate normally in the absence of Cdk4 but have a delayed S phase on re-entry into the cell cycle.  Moreover, mice devoid of Cdk4 are viable, but small in size and infertile.  These mice also develop insulin-deficient diabetes due to a redn. in β-islet pancreatic cells.  In contrast, mice expressing a mutant Cdk4 that cannot bind the cell-cycle inhibitor P16INK4a display pancreatic hyperplasia due to abnormal proliferation of β-islet cells.  These results establish Cdk4 as an essential regulator of specific cell types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofmhLD8YQB97Vg90H21EOLACvtfcHk0lhyerBwM3yRqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtVags7o%253D&md5=82326fc337b7b1ddabf2cb0fcfd6c288</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F8751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F8751%26sid%3Dliteratum%253Aachs%26aulast%3DRane%26aufirst%3DS.%2BG.%26aulast%3DDubus%26aufirst%3DP.%26aulast%3DMettus%26aufirst%3DR.%2BV.%26aulast%3DGalbreath%26aufirst%3DE.%2BJ.%26aulast%3DBoden%26aufirst%3DG.%26aulast%3DReddy%26aufirst%3DE.%2BP.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DLoss%2520of%2520Cdk4%2520expression%2520causes%2520insulin-deficient%2520diabetes%2520and%2520Cdk4%2520activation%2520results%2520in%2520beta-islet%2520cell%2520hyperplasia%26jtitle%3DNature%2520Genet.%26date%3D1999%26volume%3D22%26spage%3D44%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Tsutsui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesabi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moons, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandolfi, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansel, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyokawa, H.</span><span> </span><span class="NLM_article-title">Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">7011</span><span class="NLM_x">–</span> <span class="NLM_lpage">7019</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1128%2FMCB.19.10.7011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=10490638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADyaK1MXmtlals7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=7011-7019&author=T.+Tsutsuiauthor=B.+Hesabiauthor=D.+S.+Moonsauthor=P.+P.+Pandolfiauthor=K.+S.+Hanselauthor=A.+Koffauthor=H.+Kiyokawa&title=Targeted+disruption+of+CDK4+delays+cell+cycle+entry+with+enhanced+p27%28Kip1%29+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted disruption of CDK4 delays cell cycle entry with enhanced p27Kip1 activity</span></div><div class="casAuthors">Tsutsui, Tateki; Hesabi, Bahar; Moons, David S.; Pandolfi, Pier Paolo; Hansel, Kimberly S.; Koff, Andrew; Kiyokawa, Hiroaki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">7011-7019</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The mechanism by which cyclin-dependent kinase 4 (CDK4) regulates cell cycle progression is not entirely clear.  Cyclin D/CDK4 appears to initiate phosphorylation of retinoblastoma protein (Rb) leading to inactivation of the S-phase-inhibitory action of Rb.  However, cyclin D/CDK4 has been postulated to act in a noncatalytic manner to regulate the cyclin E/CDK2-inhibitory activity of p27Kip1 by sequestration.  In this study we investigated the roles of CDK4 in cell cycle regulation by targeted disruption of the mouse CDK4 gene.  CDK4-/- mice survived embryogenesis and showed growth retardation and reproductive dysfunction assocd. with hypoplastic seminiferous tubules in the testis and perturbed corpus luteum formation in the ovary.  These phenotypes appear to be opposite to those of p27-deficient mice such as gigantism and gonadal hyperplasia.  A majority of CDK4-/- mice developed diabetes mellitus by 6 wk, assocd. with degeneration of pancreatic islets.  Fibroblasts from CDK4-/- mouse embryos proliferated similarly to wild-type embryonic fibroblasts under conditions that promote continuous growth.  However, quiescent CDK4-/- fibroblasts exhibited a substantial (∼6-h) delay in S-phase entry after serum stimulation.  This cell cycle perturbation by CDK4 disruption was assocd. with increased binding of p27 to cyclin E/CDK2 and diminished activation of CDK2 accompanied by impaired Rb phosphorylation.  Importantly, fibroblasts from CDK4-/- p27-/- embryos displayed partially restored kinetics of the G0-S transition, indicating the significance of the sequestration of p27 by CDK4.  These results suggest that at least part of CDK4's participation in the rate-limiting mechanism for the G0-S transition consists of controlling p27 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKIPUccGpY97Vg90H21EOLACvtfcHk0lhyerBwM3yRqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtlals7c%253D&md5=bba944ba00b313a19943eaa2acad2301</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1128%2FMCB.19.10.7011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.19.10.7011%26sid%3Dliteratum%253Aachs%26aulast%3DTsutsui%26aufirst%3DT.%26aulast%3DHesabi%26aufirst%3DB.%26aulast%3DMoons%26aufirst%3DD.%2BS.%26aulast%3DPandolfi%26aufirst%3DP.%2BP.%26aulast%3DHansel%26aufirst%3DK.%2BS.%26aulast%3DKoff%26aufirst%3DA.%26aulast%3DKiyokawa%26aufirst%3DH.%26atitle%3DTargeted%2520disruption%2520of%2520CDK4%2520delays%2520cell%2520cycle%2520entry%2520with%2520enhanced%2520p27%2528Kip1%2529%2520activity%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1999%26volume%3D19%26spage%3D7011%26epage%3D7019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotillo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santamaria, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerezo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">493</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2004&pages=493-504&author=M.+Malumbresauthor=R.+Sotilloauthor=D.+Santamariaauthor=J.+Galanauthor=A.+Cerezoauthor=S.+Ortegaauthor=P.+Dubusauthor=M.+Barbacid&title=Mammalian+cells+cycle+without+the+D-type+cyclin-dependent+kinases+Cdk4+and+Cdk6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DSotillo%26aufirst%3DR.%26aulast%3DSantamaria%26aufirst%3DD.%26aulast%3DGalan%26aufirst%3DJ.%26aulast%3DCerezo%26aufirst%3DA.%26aulast%3DOrtega%26aufirst%3DS.%26aulast%3DDubus%26aufirst%3DP.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DMammalian%2520cells%2520cycle%2520without%2520the%2520D-type%2520cyclin-dependent%2520kinases%2520Cdk4%2520and%2520Cdk6%26jtitle%3DCell%26date%3D2004%26volume%3D118%26spage%3D493%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Yu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahnstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagozdzon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyokawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stal, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span> </span><span class="NLM_article-title">Requirement for CDK4 kinase function in breast cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1016%2Fj.ccr.2005.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=16413469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD28XosFersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=23-32&author=Q.+Yuauthor=E.+Sicinskaauthor=Y.+Gengauthor=M.+Ahnstromauthor=A.+Zagozdzonauthor=Y.+Kongauthor=H.+Gardnerauthor=H.+Kiyokawaauthor=L.+N.+Harrisauthor=O.+Stalauthor=P.+Sicinski&title=Requirement+for+CDK4+kinase+function+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement for CDK4 kinase function in breast cancer</span></div><div class="casAuthors">Yu, Qunyan; Sicinska, Ewa; Geng, Yan; Ahnstrom, Marie; Zagozdzon, Agnieszka; Kong, Yinxin; Gardner, Humphrey; Kiyokawa, Hiroaki; Harris, Lyndsay N.; Stal, Olle; Sicinski, Piotr</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-32</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cyclin D1 is overexpressed in the majority of human breast cancers.  The authors previously found that mice lacking cyclin D1 are resistant to mammary carcinomas triggered by the ErbB-2 oncogene.  In this study, the authors investigated which function of cyclin D1 is required for ErbB-2-driven mammary oncogenesis.  The authors report that the ability of cyclin D1 to activate cyclin-dependent kinase CDK4 underlies the crit. role for cyclin D1 in breast cancer formation.  The authors also found that the continued presence of CDK4-assocd. kinase activity is required to maintain breast tumorigenesis.  The authors analyzed primary human breast cancers and found high cyclin D1 levels in a subset (∼25%) of ErbB-2-overexpressing tumors.  The authors propose that this subset of breast cancer patients might benefit from inhibiting CDK4 kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7XtIoi9OqULVg90H21EOLACvtfcHk0lhyerBwM3yRqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosFersw%253D%253D&md5=de0dbbf7f2463d60b126c201ac6bb7f6</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2005.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2005.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DSicinska%26aufirst%3DE.%26aulast%3DGeng%26aufirst%3DY.%26aulast%3DAhnstrom%26aufirst%3DM.%26aulast%3DZagozdzon%26aufirst%3DA.%26aulast%3DKong%26aufirst%3DY.%26aulast%3DGardner%26aufirst%3DH.%26aulast%3DKiyokawa%26aufirst%3DH.%26aulast%3DHarris%26aufirst%3DL.%2BN.%26aulast%3DStal%26aufirst%3DO.%26aulast%3DSicinski%26aufirst%3DP.%26atitle%3DRequirement%2520for%2520CDK4%2520kinase%2520function%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D23%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Landis, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlyk, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinds, P. W.</span><span> </span><span class="NLM_article-title">Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=13-22&author=M.+W.+Landisauthor=B.+S.+Pawlykauthor=T.+Liauthor=P.+Sicinskiauthor=P.+W.+Hinds&title=Cyclin+D1-dependent+kinase+activity+in+murine+development+and+mammary+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLandis%26aufirst%3DM.%2BW.%26aulast%3DPawlyk%26aufirst%3DB.%2BS.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DSicinski%26aufirst%3DP.%26aulast%3DHinds%26aufirst%3DP.%2BW.%26atitle%3DCyclin%2520D1-dependent%2520kinase%2520activity%2520in%2520murine%2520development%2520and%2520mammary%2520tumorigenesis%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D13%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Reddy, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mettus, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rane, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grana, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litvin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, E. P.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinase 4 expression is essential for neu-induced breast tumorigenesis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">10174</span><span class="NLM_x">–</span> <span class="NLM_lpage">10178</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=10174-10178&author=H.+K.+Reddyauthor=R.+V.+Mettusauthor=S.+G.+Raneauthor=X.+Granaauthor=J.+Litvinauthor=E.+P.+Reddy&title=Cyclin-dependent+kinase+4+expression+is+essential+for+neu-induced+breast+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DH.%2BK.%26aulast%3DMettus%26aufirst%3DR.%2BV.%26aulast%3DRane%26aufirst%3DS.%2BG.%26aulast%3DGrana%26aufirst%3DX.%26aulast%3DLitvin%26aufirst%3DJ.%26aulast%3DReddy%26aufirst%3DE.%2BP.%26atitle%3DCyclin-dependent%2520kinase%25204%2520expression%2520is%2520essential%2520for%2520neu-induced%2520breast%2520tumorigenesis%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D10174%26epage%3D10178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Yu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span> </span><span class="NLM_article-title">Specific protection against breast cancers by cyclin D1 ablation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">411</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1021</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2001&pages=1017-1021&author=Q.+Yuauthor=Y.+Gengauthor=P.+Sicinski&title=Specific+protection+against+breast+cancers+by+cyclin+D1+ablation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DGeng%26aufirst%3DY.%26aulast%3DSicinski%26aufirst%3DP.%26atitle%3DSpecific%2520protection%2520against%2520breast%2520cancers%2520by%2520cyclin%2520D1%2520ablation%26jtitle%3DNature%26date%3D2001%26volume%3D411%26spage%3D1017%26epage%3D1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Is Cyclin D1-CDK4 kinase a bona fide cancer target?</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=2-4&author=M.+Malumbresauthor=M.+Barbacid&title=Is+Cyclin+D1-CDK4+kinase+a+bona+fide+cancer+target%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DIs%2520Cyclin%2520D1-CDK4%2520kinase%2520a%2520bona%2520fide%2520cancer%2520target%253F%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D2%26epage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Roy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adamczewski, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seroz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeulen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tassan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeffer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoeijmakers, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egly, J. M.</span><span> </span><span class="NLM_article-title">The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1093</span><span class="NLM_x">–</span> <span class="NLM_lpage">1101</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1994&pages=1093-1101&author=R.+Royauthor=J.+P.+Adamczewskiauthor=T.+Serozauthor=W.+Vermeulenauthor=J.+P.+Tassanauthor=L.+Schaefferauthor=E.+A.+Niggauthor=J.+H.+Hoeijmakersauthor=J.+M.+Egly&title=The+MO15+cell+cycle+kinase+is+associated+with+the+TFIIH+transcription-DNA+repair+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DR.%26aulast%3DAdamczewski%26aufirst%3DJ.%2BP.%26aulast%3DSeroz%26aufirst%3DT.%26aulast%3DVermeulen%26aufirst%3DW.%26aulast%3DTassan%26aufirst%3DJ.%2BP.%26aulast%3DSchaeffer%26aufirst%3DL.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26aulast%3DHoeijmakers%26aufirst%3DJ.%2BH.%26aulast%3DEgly%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520MO15%2520cell%2520cycle%2520kinase%2520is%2520associated%2520with%2520the%2520TFIIH%2520transcription-DNA%2520repair%2520factor%26jtitle%3DCell%26date%3D1994%26volume%3D79%26spage%3D1093%26epage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Serizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makela, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conaway, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conaway, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. A.</span><span> </span><span class="NLM_article-title">Association of Cdk-activating kinase subunits with transcription factor TFIIH</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x">, </span> <span class="NLM_fpage">280</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=1995&pages=280-282&author=H.+Serizawaauthor=T.+P.+Makelaauthor=J.+W.+Conawayauthor=R.+C.+Conawayauthor=R.+A.+Weinbergauthor=R.+A.+Young&title=Association+of+Cdk-activating+kinase+subunits+with+transcription+factor+TFIIH"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSerizawa%26aufirst%3DH.%26aulast%3DMakela%26aufirst%3DT.%2BP.%26aulast%3DConaway%26aufirst%3DJ.%2BW.%26aulast%3DConaway%26aufirst%3DR.%2BC.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26aulast%3DYoung%26aufirst%3DR.%2BA.%26atitle%3DAssociation%2520of%2520Cdk-activating%2520kinase%2520subunits%2520with%2520transcription%2520factor%2520TFIIH%26jtitle%3DNature%26date%3D1995%26volume%3D374%26spage%3D280%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Fisher, R. P.</span><span> </span><span class="NLM_article-title">Secrets of a double agent: CDK7 in cell-cycle control and transcription</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">5171</span><span class="NLM_x">–</span> <span class="NLM_lpage">5180</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1242%2Fjcs.02718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=16280550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlWru73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2005&pages=5171-5180&author=R.+P.+Fisher&title=Secrets+of+a+double+agent%3A+CDK7+in+cell-cycle+control+and+transcription"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Secrets of a double agent: CDK7 in cell cycle control and transcription</span></div><div class="casAuthors">Fisher, Robert P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5171-5180</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  In metazoans, cyclin-dependent kinase 7 (CDK7) has essential roles in both the cell division cycle and transcription, as a CDK-activating kinase (CAK) and as a component of the general transcription factor TFIIH, resp.  Controversy over its double duty has been resolved, but questions remain.  First, how does CDK7 achieve the dual substrate specificity necessary to perform both roles.  Second, is there a deeper connection implied by the dichotomy of CDK7 function, for example similar mechanisms controlling cell division and gene expression, and/or actual coordination of the two processes.  Enzymol. studies have revealed solns. to the unusual substrate recognition problem, and there is evidence that the distinct functions of CDK7 can be regulated independently.  Finally, despite divergence in their wiring, the CAK-CDK networks of budding yeast, fission yeast and metazoans all link transcriptional regulation with operation of the cell cycle machinery.  This connection might help to ensure that mRNAs encoding effectors of cell division are expressed at the right time in the cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjIga058ymZrVg90H21EOLACvtfcHk0lj4UXVWhg6ANQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlWru73F&md5=d97c0b0080a97d0c9692f76f63d364f8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1242%2Fjcs.02718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.02718%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DR.%2BP.%26atitle%3DSecrets%2520of%2520a%2520double%2520agent%253A%2520CDK7%2520in%2520cell-cycle%2520control%2520and%2520transcription%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2005%26volume%3D118%26spage%3D5171%26epage%3D5180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">DePinto, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goelzer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tovar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blain, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevins, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luistro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolinsky, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felix, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heimbrook, D.</span><span> </span><span class="NLM_article-title">In vitro and in vivo activity of R547: a potent and selective cyclin-dependent kinase inhibitor currently in phase I clinical trials</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">2644</span><span class="NLM_x">–</span> <span class="NLM_lpage">2658</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1158%2F1535-7163.MCT-06-0355" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=17121911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1els7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=2644-2658&author=W.+DePintoauthor=X.+J.+Chuauthor=X.+Yinauthor=M.+Smithauthor=K.+Packmanauthor=P.+Goelzerauthor=A.+Loveyauthor=Y.+Chenauthor=H.+Qianauthor=R.+Hamidauthor=Q.+Xiangauthor=C.+Tovarauthor=R.+Blainauthor=T.+Nevinsauthor=B.+Higginsauthor=L.+Luistroauthor=K.+Kolinskyauthor=B.+Felixauthor=S.+Hussainauthor=D.+Heimbrook&title=In+vitro+and+in+vivo+activity+of+R547%3A+a+potent+and+selective+cyclin-dependent+kinase+inhibitor+currently+in+phase+I+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo activity of R547: a potent and selective cyclin-dependent kinase inhibitor currently in phase I clinical trials</span></div><div class="casAuthors">DePinto, Wanda; Chu, Xin-Jie; Yin, Xuefeng; Smith, Melissa; Packman, Kathryn; Goelzer, Petra; Lovey, Allen; Chen, Yingsi; Qian, Hong; Hamid, Rachid; Xiang, Qing; Tovar, Christian; Blain, Roger; Nevins, Tom; Higgins, Brian; Luistro, Leopoldo; Kolinsky, Kenneth; Felix, Bernardo; Hussain, Sazzad; Heimbrook, David</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2644-2658</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The cyclin-dependent protein kinases are key regulators of cell cycle progression.  Aberrant expression or altered activity of distinct cyclin-dependent kinase (CDK) complexes results in escape of cells from cell cycle control, leading to unrestricted cell proliferation.  CDK inhibitors have the potential to induce cell cycle arrest and apoptosis in cancer cells, and identifying small-mol. CDK inhibitors has been a major focus in cancer research.  Several CDK inhibitors are entering the clinic, the most recent being selective CDK2 and CDK4 inhibitors.  We have identified a diaminopyrimidine compd., R547, which is a potent and selective ATP-competitive CDK inhibitor.  In cell-free assays, R547 effectively inhibited CDK1/cyclin B, CDK2/cyclin E, and CDK4/cyclin D1 (Ki = 1-3 nmol/L) and was inactive (Ki > 5000 nmol/L) against a panel of >120 unrelated kinases.  In vitro, R547 effectively inhibited the proliferation of tumor cell lines independent of multidrug resistant status, histol. type, retinoblastoma protein, or p53 status, with IC50s ≤ 0.60 μmol/L.  The growth-inhibitory activity is characterized by a cell cycle block at G1 and G2 phases and induction of apoptosis.  R547 reduced phosphorylation of the cellular retinoblastoma protein at specific CDK phosphorylation sites at the same concns. that induced cell cycle arrest, suggesting a potential pharmacodynamic marker for clin. use.  In vivo, R547 showed antitumor activity in all of the models tested to date, including six human tumor xenografts and an orthotopic syngeneic rat model.  R547 was efficacious with daily oral dosing as well as with once weekly i.v. dosing in established human tumor models and at the targeted efficacious exposures inhibited phosphorylation of the retinoblastoma protein in the tumors.  The selective kinase inhibition profile and the preclin. antitumor activity of R547 suggest that it may be promising for development for use in the treatment of solid tumors.  R547 is currently being evaluated in phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTvfleWG6NybVg90H21EOLACvtfcHk0lj4UXVWhg6ANQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1els7nM&md5=ce7c9fc59ec7e500778035b4a9103bf5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0355%26sid%3Dliteratum%253Aachs%26aulast%3DDePinto%26aufirst%3DW.%26aulast%3DChu%26aufirst%3DX.%2BJ.%26aulast%3DYin%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DGoelzer%26aufirst%3DP.%26aulast%3DLovey%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DQian%26aufirst%3DH.%26aulast%3DHamid%26aufirst%3DR.%26aulast%3DXiang%26aufirst%3DQ.%26aulast%3DTovar%26aufirst%3DC.%26aulast%3DBlain%26aufirst%3DR.%26aulast%3DNevins%26aufirst%3DT.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DLuistro%26aufirst%3DL.%26aulast%3DKolinsky%26aufirst%3DK.%26aulast%3DFelix%26aufirst%3DB.%26aulast%3DHussain%26aufirst%3DS.%26aulast%3DHeimbrook%26aufirst%3DD.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520activity%2520of%2520R547%253A%2520a%2520potent%2520and%2520selective%2520cyclin-dependent%2520kinase%2520inhibitor%2520currently%2520in%2520phase%2520I%2520clinical%2520trials%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D2644%26epage%3D2658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodhead, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulstridge, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devine, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Early, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltell, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seavers, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squires, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trewartha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolford, A. J.</span><span> </span><span class="NLM_article-title">Identification of <i>N</i>-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1<i>H</i>-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4986</span><span class="NLM_x">–</span> <span class="NLM_lpage">4999</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800382h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4986-4999&author=P.+G.+Wyattauthor=A.+J.+Woodheadauthor=V.+Berdiniauthor=J.+A.+Boulstridgeauthor=M.+G.+Carrauthor=D.+M.+Crossauthor=D.+J.+Davisauthor=L.+A.+Devineauthor=T.+R.+Earlyauthor=R.+E.+Feltellauthor=E.+J.+Lewisauthor=R.+L.+McMenaminauthor=E.+F.+Navarroauthor=M.+A.+O%E2%80%99Brienauthor=M.+O%E2%80%99Reillyauthor=M.+Reuleauthor=G.+Saxtyauthor=L.+C.+Seaversauthor=D.+M.+Smithauthor=M.+S.+Squiresauthor=G.+Trewarthaauthor=M.+T.+Walkerauthor=A.+J.+Woolford&title=Identification+of+N-%284-piperidinyl%29-4-%282%2C6-dichlorobenzoylamino%29-1H-pyrazole-3-carboxamide+%28AT7519%29%2C+a+novel+cyclin+dependent+kinase+inhibitor+using+fragment-based+X-ray+crystallography+and+structure+based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm800382h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800382h%26sid%3Dliteratum%253Aachs%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DBoulstridge%26aufirst%3DJ.%2BA.%26aulast%3DCarr%26aufirst%3DM.%2BG.%26aulast%3DCross%26aufirst%3DD.%2BM.%26aulast%3DDavis%26aufirst%3DD.%2BJ.%26aulast%3DDevine%26aufirst%3DL.%2BA.%26aulast%3DEarly%26aufirst%3DT.%2BR.%26aulast%3DFeltell%26aufirst%3DR.%2BE.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DMcMenamin%26aufirst%3DR.%2BL.%26aulast%3DNavarro%26aufirst%3DE.%2BF.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%2BA.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DReule%26aufirst%3DM.%26aulast%3DSaxty%26aufirst%3DG.%26aulast%3DSeavers%26aufirst%3DL.%2BC.%26aulast%3DSmith%26aufirst%3DD.%2BM.%26aulast%3DSquires%26aufirst%3DM.%2BS.%26aulast%3DTrewartha%26aufirst%3DG.%26aulast%3DWalker%26aufirst%3DM.%2BT.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.%26atitle%3DIdentification%2520of%2520N-%25284-piperidinyl%2529-4-%25282%252C6-dichlorobenzoylamino%2529-1H-pyrazole-3-carboxamide%2520%2528AT7519%2529%252C%2520a%2520novel%2520cyclin%2520dependent%2520kinase%2520inhibitor%2520using%2520fragment-based%2520X-ray%2520crystallography%2520and%2520structure%2520based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4986%26epage%3D4999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Dickson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G. K.</span><span> </span><span class="NLM_article-title">Development of cell-cycle inhibitors for cancer therapy</span> <span class="citation_source-journal">Curr. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=19370178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A280%3ADC%252BD1M3otVaqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=36-43&author=M.+A.+Dicksonauthor=G.+K.+Schwartz&title=Development+of+cell-cycle+inhibitors+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Development of cell-cycle inhibitors for cancer therapy</span></div><div class="casAuthors">Dickson M A; Schwartz G K</div><div class="citationInfo"><span class="NLM_cas:title">Current oncology (Toronto, Ont.)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">36-43</span>
        ISSN:<span class="NLM_cas:issn">1198-0052</span>.
    </div><div class="casAbstract">The cell cycle governs the transition from quiescence through cell growth to proliferation.  The key parts of the cell cycle machinery are the cyclin-dependent kinases (CDKS) and the regulatory proteins called cyclins.  The CDKS are rational targets for cancer therapy because their expression in cancer cells is often aberrant and their inhibition can induce cell death.  Inhibitors of CDKS can also block transcription.Several drugs targeting the cell cycle have entered clinical trials.  These agents include flavopiridol, indisulam, AZD5438, SNS-032, bryostatin-1, seliciclib, PD 0332991, and SCH 727965.  Phase i studies have demonstrated that these drugs can generally be administered safely.  Phase ii studies have shown little single-agent activity in solid tumors, but combination studies with cytotoxic chemotherapy have been more promising.  In hematologic malignancies, reports have shown encouraging single-agent and combination activity.  Pharmacodynamic studies show that the dose and schedule of these drugs are crucial to permit maximum therapeutic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTgaRuY_68sqszK395ZObgVfW6udTcc2ebt4eRuryFit7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3otVaqsg%253D%253D&md5=450695393901bd4eee8c4183717b1e42</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDickson%26aufirst%3DM.%2BA.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26atitle%3DDevelopment%2520of%2520cell-cycle%2520inhibitors%2520for%2520cancer%2520therapy%26jtitle%3DCurr.%2520Oncol.%26date%3D2009%26volume%3D16%26spage%3D36%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Ali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heathcote, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroll, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jogalekar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheiper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brackow, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siwicka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchter, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Periyasamy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolhurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanneganti, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aboagye, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span> </span><span class="NLM_article-title">The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">6208</span><span class="NLM_x">–</span> <span class="NLM_lpage">6215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=6208-6215&author=S.+Aliauthor=D.+A.+Heathcoteauthor=S.+H.+Krollauthor=A.+S.+Jogalekarauthor=B.+Scheiperauthor=H.+Patelauthor=J.+Brackowauthor=A.+Siwickaauthor=M.+J.+Fuchterauthor=M.+Periyasamyauthor=R.+S.+Tolhurstauthor=S.+K.+Kannegantiauthor=J.+P.+Snyderauthor=D.+C.+Liottaauthor=E.+O.+Aboagyeauthor=A.+G.+Barrettauthor=R.+C.+Coombes&title=The+development+of+a+selective+cyclin-dependent+kinase+inhibitor+that+shows+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DS.%26aulast%3DHeathcote%26aufirst%3DD.%2BA.%26aulast%3DKroll%26aufirst%3DS.%2BH.%26aulast%3DJogalekar%26aufirst%3DA.%2BS.%26aulast%3DScheiper%26aufirst%3DB.%26aulast%3DPatel%26aufirst%3DH.%26aulast%3DBrackow%26aufirst%3DJ.%26aulast%3DSiwicka%26aufirst%3DA.%26aulast%3DFuchter%26aufirst%3DM.%2BJ.%26aulast%3DPeriyasamy%26aufirst%3DM.%26aulast%3DTolhurst%26aufirst%3DR.%2BS.%26aulast%3DKanneganti%26aufirst%3DS.%2BK.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DAboagye%26aufirst%3DE.%2BO.%26aulast%3DBarrett%26aufirst%3DA.%2BG.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26atitle%3DThe%2520development%2520of%2520a%2520selective%2520cyclin-dependent%2520kinase%2520inhibitor%2520that%2520shows%2520antitumor%2520activity%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D6208%26epage%3D6215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Parry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanahan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabhavalkar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiswell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seghezzi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paruch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doll, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomeir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windsor, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oft, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschmeier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, E. M.</span><span> </span><span class="NLM_article-title">Dinaciclib (SCH 727965), a novel and potent cyclin-dependent kinase inhibitor</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2344</span><span class="NLM_x">–</span> <span class="NLM_lpage">2353</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1158%2F1535-7163.MCT-10-0324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=20663931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVOjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=2344-2353&author=D.+Parryauthor=T.+Guziauthor=F.+Shanahanauthor=N.+Davisauthor=D.+Prabhavalkarauthor=D.+Wiswellauthor=W.+Seghezziauthor=K.+Paruchauthor=M.+P.+Dwyerauthor=R.+Dollauthor=A.+Nomeirauthor=W.+Windsorauthor=T.+Fischmannauthor=Y.+Wangauthor=M.+Oftauthor=T.+Chenauthor=P.+Kirschmeierauthor=E.+M.+Lees&title=Dinaciclib+%28SCH+727965%29%2C+a+novel+and+potent+cyclin-dependent+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor</span></div><div class="casAuthors">Parry, David; Guzi, Timothy; Shanahan, Frances; Davis, Nicole; Prabhavalkar, Deepa; Wiswell, Derek; Seghezzi, Wolfgang; Paruch, Kamil; Dwyer, Michael P.; Doll, Ronald; Nomeir, Amin; Windsor, William; Fischmann, Thierry; Wang, Yaolin; Oft, Martin; Chen, Taiying; Kirschmeier, Paul; Lees, Emma M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2344-2353</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cyclin-dependent kinases (CDK) are key pos. regulators of cell cycle progression and attractive targets in oncol.  SCH 727965 inhibits CDK2, CDK5, CDK1, and CDK9 activity in vitro with IC50 values of 1, 1, 3, and 4 nmol/L, resp.  SCH 727965 was selected as a clin. candidate using a functional screen in vivo that integrated both efficacy and safety parameters.  Compared with flavopiridol, SCH 727965 exhibits superior activity with an improved therapeutic index.  In cell-based assays, SCH 727965 completely suppressed retinoblastoma phosphorylation, which correlated with apoptosis onset and total inhibition of bromodeoxyuridine incorporation in >100 tumor cell lines of diverse origin and background.  Moreover, short exposures to SCH 727965 were sufficient for long-lasting cellular effects.  SCH 727965 induced regression of established solid tumors in a range of mouse models following intermittent scheduling of doses below the maximally tolerated level.  This was assocd. with modulation of pharmacodynamic biomarkers in skin punch biopsies and rapidly reversible, mechanism-based effects on hematol. parameters.  These results suggest that SCH 727965 is a potent and selective CDK inhibitor and a novel cytotoxic agent.  Mol Cancer Ther; 9(8); 2344-53.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxn1NtmEAh7LVg90H21EOLACvtfcHk0ljcQCWBi1RWhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVOjtrw%253D&md5=bd2d30fdfdca0f2bceb3f5c0b44b8630</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-0324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-0324%26sid%3Dliteratum%253Aachs%26aulast%3DParry%26aufirst%3DD.%26aulast%3DGuzi%26aufirst%3DT.%26aulast%3DShanahan%26aufirst%3DF.%26aulast%3DDavis%26aufirst%3DN.%26aulast%3DPrabhavalkar%26aufirst%3DD.%26aulast%3DWiswell%26aufirst%3DD.%26aulast%3DSeghezzi%26aufirst%3DW.%26aulast%3DParuch%26aufirst%3DK.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DDoll%26aufirst%3DR.%26aulast%3DNomeir%26aufirst%3DA.%26aulast%3DWindsor%26aufirst%3DW.%26aulast%3DFischmann%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DOft%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DKirschmeier%26aufirst%3DP.%26aulast%3DLees%26aufirst%3DE.%2BM.%26atitle%3DDinaciclib%2520%2528SCH%2520727965%2529%252C%2520a%2520novel%2520and%2520potent%2520cyclin-dependent%2520kinase%2520inhibitor%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D2344%26epage%3D2353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittaker, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClue, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrie, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelland, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">In vitro and in vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine and CYC202</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">4875</span><span class="NLM_x">–</span> <span class="NLM_lpage">4887</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1158%2F1078-0432.CCR-04-2264" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=16000586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvVGgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=4875-4887&author=F.+I.+Raynaudauthor=S.+R.+Whittakerauthor=P.+M.+Fischerauthor=S.+McClueauthor=M.+I.+Waltonauthor=S.+E.+Barrieauthor=M.+D.+Garrettauthor=P.+Rogersauthor=S.+J.+Clarkeauthor=L.+R.+Kellandauthor=M.+Valentiauthor=L.+Bruntonauthor=S.+Ecclesauthor=D.+P.+Laneauthor=P.+Workman&title=In+vitro+and+in+vivo+pharmacokinetic-pharmacodynamic+relationships+for+the+trisubstituted+aminopurine+cyclin-dependent+kinase+inhibitors+olomoucine%2C+bohemine+and+CYC202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and In vivo Pharmacokinetic-Pharmacodynamic Relationships for the Trisubstituted Aminopurine Cyclin-Dependent Kinase Inhibitors Olomoucine, Bohemine and CYC202</span></div><div class="casAuthors">Raynaud, Florence I.; Whittaker, Steven R.; Fischer, Peter M.; McClue, Steven; Walton, Michael I.; Barrie, S. Elaine; Garrett, Michelle D.; Rogers, Paul; Clarke, Simon J.; Kelland, Lloyd R.; Valenti, Melanie; Brunton, Lisa; Eccles, Suzanne; Lane, David P.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4875-4887</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: To investigate pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine, and CYC202 (R-roscovitine; seliciclib) in the HCT116 human colon carcinoma model.  Exptl. Design: The in vitro activity of the agents was detd. in a human tumor panel using the sulforhodamine B assay.  The concn. and time dependence was established in HCT116 cells.  Mol. biomarkers, including RB phosphorylation and cyclin expression, were assessed by Western blotting.  Pharmacokinetic properties were characterized in mice following anal. by liq. chromatog.-tandem mass spectrometry.  Based on these studies, a dosing regimen was developed for CYC202 that allowed therapeutic exposures in the HCT116 tumor xenograft.  RESULTS: The antitumor potency of the agents in vitro was in the order olomoucine (IC50, 56 μmol/L) < bohemine (IC50, 27 μmol/L) < CYC202 (IC50, 15 μmol/L), corresponding to their activities as cyclin-dependent kinase inhibitors.  Antitumor activity increased with exposure time up to 16 h.  The agents caused inhibition of RB and RNA polymerase II phosphorylation and depletion of cyclins.  They exhibited relatively rapid clearance following administration to mice.  CYC202 displayed the slowest clearance from plasma and the highest tumor uptake, with oral bioavailability of 86%.  Oral dosing of CYC202 gave active concns. in the tumor, modulation of pharmacodynamic markers, and inhibition of tumor growth.  CONCLUSIONS: CYC202 showed therapeutic activity on human cancer cell lines in vitro and on xenografts.  Pharmacodynamic markers are altered in vitro and in vivo, consistent with the inhibition of cyclin-dependent kinases.  Such markers may be potentially useful in the clin. development of CYC202 and other cyclin-dependent kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF8GDYVKzb7rVg90H21EOLACvtfcHk0ljcQCWBi1RWhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvVGgsLw%253D&md5=ecb8798ef675b44ea4ab5403940ce6ad</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-2264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-2264%26sid%3Dliteratum%253Aachs%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DWhittaker%26aufirst%3DS.%2BR.%26aulast%3DFischer%26aufirst%3DP.%2BM.%26aulast%3DMcClue%26aufirst%3DS.%26aulast%3DWalton%26aufirst%3DM.%2BI.%26aulast%3DBarrie%26aufirst%3DS.%2BE.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DRogers%26aufirst%3DP.%26aulast%3DClarke%26aufirst%3DS.%2BJ.%26aulast%3DKelland%26aufirst%3DL.%2BR.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DBrunton%26aufirst%3DL.%26aulast%3DEccles%26aufirst%3DS.%26aulast%3DLane%26aufirst%3DD.%2BP.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520pharmacokinetic-pharmacodynamic%2520relationships%2520for%2520the%2520trisubstituted%2520aminopurine%2520cyclin-dependent%2520kinase%2520inhibitors%2520olomoucine%252C%2520bohemine%2520and%2520CYC202%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D4875%26epage%3D4887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">Vicinal diol cyclic sulfates. Like epoxides only more reactive</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">7538</span><span class="NLM_x">–</span> <span class="NLM_lpage">7539</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00230a045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=1988&pages=7538-7539&author=Y.+Gaoauthor=K.+B.+Sharpless&title=Vicinal+diol+cyclic+sulfates.+Like+epoxides+only+more+reactive"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fja00230a045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00230a045%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DVicinal%2520diol%2520cyclic%2520sulfates.%2520Like%2520epoxides%2520only%2520more%2520reactive%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1988%26volume%3D110%26spage%3D7538%26epage%3D7539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Calderón, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyagüez, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Mayoralas, A.</span><span> </span><span class="NLM_article-title">Synthesis of Azasugars through a Proline-Catalyzed Reaction</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">6258</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo060568b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=6258&author=F.+Calder%C3%B3nauthor=E.+G.+Doyag%C3%BCezauthor=A.+Fern%C3%A1ndez-Mayoralas&title=Synthesis+of+Azasugars+through+a+Proline-Catalyzed+Reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjo060568b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo060568b%26sid%3Dliteratum%253Aachs%26aulast%3DCalder%25C3%25B3n%26aufirst%3DF.%26aulast%3DDoyag%25C3%25BCez%26aufirst%3DE.%2BG.%26aulast%3DFern%25C3%25A1ndez-Mayoralas%26aufirst%3DA.%26atitle%3DSynthesis%2520of%2520Azasugars%2520through%2520a%2520Proline-Catalyzed%2520Reaction%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D6258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Kollonitsch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabor, V.</span><span> </span><span class="NLM_article-title">New and known complex borohydrides and some of their applications in organic syntheses</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1954</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1038%2F173125a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADyaG2MXhtFKqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=1954&pages=125-126&author=J.+Kollonitschauthor=O.+Fuchsauthor=V.+Gabor&title=New+and+known+complex+borohydrides+and+some+of+their+applications+in+organic+syntheses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">New and known complex borohydrides and some of their applications in organic syntheses</span></div><div class="casAuthors">Kollonitsch, Janos; Fuchs, Oszkar; Gabor, Valeria</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1954</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">125-6</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">NaBH4 (I) and LiCl at -10° in abs. alc. yielded LiBH4 (II) in 85-90% conversion.  II in alc. showed no decompn. in 2-4 hrs. at 0°.  Alc. solns. of Ca(BH4)2 (III) and Mg(BH4)2 (IV) were prepd. similarly at -50° to -20° in 80% conversion.  III and IV are much more sensitive to H2O than II, have reducing properties similar to those of alkali borohydrides, reduce dehydroandrosterone to androstene in good yield at -5° (as does II), do not effect nitro groups, carboxyl groups, or double bonds, and give nearly neutral solns., which can reduce alkali-sensitive compds. such as sugar derivs.  I and LiI in tetrahydrofuran with p-O2NC6H4CO2Et gave 80% p-O2NC6H4CH2OH, with II postulated as the intermediate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMuvlLWTwDDbVg90H21EOLACvtfcHk0liHHRWC39p96Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG2MXhtFKqug%253D%253D&md5=087e499564fd73e8745154e6659a0a52</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2F173125a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F173125a0%26sid%3Dliteratum%253Aachs%26aulast%3DKollonitsch%26aufirst%3DJ.%26aulast%3DFuchs%26aufirst%3DO.%26aulast%3DGabor%26aufirst%3DV.%26atitle%3DNew%2520and%2520known%2520complex%2520borohydrides%2520and%2520some%2520of%2520their%2520applications%2520in%2520organic%2520syntheses%26jtitle%3DNature%26date%3D1954%26volume%3D173%26spage%3D125%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">De Azevedo, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leclerc, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havlicek, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strnad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span> </span><span class="NLM_article-title">Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">243</span><span class="NLM_x">, </span> <span class="NLM_fpage">518</span><span class="NLM_x">–</span> <span class="NLM_lpage">526</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1111%2Fj.1432-1033.1997.0518a.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=9030780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADyaK2sXhtVWiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=243&publication_year=1997&pages=518-526&author=W.+F.+De+Azevedoauthor=S.+Leclercauthor=L.+Meijerauthor=L.+Havlicekauthor=M.+Strnadauthor=S.+H.+Kim&title=Inhibition+of+cyclin-dependent+kinases+by+purine+analogues%3A+crystal+structure+of+human+cdk2+complexed+with+roscovitine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of cyclin-dependent kinases by purine analogs. Crystal structure of human cdk2 complexed with roscovitine</span></div><div class="casAuthors">De Azevedo, Walter Filgueira; Leclerc, Sophie; Meijer, Laurent; Havlicek, Libor; Strnad, Miroslav; Kim, Sung Hou</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">243</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">518-526</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Cyclin-dependent kinases (cdk) control the cell division cycle (cdc).  These kinases and their regulators are frequently deregulated in human tumors.  A potent inhibitor of cdks, roscovitine [2-(1-ethyl-2-hydro-xyethylamino)-6-benzylamino-9-isopropylpurine], was identified by screening a series of C2,N6,N9-substituted adenines on purified cdc2/cyclin B.  Roscovitine displays high efficiency and high selectivity (Meijer, L., Borgne, A., Mulner, O., Chong, J. P. J., Blow, J. J., Inagaki, N., Inagaki, M., Delcros, J. G. & Moulinoux, J. P. (1997) Eur. J. Biochem. 243, 527-536).  It behaves as a competitive inhibitor for ATP binding to cdc2.  We detd. the crystal structure of a complex between cdk2 and roscovitine at 0.24-nm (2.4 Å) resoln. and refined to an Rfactor of 0.18.  The purine portion of the inhibitor binds to the adenine binding pocket of cdk2.  The position of the benzyl ring group of the inhibitor enables the inhibitor to make contacts with the enzyme not obsd. in the ATP-complex structure.  Anal. of the position of this benzyl ring explains the specificity of roscovitine in inhibiting cdk2.  The structure also reveals that the (R)-stereoisomer of roscovitine is bound to cdk2.  The (R)-isomer is about twice as potent in inhibiting cdc2/cyclin B than the (S)-isomer.  Results from structure/activity studies and from anal. of the cdk2/roscovitine complex crystal structure should allow the design of even more potent cdk inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK34z2RUbiELVg90H21EOLACvtfcHk0liHHRWC39p96Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtVWiu7s%253D&md5=65e91c4860cdf1c1982576402c387f5e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1997.0518a.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1997.0518a.x%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BAzevedo%26aufirst%3DW.%2BF.%26aulast%3DLeclerc%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DHavlicek%26aufirst%3DL.%26aulast%3DStrnad%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DS.%2BH.%26atitle%3DInhibition%2520of%2520cyclin-dependent%2520kinases%2520by%2520purine%2520analogues%253A%2520crystal%2520structure%2520of%2520human%2520cdk2%2520complexed%2520with%2520roscovitine%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1997%26volume%3D243%26spage%3D518%26epage%3D526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Tetsu, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, F.</span><span> </span><span class="NLM_article-title">Proliferation of cancer cells despite CDK2 inhibition</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=233-245&author=O.+Tetsuauthor=F.+McCormick&title=Proliferation+of+cancer+cells+despite+CDK2+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTetsu%26aufirst%3DO.%26aulast%3DMcCormick%26aufirst%3DF.%26atitle%3DProliferation%2520of%2520cancer%2520cells%2520despite%2520CDK2%2520inhibition%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D3%26spage%3D233%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Genovese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caputi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claudio, P. P.</span><span> </span><span class="NLM_article-title">Cell cycle control and beyond: emerging roles for the retinoblastoma gene family</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">5201</span><span class="NLM_x">–</span> <span class="NLM_lpage">5209</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=5201-5209&author=C.+Genoveseauthor=D.+Traniauthor=M.+Caputiauthor=P.+P.+Claudio&title=Cell+cycle+control+and+beyond%3A+emerging+roles+for+the+retinoblastoma+gene+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGenovese%26aufirst%3DC.%26aulast%3DTrani%26aufirst%3DD.%26aulast%3DCaputi%26aufirst%3DM.%26aulast%3DClaudio%26aufirst%3DP.%2BP.%26atitle%3DCell%2520cycle%2520control%2520and%2520beyond%253A%2520emerging%2520roles%2520for%2520the%2520retinoblastoma%2520gene%2520family%26jtitle%3DOncogene%26date%3D2006%26volume%3D25%26spage%3D5201%26epage%3D5209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Giacinti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, A.</span><span> </span><span class="NLM_article-title">RB and cell cycle progression</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">5220</span><span class="NLM_x">–</span> <span class="NLM_lpage">5227</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=5220-5227&author=C.+Giacintiauthor=A.+Giordano&title=RB+and+cell+cycle+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiacinti%26aufirst%3DC.%26aulast%3DGiordano%26aufirst%3DA.%26atitle%3DRB%2520and%2520cell%2520cycle%2520progression%26jtitle%3DOncogene%26date%3D2006%26volume%3D25%26spage%3D5220%26epage%3D5227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Zarkowska, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mittnacht, S.</span><span> </span><span class="NLM_article-title">Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">12738</span><span class="NLM_x">–</span> <span class="NLM_lpage">12746</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=12738-12746&author=T.+Zarkowskaauthor=S.+Mittnacht&title=Differential+phosphorylation+of+the+retinoblastoma+protein+by+G1%2FS+cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZarkowska%26aufirst%3DT.%26aulast%3DMittnacht%26aufirst%3DS.%26atitle%3DDifferential%2520phosphorylation%2520of%2520the%2520retinoblastoma%2520protein%2520by%2520G1%252FS%2520cyclin-dependent%2520kinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D12738%26epage%3D12746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Takaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukasawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki-Takahashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitagawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, H.</span><span> </span><span class="NLM_article-title">Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1093%2Fjb%2Fmvi050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=15809340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlt1CmsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2005&pages=381-386&author=T.+Takakiauthor=K.+Fukasawaauthor=I.+Suzuki-Takahashiauthor=K.+Sembaauthor=M.+Kitagawaauthor=Y.+Tayaauthor=H.+Hirai&title=Preferences+for+phosphorylation+sites+in+the+retinoblastoma+protein+of+D-type+cyclin-dependent+kinases%2C+Cdk4+and+Cdk6%2C+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro</span></div><div class="casAuthors">Takaki, Tohru; Fukasawa, Kazuhiro; Suzuki-Takahashi, Ikuko; Semba, Kentaro; Kitagawa, Masatoshi; Taya, Yoichi; Hirai, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">381-386</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">D-type cyclin-dependent kinases (Cdk4 and Cdk6) regulate the G1 to S phase progression of the mammalian cell cycle.  It has been suggested that Cdk4 and Cdk6 may have distinct functions in vivo, even though they are indistinguishable biochem.  Here we show that although these Cdks phosphorylate multiple residues in pRB, they do so with different residue selectivities in vitro; Thr821 and Thr826 are preferentially phosphorylated by Cdk6 and Cdk4, resp.  This raises the possibility different substrate specificities lead to their different roles in the regulation of cellular events.  Furthermore, our results indicate the new concept that Cdk itself contributes to substrate recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnX0lrugo4WbVg90H21EOLACvtfcHk0liiZ9T6DGyZAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlt1CmsLo%253D&md5=f0ea5bb1671c6a4764d85fab7cdfdb6f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvi050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvi050%26sid%3Dliteratum%253Aachs%26aulast%3DTakaki%26aufirst%3DT.%26aulast%3DFukasawa%26aufirst%3DK.%26aulast%3DSuzuki-Takahashi%26aufirst%3DI.%26aulast%3DSemba%26aufirst%3DK.%26aulast%3DKitagawa%26aufirst%3DM.%26aulast%3DTaya%26aufirst%3DY.%26aulast%3DHirai%26aufirst%3DH.%26atitle%3DPreferences%2520for%2520phosphorylation%2520sites%2520in%2520the%2520retinoblastoma%2520protein%2520of%2520D-type%2520cyclin-dependent%2520kinases%252C%2520Cdk4%2520and%2520Cdk6%252C%2520in%2520vitro%26jtitle%3DJ.%2520Biochem.%26date%3D2005%26volume%3D137%26spage%3D381%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Campbell, A. D.; Raynham, T. M.; Taylor, R. J. K.</span><span> </span><span class="NLM_article-title">Pyrazolopyrimidine compounds and their use in medicine</span>.  <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">1998</span><span class="NLM_x">, </span> <span class="NLM_fpage">1707</span>− <span class="NLM_lpage">1709</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1055%2Fs-1998-4504" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1998&publication_year=1998&pages=1707-1709&author=A.+D.+Campbell&author=T.+M.+Raynham&author=R.+J.+K.+Taylor&title=Pyrazolopyrimidine+compounds+and+their+use+in+medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1055%2Fs-1998-4504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1998-4504%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DA.%2BD.%26atitle%3DPyrazolopyrimidine%2520compounds%2520and%2520their%2520use%2520in%2520medicine%26jtitle%3DSynthesis%26date%3D1998%26volume%3D1998%26spage%3D1707%26epage%3D1709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washbrook, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egly, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S.</span><span> </span><span class="NLM_article-title">Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=127-137&author=D.+Chenauthor=T.+Riedlauthor=E.+Washbrookauthor=P.+E.+Paceauthor=R.+C.+Coombesauthor=J.+M.+Eglyauthor=S.+Ali&title=Activation+of+estrogen+receptor+alpha+by+S118+phosphorylation+involves+a+ligand-dependent+interaction+with+TFIIH+and+participation+of+CDK7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DD.%26aulast%3DRiedl%26aufirst%3DT.%26aulast%3DWashbrook%26aufirst%3DE.%26aulast%3DPace%26aufirst%3DP.%2BE.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26aulast%3DEgly%26aufirst%3DJ.%2BM.%26aulast%3DAli%26aufirst%3DS.%26atitle%3DActivation%2520of%2520estrogen%2520receptor%2520alpha%2520by%2520S118%2520phosphorylation%2520involves%2520a%2520ligand-dependent%2520interaction%2520with%2520TFIIH%2520and%2520participation%2520of%2520CDK7%26jtitle%3DMol.%2520Cell%26date%3D2000%26volume%3D6%26spage%3D127%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">McNae, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kontipidis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worrall, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walkinshaw, M. D.</span><span> </span><span class="NLM_article-title">Studying protein−ligand interactions using protein crystallography</span> <span class="citation_source-journal">Crystallogr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1080%2F08893110500078639" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtVWmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=61-71&author=I.+W.+McNaeauthor=D.+Kanauthor=G.+Kontipidisauthor=A.+Pattersonauthor=P.+Taylorauthor=L.+Worrallauthor=M.+D.+Walkinshaw&title=Studying+protein%E2%88%92ligand+interactions+using+protein+crystallography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Studying protein-ligand interactions using protein crystallography</span></div><div class="casAuthors">McNae, Iain W.; Kan, Daphne; Kontopidis, George; Patterson, Alan; Taylor, Paul; Worrall, Liam; Walkinshaw, Malcolm D.</div><div class="citationInfo"><span class="NLM_cas:title">Crystallography Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-71</span>CODEN:
                <span class="NLM_cas:coden">CRRVEN</span>;
        ISSN:<span class="NLM_cas:issn">0889-311X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein X-ray crystallog. is now a relatively high-throughput technique that plays a major role in structure-based drug design programs where the method of soaking small org. ligands into protein crystals is used to confirm or identify binding modes.  In this review, we discuss some exptl. approaches for 'soaking-in' ligands into protein crystals where the major problem is poor soly. of the ligand.  We also provide examples showing how crystal soaking can be used as a technique for establishing ligand binding strength: Kc (the apparent ligand-protein dissocn. const. in the crystal), which for some proteins at least, is found to be very similar to the soln. Kd.  Kinetic effects are also found to be important and the rate at which ligands soak into crystals is shown to vary by orders of magnitude from 10-1 to 107 s depending on the system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIx5SpvuGj67Vg90H21EOLACvtfcHk0liiZ9T6DGyZAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtVWmsrk%253D&md5=ce7b163b0a2fe7047e11c12546e64258</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1080%2F08893110500078639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F08893110500078639%26sid%3Dliteratum%253Aachs%26aulast%3DMcNae%26aufirst%3DI.%2BW.%26aulast%3DKan%26aufirst%3DD.%26aulast%3DKontipidis%26aufirst%3DG.%26aulast%3DPatterson%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DWorrall%26aufirst%3DL.%26aulast%3DWalkinshaw%26aufirst%3DM.%2BD.%26atitle%3DStudying%2520protein%25E2%2588%2592ligand%2520interactions%2520using%2520protein%2520crystallography%26jtitle%3DCrystallogr.%2520Rev.%26date%3D2005%26volume%3D11%26spage%3D61%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Lebedev, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span> </span><span class="NLM_article-title">Model preparation in MOLREP and examples of model improvement using X-ray data</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=33-39&author=A.+A.+Lebedevauthor=A.+A.+Vaginauthor=G.+N.+Murshudov&title=Model+preparation+in+MOLREP+and+examples+of+model+improvement+using+X-ray+data"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26atitle%3DModel%2520preparation%2520in%2520MOLREP%2520and%2520examples%2520of%2520model%2520improvement%2520using%2520X-ray%2520data%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2008%26volume%3D64%26spage%3D33%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Zwart, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamzin, V. S.</span><span> </span><span class="NLM_article-title">Modelling bound ligands in protein crystal structures</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2230</span><span class="NLM_x">–</span> <span class="NLM_lpage">2239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2230-2239&author=P.+H.+Zwartauthor=G.+G.+Langerauthor=V.+S.+Lamzin&title=Modelling+bound+ligands+in+protein+crystal+structures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZwart%26aufirst%3DP.%2BH.%26aulast%3DLanger%26aufirst%3DG.%2BG.%26aulast%3DLamzin%26aufirst%3DV.%2BS.%26atitle%3DModelling%2520bound%2520ligands%2520in%2520protein%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2230%26epage%3D2239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebedev, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potterton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span> </span><span class="NLM_article-title">REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2184</span><span class="NLM_x">–</span> <span class="NLM_lpage">2195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1107%2FS0907444904023510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=15572771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2184-2195&author=A.+A.+Vaginauthor=R.+A.+Steinerauthor=A.+A.+Lebedevauthor=L.+Pottertonauthor=S.+McNicholasauthor=F.+Longauthor=G.+N.+Murshudov&title=REFMAC5+dictionary%3A+organization+of+prior+chemical+knowledge+and+guidelines+for+its+use"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use</span></div><div class="casAuthors">Vagin, Alexei A.; Steiner, Roberto A.; Lebedev, Andrey A.; Potterton, Liz; McNicholas, Stuart; Long, Fei; Murshudov, Garib N.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2184-2195</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">One of the most important aspects of macromol. structure refinement is the use of prior chem. knowledge.  Bond lengths, bond angles and other chem. properties are used in restrained refinement as subsidiary conditions.  This contribution describes the organization and some aspects of the use of the flexible and human/machine-readable dictionary of prior chem. knowledge used by the max.-likelihood macromol.-refinement program REFMAC5.  The dictionary stores information about monomers which represent the constitutive building blocks of biol. macromols. (amino acids, nucleic acids and saccharides) and about numerous org./inorg. compds. commonly found in macromol. crystallog.  It also describes the modifications the building blocks undergo as a result of chem. reactions and the links required for polymer formation.  More than 2000 monomer entries, 100 modification entries and 200 link entries are currently available.  Algorithms and tools for updating and adding new entries to the dictionary have also been developed and are presented here.  In many cases, the REFMAC5 dictionary allows entirely automatic generation of restraints within REFMAC5 refinement runs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRjDd-k3YHGrVg90H21EOLACvtfcHk0lhp9eA5tuAmVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73F&md5=005910422c5fb72fe2434c39b5321bf4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS0907444904023510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904023510%26sid%3Dliteratum%253Aachs%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPotterton%26aufirst%3DL.%26aulast%3DMcNicholas%26aufirst%3DS.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26atitle%3DREFMAC5%2520dictionary%253A%2520organization%2520of%2520prior%2520chemical%2520knowledge%2520and%2520guidelines%2520for%2520its%2520use%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2184%26epage%3D2195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Skehan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storeng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vistica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bokesch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span> </span><span class="NLM_article-title">New colorimetric cytotoxicity assay for anticancer-drug screening</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1093%2Fjnci%2F82.13.1107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=2359136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADyaK3cXltVylsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1990&pages=1107-1112&author=P.+Skehanauthor=R.+Storengauthor=D.+Scudieroauthor=A.+Monksauthor=J.+McMahonauthor=D.+Visticaauthor=J.+T.+Warrenauthor=H.+Bokeschauthor=S.+Kenneyauthor=M.+R.+Boyd&title=New+colorimetric+cytotoxicity+assay+for+anticancer-drug+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">New colorimetric cytotoxicity assay for anticancer-drug screening</span></div><div class="casAuthors">Skehan, Philip; Storeng, Ritsa; Scudiero, Dominic; Monks, Anne; McMahon, James; Vistica, David; Warren, Jonathan T.; Bokesch, Heidi; Kenney, Susan; Boyd, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1107-12</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">A rapid, sensitive, and inexpensive method was developed for measuring the cellular protein content of adherent and suspension cultures in 96-well microtiter plates.  The method is suitable for ordinary lab. purposes and for very large-scale applications, such as the National Cancer Institute's disease-oriented in vitro anticancer-drug discovery screen, which requires the use of several million culture wells per yr.  Cultures fixed with trichloroacetic acid were stained for 30 min with 0.4% (wt/vol) sulforhodamine B (SRB) dissolved in 1% acetic acid.  Unbound dye was removed by four washes with 1% acetic acid, and protein-bound dye was extd. with 10 mM unbuffered Tris base [tris(hydroxymethyl)aminomethane] for detn. of optical d. in a computer-interfaced, 96-well microtiter plate reader.  The SRB assay results were linear with the no. of cells and with values for cellular protein measured by both the Lowry and Bradford assays at densities ranging from sparse subconfluence to multilayered supraconfluence.  The signal-to-noise ratio at 564 nm was approx. 1.5 with 1,000 cells per well.  The sensitivity of the SRB assay compared favorably with sensitivities of several fluorescence assays and was superior to those of both the Lowry and Bradford assays and to those of 20 other visible dyes.  The SRB assay provides a colorimetric end point that is nondestructive, indefinitely stable, and visible to the naked eye.  It provides a sensitive measure of drug-induced cytotoxicity, is useful in quantitating clonogenicity, and is well suited to high-vol., automated drug screening.  SRB fluoresces strongly with laser excitation at 488 nm and can be measured quant. at the single-cell level by static fluorescence cytometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA1MIZ3rkcqLVg90H21EOLACvtfcHk0lhp9eA5tuAmVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXltVylsL8%253D&md5=d7bc1784a1f181842d2999efa7fa870c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F82.13.1107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F82.13.1107%26sid%3Dliteratum%253Aachs%26aulast%3DSkehan%26aufirst%3DP.%26aulast%3DStoreng%26aufirst%3DR.%26aulast%3DScudiero%26aufirst%3DD.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DMcMahon%26aufirst%3DJ.%26aulast%3DVistica%26aufirst%3DD.%26aulast%3DWarren%26aufirst%3DJ.%2BT.%26aulast%3DBokesch%26aufirst%3DH.%26aulast%3DKenney%26aufirst%3DS.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DNew%2520colorimetric%2520cytotoxicity%2520assay%2520for%2520anticancer-drug%2520screening%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1990%26volume%3D82%26spage%3D1107%26epage%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Lopez-Garcia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Periyasamy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kindle, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heery, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buluwela, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamalati, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S.</span><span> </span><span class="NLM_article-title">ZNF366 is an estrogen receptor corepressor that acts through CtBP and histone deacetylases</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">6126</span><span class="NLM_x">–</span> <span class="NLM_lpage">6136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=6126-6136&author=J.+Lopez-Garciaauthor=M.+Periyasamyauthor=R.+S.+Thomasauthor=M.+Christianauthor=M.+Leaoauthor=P.+Jatauthor=K.+B.+Kindleauthor=D.+M.+Heeryauthor=M.+G.+Parkerauthor=L.+Buluwelaauthor=T.+Kamalatiauthor=S.+Ali&title=ZNF366+is+an+estrogen+receptor+corepressor+that+acts+through+CtBP+and+histone+deacetylases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Garcia%26aufirst%3DJ.%26aulast%3DPeriyasamy%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DR.%2BS.%26aulast%3DChristian%26aufirst%3DM.%26aulast%3DLeao%26aufirst%3DM.%26aulast%3DJat%26aufirst%3DP.%26aulast%3DKindle%26aufirst%3DK.%2BB.%26aulast%3DHeery%26aufirst%3DD.%2BM.%26aulast%3DParker%26aufirst%3DM.%2BG.%26aulast%3DBuluwela%26aufirst%3DL.%26aulast%3DKamalati%26aufirst%3DT.%26aulast%3DAli%26aufirst%3DS.%26atitle%3DZNF366%2520is%2520an%2520estrogen%2520receptor%2520corepressor%2520that%2520acts%2520through%2520CtBP%2520and%2520histone%2520deacetylases%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2006%26volume%3D34%26spage%3D6126%26epage%3D6136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balmain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNally, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohas, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchison, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierrepoint, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlatt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straughan, D. W.</span><span> </span><span class="NLM_article-title">UKCCCR guidelines for the welfare of animals in experimental neoplasia</span> <span class="citation_source-journal">Lab. Anim.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1258%2F002367788780746467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=3172698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A280%3ADyaL1M%252Fht1ymtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1988&pages=195-201&author=P.+Workmanauthor=A.+Balmainauthor=J.+A.+Hickmanauthor=N.+J.+McNallyauthor=A.+M.+Rohasauthor=N.+A.+Mitchisonauthor=C.+G.+Pierrepointauthor=R.+Raymondauthor=C.+Rowlattauthor=T.+C.+Stephensauthor=J.+Wallaceauthor=D.+W.+Straughan&title=UKCCCR+guidelines+for+the+welfare+of+animals+in+experimental+neoplasia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">UKCCCR guidelines for the welfare of animals in experimental neoplasia</span></div><div class="casAuthors">Workman P; Balmain A; Hickman J A; McNally N J; Rohas A M; Mitchison N A; Pierrepoint C G; Raymond R; Rowlatt C; Stephens T C</div><div class="citationInfo"><span class="NLM_cas:title">Laboratory animals</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">195-201</span>
        ISSN:<span class="NLM_cas:issn">0023-6772</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSpbCFa3IXp3kcLvDNbOD4DfW6udTcc2eYCsIL8pie23rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M%252Fht1ymtA%253D%253D&md5=632d4a2f5869b721721884546190da34</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1258%2F002367788780746467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1258%252F002367788780746467%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DBalmain%26aufirst%3DA.%26aulast%3DHickman%26aufirst%3DJ.%2BA.%26aulast%3DMcNally%26aufirst%3DN.%2BJ.%26aulast%3DRohas%26aufirst%3DA.%2BM.%26aulast%3DMitchison%26aufirst%3DN.%2BA.%26aulast%3DPierrepoint%26aufirst%3DC.%2BG.%26aulast%3DRaymond%26aufirst%3DR.%26aulast%3DRowlatt%26aufirst%3DC.%26aulast%3DStephens%26aufirst%3DT.%2BC.%26aulast%3DWallace%26aufirst%3DJ.%26aulast%3DStraughan%26aufirst%3DD.%2BW.%26atitle%3DUKCCCR%2520guidelines%2520for%2520the%2520welfare%2520of%2520animals%2520in%2520experimental%2520neoplasia%26jtitle%3DLab.%2520Anim.%26date%3D1988%26volume%3D22%26spage%3D195%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Banker, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. A.</span><span> </span><span class="NLM_article-title">Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">974</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1002%2Fjps.10332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=12712416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1ehsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2003&pages=967-974&author=M.+J.+Bankerauthor=T.+H.+Clarkauthor=J.+A.+Williams&title=Development+and+validation+of+a+96-well+equilibrium+dialysis+apparatus+for+measuring+plasma+protein+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding</span></div><div class="casAuthors">Banker, Michael J.; Clark, Tracey H.; Williams, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">967-974</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A 96-well equil. dialysis block was designed and constructed that is compatible with most std. 96-well format lab. supplies and instruments.  The unique design of the dialysis app. allows one to dispense and aspirate from either or both the sample and dialyzate sides from the top of the app., which is not possible with systems currently on the market.  This feature permits the investigator to analyze a large no. of samples, time points, or replicates in the same expt.  The novel alignment of the dialysis membrane vertically in the well maximizes the surface-to-vol. ratio, eliminates problems assocd. with trapped air pockets, and allows one to add or remove samples independently or all at once.  Furthermore, the design of the app. allows both the sample and dialyzate sides of the dialysis well to be accessible by robotic systems, so assays can be readily automated.  Teflon construction is used to minimize nonspecific binding of test samples to the app.  The device is reusable, easily assembled, and can be shaken in controlled temp. environments to decrease the time required to reach equil. as well as facilitate dissoln. of test compds.  Plasma protein binding values obtained for 10 diverse compds. using std. dialysis equipment and the 96-well dialysis block validates this method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp9qyX_9tHHrVg90H21EOLACvtfcHk0lj5P8JZZV5mFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1ehsrs%253D&md5=0948f0a11373c57be06be9e0d604ad40</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2Fjps.10332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.10332%26sid%3Dliteratum%253Aachs%26aulast%3DBanker%26aufirst%3DM.%2BJ.%26aulast%3DClark%26aufirst%3DT.%2BH.%26aulast%3DWilliams%26aufirst%3DJ.%2BA.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%252096-well%2520equilibrium%2520dialysis%2520apparatus%2520for%2520measuring%2520plasma%2520protein%2520binding%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2003%26volume%3D92%26spage%3D967%26epage%3D974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Gres, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julian, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourrie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meunier, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roques, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulenc, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabre, G.</span><span> </span><span class="NLM_article-title">Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">726</span><span class="NLM_x">–</span> <span class="NLM_lpage">733</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1998&pages=726-733&author=M.+C.+Gresauthor=B.+Julianauthor=M.+Bourrieauthor=V.+Meunierauthor=C.+Roquesauthor=M.+Bergerauthor=X.+Boulencauthor=Y.+Bergerauthor=G.+Fabre&title=Correlation+between+oral+drug+absorption+in+humans%2C+and+apparent+drug+permeability+in+TC-7+cells%2C+a+human+epithelial+intestinal+cell+line%3A+comparison+with+the+parental+Caco-2+cell+line"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGres%26aufirst%3DM.%2BC.%26aulast%3DJulian%26aufirst%3DB.%26aulast%3DBourrie%26aufirst%3DM.%26aulast%3DMeunier%26aufirst%3DV.%26aulast%3DRoques%26aufirst%3DC.%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DBoulenc%26aufirst%3DX.%26aulast%3DBerger%26aufirst%3DY.%26aulast%3DFabre%26aufirst%3DG.%26atitle%3DCorrelation%2520between%2520oral%2520drug%2520absorption%2520in%2520humans%252C%2520and%2520apparent%2520drug%2520permeability%2520in%2520TC-7%2520cells%252C%2520a%2520human%2520epithelial%2520intestinal%2520cell%2520line%253A%2520comparison%2520with%2520the%2520parental%2520Caco-2%2520cell%2520line%26jtitle%3DPharm.%2520Res.%26date%3D1998%26volume%3D15%26spage%3D726%26epage%3D733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Kuhnz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gieschen, H.</span><span> </span><span class="NLM_article-title">Predicting the oral bioavailability of 19-nortestosterone progestins in vivo from their metabolic stability in human liver microsomal preparations in vitro</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1120</span><span class="NLM_x">–</span> <span class="NLM_lpage">1127</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1998&pages=1120-1127&author=W.+Kuhnzauthor=H.+Gieschen&title=Predicting+the+oral+bioavailability+of+19-nortestosterone+progestins+in+vivo+from+their+metabolic+stability+in+human+liver+microsomal+preparations+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuhnz%26aufirst%3DW.%26aulast%3DGieschen%26aufirst%3DH.%26atitle%3DPredicting%2520the%2520oral%2520bioavailability%2520of%252019-nortestosterone%2520progestins%2520in%2520vivo%2520from%2520their%2520metabolic%2520stability%2520in%2520human%2520liver%2520microsomal%2520preparations%2520in%2520vitro%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1998%26volume%3D26%26spage%3D1120%26epage%3D1127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Deliv. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1016%2FS0169-409X%2800%2900129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=11259830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2001&pages=3-26&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-26</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is greater than 500 and the calcd. Log P (CLogP) is greater than 5 (or MlogP >4.15).  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYDqa02g16urVg90H21EOLACvtfcHk0lj5P8JZZV5mFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D&md5=c60bb89da68f051c0ee7ac4c0468a0e4</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2800%2900129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252800%252900129-0%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Deliv.%2520Rev.%26date%3D2001%26volume%3D46%26spage%3D3%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Sarwar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peston, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinnett, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madden, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lykkesfeldt, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shousha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S.</span><span> </span><span class="NLM_article-title">Phosphorylation of ER{alpha} at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ER{alpha} phosphorylation in breast cancer progression</span> <span class="citation_source-journal">Endocr.-Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">851</span><span class="NLM_x">–</span> <span class="NLM_lpage">861</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=851-861&author=N.+Sarwarauthor=J.+S.+Kimauthor=J.+Jiangauthor=D.+Pestonauthor=H.+D.+Sinnettauthor=P.+Maddenauthor=J.+M.+Geeauthor=R.+I.+Nicholsonauthor=A.+E.+Lykkesfeldtauthor=S.+Shoushaauthor=R.+C.+Coombesauthor=S.+Ali&title=Phosphorylation+of+ER%7Balpha%7D+at+serine+118+in+primary+breast+cancer+and+in+tamoxifen-resistant+tumours+is+indicative+of+a+complex+role+for+ER%7Balpha%7D+phosphorylation+in+breast+cancer+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarwar%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DPeston%26aufirst%3DD.%26aulast%3DSinnett%26aufirst%3DH.%2BD.%26aulast%3DMadden%26aufirst%3DP.%26aulast%3DGee%26aufirst%3DJ.%2BM.%26aulast%3DNicholson%26aufirst%3DR.%2BI.%26aulast%3DLykkesfeldt%26aufirst%3DA.%2BE.%26aulast%3DShousha%26aufirst%3DS.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26aulast%3DAli%26aufirst%3DS.%26atitle%3DPhosphorylation%2520of%2520ER%257Balpha%257D%2520at%2520serine%2520118%2520in%2520primary%2520breast%2520cancer%2520and%2520in%2520tamoxifen-resistant%2520tumours%2520is%2520indicative%2520of%2520a%2520complex%2520role%2520for%2520ER%257Balpha%257D%2520phosphorylation%2520in%2520breast%2520cancer%2520progression%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D2006%26volume%3D13%26spage%3D851%26epage%3D861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Liscovitch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravid, D.</span><span> </span><span class="NLM_article-title">A case study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">245</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">352</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm100732t&amp;key=10.1016%2Fj.canlet.2006.01.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm100732t&amp;key=16504380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm100732t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1enuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=245&publication_year=2007&pages=350-352&author=M.+Liscovitchauthor=D.+Ravid&title=A+case+study+in+misidentification+of+cancer+cell+lines%3A+MCF-7%2FAdrR+cells+%28re-designated+NCI%2FADR-RES%29+are+derived+from+OVCAR-8+human+ovarian+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">A case study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells</span></div><div class="casAuthors">Liscovitch, Mordechai; Ravid, Dana</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">245</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">350-352</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Multidrug-resistant MCF-7 breast adenocarcinoma cells (originally named MCF-7/AdrR cells and later re-designated NCI/ADR-RES) have served as an important and widely used research tool during the last two decades.  However, the real identity of these cells has been in doubt since 1998 and has since been debated.  The origin of NCI/ADR-RES cells has now been revealed by SNP and karyotypic analyses, carried out at the Sanger Institute and the NCI, resp.  The results of these analyses, recently posted on the Web, show that NCI/ADR-RES cells are derived from OVCAR-8 ovarian adenocarcinoma cells.  The case of NCI/ADR-RES cells highlights a wide-spread problem of cell line cross-contamination and misidentification.  Fortunately, this is a tractable problem that can be avoided by scrupulous genotyping of cell stocks and adoption of a few simple rules in cell culture practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr51zv6pSfF_bVg90H21EOLACvtfcHk0lg7QruYpBfcxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1enuw%253D%253D&md5=0d460541e164f6fb5b2abaf6bc573b51</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2006.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2006.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DLiscovitch%26aufirst%3DM.%26aulast%3DRavid%26aufirst%3DD.%26atitle%3DA%2520case%2520study%2520in%2520misidentification%2520of%2520cancer%2520cell%2520lines%253A%2520MCF-7%252FAdrR%2520cells%2520%2528re-designated%2520NCI%252FADR-RES%2529%2520are%2520derived%2520from%2520OVCAR-8%2520human%2520ovarian%2520carcinoma%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2007%26volume%3D245%26spage%3D350%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Parratt, M.; Bower, J. F.; Williamson, D.; Cansfield, A.</span><span> </span><span class="NLM_article-title">Pyrazolopyrimidine compounds and their use in medicine</span>. Patent WO2004/087707A1,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+Parratt&author=J.+F.+Bower&author=D.+Williamson&author=A.+Cansfield&title=Pyrazolopyrimidine+compounds+and+their+use+in+medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DParratt%26aufirst%3DM.%26atitle%3DPyrazolopyrimidine%2520compounds%2520and%2520their%2520use%2520in%2520medicine%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2A4L" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2A4L','PDB','2A4L'); return false;">PDB: 2A4L</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1HCK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1HCK','PDB','1HCK'); return false;">PDB: 1HCK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NS9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NS9','PDB','3NS9'); return false;">PDB: 3NS9</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i44"><a href="/doi/suppl/10.1021/jm100732t">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_50486"></div></div></div></div></div><hr /></hr><p class="last">In vitro kinase and cell growth inhibition data, cell cycle profiles, and spectral data for <b>4k</b>, as well as additional synthetic methods. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm100732t/suppl_file/jm100732t_si_001.pdf">jm100732t_si_001.pdf (2.06 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm100732t&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm100732t%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-24" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm100732t" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67995dc85f9a3d9a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
